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1.  INTRODUCTION 
 
1.1  Mitochodrial respiratory chain 
 
The mitochondrial electron transport chain (ETC) is a part of the oxidative phosphorylation 
(OXPHOS)  metabolic  pathway.  Its  components  catalyze  the  transfer  of  electrons  from 
nicotinamide  adenine  dinucleotide  (NADH)  or  succinate  produced  in  catabolic  pathways 
onto molecular oxygen. The key constituents of the pathway (Figure 1.1) include four multi-
subunit protein complexes embedded in the inner mitochondrial membrane (IMM): 
  NADH:ubiquinone oxidoreductase (complex I), 
  succinate:ubiquinone oxidoreductase (complex II), 
  ubiquinol:cytochrome c oxidoreductase (complex III),  
  cytochrome c oxidase (complex IV), 
and the mobile electron carriers 
  ubiquinone (Q),  
  cytochrome c.  
Most electrons enter the ETC through complex I, which oxidizes NADH. The electrons 
travel then over a number of redox centers such as iron-sulfur clusters (in complexes I, II and 
III), hemes (in complexes II, III and IV) and flavins (flavin mononucleotide (FMN) or flavin 
adenine dinucleotide (FAD) in complexes I and  II).  An alternative electron entry side  is 
constituted by the succinate:ubiquinone oxidoreductase or complex II, which is a member of 
both, the ETC and the citric acid cycle. The electron transfer is coupled to a vectorial proton 
translocation across the inner mitochondrial membrane performed by complex I, III and IV. 
The proton translocation creates a chemiosmotic potential, which is utilized by the F1FO-ATP 
synthase (complex V) for the regeneration of ATP from adenosine diphosphate (ADP) [1].  
Mitochondria from different organisms contain up to four alternative dehydrogenases 
[2] and a non-heme alternative oxidase [3;4] in addition to the main components of the ETC.  
 
 
2 
These simple enzymes catalyze the same redox reaction as their multi-subunit counterparts 
complex I and IV, respectively, though they are not able to pump protons.  
A  fraction  of  the  electrons  travelling  through  the  ETC  never  manage  to  reduce 
molecular oxygen to water at complex IV. Instead, about 1% of the electrons escape at the 
level of complexes I and III reducing oxygen incompletely [5;6] thereby yielding reactive 
oxygen species (ROS) such as the superoxide anion (O2
-.). These highly reactive molecules 
play  an  important  role  in  cellular  signaling;  however,  its  excessive  production  leads  to 
oxidative stress and eventually to the cell damage.  
 
 
 
Figure 1.1  Schematic representation of the mitochondrial electron transfer chain 
A representation of the three dimensional structures of respiratory chain complexes I-IV embedded in the IMM 
is shown. Complex I is the only member of the ETC for which only the structure of the hydrophilic part is 
available. Substrates and products of the enzymatic reactions are shown in grey; inhibitors of the enzymes in 
blue.  The  black  arrows  indicate  pathways  of  the  quinone  accepting  electrons  from  complex  I  or  II  and 
delivering them to complex III. Violet arrows show the electron transfer pathways inside of the complexes and 
the solid red arrows indicate sites of the reactive oxygen species production at complexes I and III. Reprinted 
from [7] 
 
The knowledge of three-dimensional structures, catalytic and regulatory properties of 
the respiratory chain complexes are of medical significance, since they are involved in the 
development  of  numerous  human  pathologies  [8;9].  The  detailed  crystal  structures  for 
complex II [10], complex III [11;12] and complex IV [13;14] have already been obtained,       INTRODUCTION 
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whereas the structure of complex V [15] is only partially available. Although complex I was 
first purified from bovine heart mitochondria almost 50 years ago [16], its detailed molecular 
structure is just partially emerging [17], and its mechanism is still elusive.  
In  the  IMM  the  respiratory  chain complexes  are organized  into  larger  assemblies 
called supercomplexes or respirasomes (Figure 1.2A) [18]. General functional advantages of 
respirasomes  are  catalytic  enhancement,  substrate  channelling,  sequestration  of  reactive 
intermediates,  and  structural  stabilization  of  the  individual  complexes.  These 
supercomplexes, formed by complexes I, III and IV, seem to interact with each other to form 
even  larger  supramolecular  structures  (Figure  1.2B)  named  "respiratory  strings"  [19]. 
Likewise, complex V monomers form dimers (Figure 1.2C) and assemble into a network of 
oligomeric ATP synthase that has been shown to stabilise and crucially modulate the tubular 
cristae morphology (Figure 1.2D) [20;21].  
 
 
Figure 1.2  Supramolecular molecular structures of the respiratory chain complexes 
The respiratory supercomplexes composed of complexes I, III and IV (A) seem to interact with each other to 
form  larger  assemblies  called  „respiratory  strings‟  (B).  Adapted  from  [22];  ATPase  synthase  dimers  (C), 
reprinted from [23], oligomerise and take part in the modulation of the mitochondrial cristae morphology (D). 
Reprinted from [24].   
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1.2  NADH:ubiquinone oxidoreductase  
 
Complex I (NADH:ubiquinone oxidoreductase, EC 1.6.5.3), the first electron transferring 
protein  complex  of  the  mitochondrial  respiratory  chain,  is  one  of  the  largest  and  most 
complicated membrane bound protein complexes known [25]. It catalyses the transfer of two 
electrons from NADH to ubiquinone, which is coupled to the translocation of four protons 
across the inner mitochondrial membrane [26]. The redox reaction can be summarized as 
follows: NADH + ubiquinone + 5H
+
Matrix → NAD
+ + ubiquinol + 4H
+
Intermembrane space. 
Almost  all  organisms  possess  complex  I,  however,  in  the  fermenting  yeasts 
Saccharomyces  and  Kluyveromyces  complex  I  is  absent  [27-29]  and  alternative 
mitochondrial  NADH:Q  oxidoreductases  [30]  are  the  only  enzymes  feeding  reducing 
equivalents from NADH into the electron transport chain. Moreover, a number of organisms 
like plants and some protists contain both complex I and alternative dehydrogenase [31;32]. 
Many mutations are known in complex I subunit genes that are associated with heritable 
diseases, including Parkinson‟s disease, Leber‟s hereditary optic neuropathy (LHON) and 
Leigh Syndrome [33;34]. 
Depending on the organism, eukaryotic complex I contains up to 45 subunits as in the 
first  studied  and  still  best  characterised  enzyme  from  bovine  heart  mitochondria  [35], 
resulting  in  a  total  molecular  mass  of  ~  1,000  kDa  [35;36].  Other  eukaryotic  model 
organisms used for complex I studies  include the yeast Y. lipolytica [37], the fungus N. 
crassa [38], the green alga Chlamydomonas reinhardtii  [39], and the plants Arabidopsis 
thaliana and Sativa oryza [40]. A simpler form of the proton-pumping NADH:ubiquinone 
oxidoreductase exhibiting a molecular mass of about 550 kDa exists in bacteria. 14 genes 
organized  in  a  single  nuo  or  nqo  operon
1  [41]  encode  the hydrophilic and hydrophobic 
subunits of bacterial complex I [42] (Table 9.18, appendix). Recently, an additional subunit 
(Nqo15) was shown to co-purify with the bacterial core enzyme from Thermus thermophilus. 
This subunit is not encoded in the same operon and seems to be only present in the closest 
relatives of T. thermophilus [43]. 
Homologues of the bacterial subunits make up the core of mitochondrial complex I 
from  mammals  and  fungi  (Table  9.18,  appendix)  and  are  sufficient  to  perform  all       INTRODUCTION 
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bioenergetic functions. Sequence analysis reveals that these 14 „central‟ subunits fall into two 
categories. Seven subunits ND1-6 and NDL4 are highly hydrophobic and are predicted to 
contain 57 transmembrane helices embedded in the IMM. Except for some plants, algae, and 
protists, they are encoded by the mitochondrial genome in most eukaryotes. The remaining 
seven hydrophilic peptides (75-kDa 51-kDa, 49-kDa, 30-kDa, 24-kDa, TYKY, PSST) are 
nuclear coded and contain binding motifs for all known redox prosthetic groups: NADH, 
flavin  mononucleotide  (FMN)  and  iron-sulfur  clusters.  This  part  of  the  complex  is 
responsible for the dehydrogenase and ubiquinone reduction activity [44]. One FMN is non-
covalently bound to the 51-kDa subunit and is the entry point for electron transfer  from 
NADH via several iron-sulfur clusters [45;46] to ubiquinone. Results from different studies 
suggest the presence of eight to nine iron-sulfur clusters (6-7 [4Fe-4S] and 2 [2Fe-2S]) in 
complex I (Figure 1.3).  
 
 
 
 
Figure 1.3  Schematic representation of a binuclear and a tetranuclear iron-sulfur cluster 
Typically, iron-sulfur clusters are co-ordinated by sulfur atoms from four liganding cysteine residues (yellow). 
Acid-labile sulfur atoms are shown as orange spheres. Iron atoms are shown as red spheres. Figure adapted 
from [47]. 
 
                                                                                                                                                                  
1 nqo for NADH:quinone oxidoreductase and nuo for NADH:ubiquinone oxidoreductase.  
 
 
6 
In the recently released bacterial X-ray structure of the peripheral arm of complex I 
from T. thermophilus (Figure 1.4A) [17] nine clusters designated N1a, N1b, N2, N3, N4, N5, 
N6a, N6b, N7 were present (Figure 1.4B). Similarly, all nine clusters were  identified in 
Escherichia coli complex I [48]. Eukaryotic complex I possesses usually eight iron-sulfur 
clusters, but only six of them N1a, N1b, N2, N3, N4, N5 were detectable in bovine heart 
complex I [49]  and only four clusters N1-N4 in Neurospora crassa [50]. The assignment of 
the EPR signals to particular clusters is still a matter of debate [51;52]. 
       
 
 
 
Figure 1.4 Structure of the hydrophilic domain of complex I from T. thermophilus and 
electron microscopic reconstruction of Y. lipolytica enzyme 
The orientation of the X-ray structure of the peripheral domain from T. thermophilus (A) with respect to the 
membrane arm is a matter of current discussion. In the orientation proposed by [17] (A) the subunit Nqo4 (49-
kDa) reaches the membrane arm and the H1 helix of the PSST subunit extends in the direction of the membrane 
distal  part  of  the  enzyme.  In  this  orientation,  arrangement  of  iron-sulfur  clusters  in  the  peripheral  arm  is 
perpendicular to the mebrane (B) [17]. Nevertheless, increasing amount of evidence favors the orientation of the 
peripheral arm with iron-sulfur clusters arranged more parallel to the mitochondrial membrane [53] and H1 
helix  extending  towards  the  membrane  arm.  Fitting  of  the  bacterial  X-ray  structure  (A)  into  the  3D 
reconstruction of complex I from Y. lipolytica in the orientation proposed by [53] is shown in (C).  
 
The hydrophilic subunits of the peripheral part of the complex stand more or less 
perpendicular on one end of the intrinsic membrane arm and point toward the matrix side in 
mitochondria and to the cytoplasm in bacteria. This orientation results in an L-shaped particle 
[54-58] as revealed by electron microscopy studies from different eukaryotic and prokaryotic 
sources.  A  3D-reconstruction  of  complex  I  from  Y.  lipolytica  [53]  represents  this       INTRODUCTION 
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characteristic complex I shape (Figure 1.4C), here fitted with the atomic structure of the 
hydrophilic part of the bacterial enzyme homologue from T. thermophilus (Figure 1.4A).  
Phylogenetic studies of the central complex I subunits revealed similarity to different 
types of hydrogenases [59;60] and three functional modules of complex I were defined: the N 
module, comprising the electron entry site, the Q module or electron output module and the P 
module, responsible for proton translocation across the inner mitochondrial membrane. The 
N  module comprises  the 75-kDa,  51-kDa  and 24-kDa,  which  are  related  to  the α  and γ 
subunits  of  NAD
+-reducing  hydrogenases  [61].  These  subunits  contain  redox  cofactors, 
which transfer electrons from NADH via FMN to a wire of iron sulfur-clusters [45;46]. The 
Q module is composed of the 49-kDa, 30-kDa, PSST and TYKY subunits and mediates the 
transfer of electrons from the N module, via three further iron-sulfur clusters to ubiquinone. 
The 49-kDa subunit and the PSST subunits display homology to the large and small subunits, 
respectively,  of water-soluble [NiFe] hydrogenases [62;63]. In E. coli, the 30-kDa subunit is 
fused  to the 49-kDa  subunit  [42].  The P  module  is composed of  seven,  mitochondrially 
encoded and membrane-embedded subunits, ND1-ND6 and NDL4. Homology studies have 
shown that subunits ND2/ND4/ND5 are members of a family of proteins also comprising the 
mrp  (multiple  resistance  and pH  adaptation)  type  Na
+/H
+  antiporters  known  for  Bacillus 
subtilis  and other  bacteria  [64;65]. These  antiporters  are  commonly  found  in bacteria.  It 
seems  likely  that  the  ion  translocation  functions  of  the  mrp  proteins  were  retained  by 
homologous complex I subunits embedded in the membrane. Despite of the availability of 
the  bacterial  X-ray  structure  of  the  peripheral  arm  (Figure  1.4A)  [17],  the  topology  of 
membrane arm proton-pumping elements is still for the most part unclear [66]. Thus, the 
mechanism of coupling between electron transport and proton-pumping activity remains still 
elusive. 
 
1.3  Accessory subunits  
Over  the  course of  evolution  the  minimal set  of  14  „central‟  subunits  that  make up  the 
prokaryotic complex I was extended significantly by nuclear coded accessory subunits in 
eukaryotes. The function of accessory subunits is largely unknown, however certain insights  
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to the role of the subunits and their assignment to different parts of complex I has been 
achieved by analysing subcomplexes (Figure 1.5).  
Purified  bovine  complex  I  was  shown  to  dissociate  upon  treatment  with  non-
denaturing detergents and chaotropes [67;68]. Using the detergent lauryldimethylamine oxide 
(LDAO), followed by ion-exchange chromatography, the bovine complex I was resolved into 
subcomplexes Iα and Iβ (Figure 1.5) [67;69]. Subcomplex I represents the major portion of 
the membrane part of complex I. Upon prolonged incubation in LDAO, fraction Iα releases 
the predominantly hydrophilic subcomplex Iλ [70], which together with Iis known as the 
hydrophobic  protein  (HP)  [71].  The  subcomplex  Iλ  can  be  further  subdivided  into  the 
soluble, catalytically active flavoprotein subcomplex (FP) (Figure 1.5) comprising the FMN 
molecule, the NADH binding site, one [2Fe-2S] and one [4Fe-4S] cluster [72-74]. Also, a 
subcomplex referred to as the iron-protein (IP) composed of the 75-kDa, 49-kDa, 30-kDa, 
TYKY and PSST subunits was isolated [75].  
 
Figure 1.5 Subcomplexes and subunits of bovine heart complex I 
 
Flavoprotein (FP) is a component of Iλ (light yellow), and Iα essentially is a combination of Iλ and Iγ (yellow). 
Iβ (blue gray) forms the major part of the membrane integral arm of complex I. Central subunits are in blue, 
accessory subunits found in all eukaryotic complexes are in red, and Metazoa specific subunits are in purple. 
Subunits marked with an asterisk are predicted to contain a single transmembrane domain [35]. Reprinted from 
[25].       INTRODUCTION 
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Analysis of the subcomplexes by gel electrophoresis, Edman degradation and mass 
spectrometry [36] provided further information about the subunits. Some of them exhibit 
remarkable sequence similarities to other proteins. Depending on the organism the number of 
accessory subunits can be as high as 31 in bovine complex I (Figure 1.5) [35]; 18 accessory 
subints  have  clear  orthologs  in  mitochondria  from  all  other  lineages  studied.  With  the 
exception of the fermenting yeast S. cerevisiae, which lacks not only the mitochondrial but 
also all nuclear genes of complex I [27] with the notable exception of the orthologue of 
mitochondrial acyl-carrier protein (SDAP). The type and number of the remaining up to 13 
accessory subunits varies among species. The plant-specific subunits include isoforms of γ-
type  carbonic  anhydrase  [76].  These  proteins  form  a  distinct  domain  attached  to  the 
membrane arm, which confers an additional catalytic function to complex I [77]. 
Four accessory subunits contain several conserved cysteines (Table 9.18, appendix), 
thus it was proposed that these proteins may be involved in iron-sulfur cluster assembly 
[39;78]. Moreover, the NMR structure of the human subunit B8 revealed a Fe2S2 ferredoxin 
fold similar to the one found in thioredoxin [79]. Subunit B14.7 exhibits some homology to 
components of the translocase of the inner membrane [69;80] and is therefore considered a 
member  of  the  TIM17/22  family  [69].  cAMP-dependent  phosphorylation  of  several 
accessory  subunits  including  ESSS,  MWFE  [81],  42-kDa  subunit  [82]  and  other  post-
translational  modifications  of  complex  I  were  observed.  The  42-kDa  subunit  has  some 
homology to bacterial deoxyribonucleotide kinase [83]. Subunit B16.6 [84] in mammals is 
identical  to  GRIM-19  (gene  associated  with  retinoid-interferon  induced  mortality),  an 
apoptosis-inducing  factor  [85;86].  GRIM-19  knockout  mice  are  deficient  for  complex  I 
assembly [87], but it remains unclear whether the presence of this protein in complex I is 
directly related to its proapoptotic function. It should be noted that subunit B16.6, but not its 
characteristic “death domain” of GRIM-19, is also conserved in fungi. Subunit B17.2 was 
first identified as DAP13 (a differentiation-associated protein) by an expression screen in 
proliferating  human  erythroid  cells  [88],  but  the  link  to  complex  I  function  is  unclear. 
Subunit B17.2 is one of three accessory (Table 9.18, appendix) and two central complex I 
subunits (49 kDa and TYKY) that form tyrosine nitrates when mitochondria are incubated 
with  peroxynitrite  [89].  NADPH,  which  does  not  participate  in  the  redox  chemistry  of  
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complex I is tightly bound as a cofactor to the 39-kDa subunit [90;91]. The sequence of this 
protein  exhibits  homologies  to  the  family  of  short-chain  dehydrogenases  and  contains  a 
conserved  NADPH-binding  motif  [64;92].  Some  insight into  functional  characteristics of 
several accessory subunits has been obtained, but the significance of most of these findings is 
still unclear.  
 
1.4  Biogenesis of complex I 
    
The eukaryotic complex I biogenesis is a complicated process, which requires a coordinated 
expression of nuclear and mitochondrial genomes. Nuclear-coded subunits destined for the 
mitochondria are synthesized in the cytosol and are directed to the matrix by the N-terminal 
presequence,  which  is  subsequently  cleaved  off  [93].  As  for  other  respiratory  chain 
complexes,  it  has  been  speculated  that  several  accessory  subunits  are  involved  in 
organization of complex I assembly. This process has been the subject of several studies 
carried out on eukaryotic organisms like N. crassa and the green algae C. reinhardtii [94-96]. 
In N. crassa it has been shown that the peripheral arm and the membrane arm are formed 
independently [97]. Mutants lacking one of the nuclear encoded subunits of the peripheral 
arm were unable to assemble the hydrophilic arm but accumulated the membrane part of the 
enzyme. The absence of only the acyl carrier protein of complex I affected assembly of the 
membrane  arm  [98].  Similarly,  the  absence  of  mitochondrially  encoded  subunits  of  the 
membrane part did not prevent assembly of the hydrophilic arm. Both parts of the enzyme 
were shown to be assembly intermediates.  In N. crassa the 49-kDa, 30-kDa, TYKY and 
PSST subunits are essential for association of the hydrophilic part [99]. For assembly of the 
membrane arm, subunits ND1-ND4, ND4L and ND6 are required and, interestingly, ND5 is 
not [99].  
In  bovine  complex  I,  14  subunits  are  classified  as  single  transmembrane  domain 
(STMD) proteins (Table 9.18, appendix). By readily inserting into the mitochondrial inner 
membrane,  these  proteins  could  promote  and  organize  assembly  of  the  mitochondrially 
encoded subunits by interacting with their highly hydrophobic transmembrane segments and 
then remain attached to the complex [37]. It is known that the hydrophobic arm is formed by 
association  of  two  assembly  intermediates  which  contain  complex  I-specific  assembly       INTRODUCTION 
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factors, called CIA30 and CIA84. These proteins are not components of mature complex I, 
but are essential for assembly of the membrane arm in N. crassa [100]. In human cells only a 
homolog of CIA30 could be found [101], but also another possible complex I chaperone, 
namely prohibitin, was identified [102]. 
Several  findings  suggest  distinct  assembly  pathways  of  complex  I  in  different 
organisms.  In N.  crassa,  the  AQDQ  homologue  is not essential  for  complex  I  assembly 
[103], whereas in human cells, mutations in the gene encoding this protein (NDUFS4) did 
affect complex I assembly [104]. It may be speculated that the biogenesis of complex I in 
different  species  occurs  in  different  ways  and  may  depend  on  its  specific  subunit 
composition. Despite of some progress made in complex I biogenesis studies, the picture 
emerging is still rather incomplete and not yet consistent. 
 
1.5  Complex I from Yarrowia lipolytica 
 
Y. lipolytica is a greatly advantageous model system for the structural and functional analysis 
of mitochondrial complex I [3]. The respiratory chain of this fast growing, non-pathogenic, 
obligate  aerobic Ascomycetes  yeast  [105;106]  is  more  similar  to  the  respiratory  chain  in 
mammals than to that in fermentative yeasts like S. cerevisiae. In contrast to S. cerevisiae 
that  does  not  contain  complex  I,  Y.  lipolytica  features  a  permanently  high  content  of 
mitochondria with constitutive expression of stable complex I. The completely sequenced 
genome of Y. lipolytica and a comprehensive set of well-developed genetic tools [3] made it 
possible to efficiently create mutations in complex I subunit genes. The generation of an 
internal version of the alternative dehydrogenase (NDH2i) [107-109] allowed for the survival 
of complex I deletion strains.  
So far, 14 central and 26 accessory subunits have been identified in Y. lipolytica  
complex I (Figure 1.6), (Table 9.18, appendix), adding up a total mass of about 950 kDa 
[37;110]. All redox prosthetic groups NADH, FMN and eight iron-sulfur clusters (6 [4Fe-4S] 
and 2 [2Fe-2S]) are present, although only five, N1-N5 can be detected by EPR spectroscopy 
[58;111]. Three accessory subunits exhibit similarities to enzymes known from fatty acid 
metabolism and carry cofactors not involved in complex I electron transfer activity. The 39-
kDa  subunit  possesses  a  tightly  bound  NADPH  cofactor  proposed  to  be  involved  in  
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stabilization of the multiprotein complex [91]. Moreover, Y. lipolytica complex I contains 
two  pantetheine-4‟phosphate  cofactors  bound  to  two  different  mitochondrial  acyl  carrier 
proteins (ACPMs). 
 
 
 
Figure 1.6  The dSDS-PAGE of purified complex I from Y. lipolytica  
Silver-stained doubled sodium dodecylsulfate-polyacrylamide gel electrophoresis (dSDS-PAGE) of a complex I 
crystal. The seven central, nuclear-coded subunits are labelled in black using bovine nomenclature and five of 
the  seven  central,  mitochondrially  coded  subunits  in  red.  Spots  that  could  be  assigned  to  the  individual 
accessory subunits by mass spectrometry are labelled in green using the Y. lipolytica nomenclature. 
1.6  Acyl carrier proteins 
 
Acyl carrier proteins (ACPs) are small (~10 kDa) acidic proteins that play a central role in 
fatty  acid  synthesis  (FAS)  (Figure  1.7).  These  abundant  proteins  are  essential  cofactors 
shuttling fatty acid chain intermediates along components of the FAS pathway. More than       INTRODUCTION 
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300  different  ACP  structures  are  available  in  the  Protein  Data  Bank,  of  which  the  best 
characterized remains the Escherichia coli ACP [112]. ACPs are composed of a common 
four α-helical bundle with a right-handed twist and a long structured loop connecting helices 
1 and (Figure 1.7A). 
   The apo-ACP is inactive and is post-translationally converted to an active holo form 
by holo-(ACP) synthase (AcpS) that transfers the pantetheine-4´-phosphate (PP) group from 
coenzyme A (CoA) to a highly conserved serine residue situated at the beginning of helix α2 
[113] (Figure 1.7A).  This group is attached  to ACP through a phosphodiester bond  and 
serves  as  a  platform  for  sulfhydryl  bound  acyl  intermediates  during  fatty  acid  synthesis 
(Figure 1.8). NMR studies showed that a PP moiety lacking the acyl chain does not interact 
with the protein and is exposed to the solvent [114;115]. As soon as poorly water-soluble 
acyl  chain  is  anchored  to  the  PP  cofactor,  the  acyl  rest  is  accommodated  in  a  plastic, 
hydrophobic  cleft  located  in  the  vicinity  of  phosphopantethylated  serine  and  flanked  by 
helices α2 and α3 (Figure 1.7C). The reactive part of the growing fatty acyl chain including 
the thioester bond and groups at positions 1 to 3 is shielded by the ACP protein moiety. Since 
exposed fatty acids can be recognised by enzymes not belonging to the  FAS and can be 
diverted  for  instance  to  fatty  acid  degradation  (  oxidation)  or  regulatory  signalling 
pathways, clearly protection is required for efficient progress of the fatty acid biosynthesis 
[116]. 
ACPs  possess  well  conserved  amino  acid  sequences  (Table  1.1,  Figure  9.4,  appendix), 
especially in the vicinity of the PP-binding serine, as well as a highly conserved cluster of 
negatively charged residues on helix α2 (Figure 1.7B). The so called „universal recognition 
helix‟ is thought to be responsible for specific interactions with other FAS enzymes [117-
122], which induces conformational changes in the ACP structure. Consequently, a protected 
fatty acid is released to the active site of a partner enzyme (Figure 1.7D) and finally, the 
modified substrate is reburied in the hydrophobic fold of the ACP. An interaction of E. coli 
ACP with the FASII enoyl reductase (Fab I) was captured in a 3D x-ray crystallographic 
structure [112]. 
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See next page for description. 
                                                    
2 no significant similarity found. 
 
Species, enzyme, NCBI accession 
Y. lipolytica ACPM1  Y. lipolytica ACPM2 
 
Subcellular location  Similarity 
(%) 
Identity
 
(%) 
Similarity
 
(%) 
Identity 
(%) 
           
Y. lipolytica ACPM1 (Q6c926)  (100)  (100)  81  63  Complex I 
H. influenzae ACP (Q4qp33)  82  58  n.a
2  n.a  Cytoplasm 
Y. lipolytica ACPM2 (Q6c7x2)  81  63  (100)  (100)  Complex I 
S. pombe ACP1 (Q10217)  80  68  66  48  Complex I 
E. coli ACP (P0a6a8)  80  58  65  47  Cytoplasm 
H. pylori ACP (Q1ctw7)  79  54  n.a.  n.a.  Cytoplasm 
A. thaliana mtACP2 (O80800)  77  50  79  48  Matrix [123] 
T. guttata ACP (B5G0K6)  77  44  70  43  Complex I 
N. crassa ACPM (P11943)  76  64  68  53  Complex I 
A. thaliana mtACP1 (P53665)  75  55  60  39  Matrix [123], 
Complex I 
C. reinhardtii ACP1 (132151)  75  55  n.a.  n.a.  Mitochondria 
T. thermophilus ACP (Q5SL79)  72  46  n.a.  n.a.  Cytoplasm 
S. cerevisiae ACP1 (P32463)  70  52  69  43  Cytoplasm 
S. salar ACPM (B5RI61)  70  46  55  34  Complex I 
H. sapiens NDUFAB1   69  42  60  36  Complex I 
A. thaliana mtACP3 (Q9fgj4)  68  45  n.a  n.a  Mitochondria 
O. sativa ACP (03g0352800)  64  47  n.a.  n.a.  Mitochondria 
M. musculus ACPM (Q9cr21)  64  41  72  44  Complex I 
B. taurus SDAP (P52505)  64  41  59  39  Complex I, Matrix 
[124] 
D. discoideum AB1 (Q54e22)  62  40  61  36  Complex I 
D. melanogaster ACPM (Q94519)  n.a.  n.a.  69  43  Complex I 
M. capsulatus ACP (Q606l6)  n.a.  n.a.  67  52  Cytoplasm 
P. troglodytes ACP (Q0mqc3)  n.a.  n.a.  60  36  Complex I 
G. gorilla ACP (Q0mqc2)  n.a.  n.a.  60  36  Complex I 
P. abelii ACP (Q0mqc1)  n.a.  n.a.  60  36  Complex I       INTRODUCTION 
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Table 1.1. Similarity and identity scores for pairwise comparisons between Y. lipolytica 
ACPM1 or ACPM2 and ACP from other organisms 
(previous page) The alignments were created using the GAP programme from the HUSAR (genius.embnet.dkfz 
-heidelberg.de) program package in standard mode. The probability of mitochondrial import was calculated 
using MitoProt II software (http://ihg.gsf.de/ihg/mitoprot.html).  
 
 
 
 
 
Figure 1.7  The acyl carrier protein structure 
(A) The ribbon diagram of the rat FAS ACP domain (2PNG), colored blue to red, corresponding to N to C 
termini  [117;125]. The  post-translationally  modified  serine  residue  on helix  2 is  shown;  (B)  The  surface 
electrostatic potential colored from red (negative) to blue (positive). Red-colored area running vertically in the 
structure comprise the universal „recognition helix‟; (C) The x-ray crystallographic structure of ACP-decanoyl 
thioester  buried  in  the  hydrophobic  pocket.  The  pantetheine-4‟-phosphate  moiety  is  shown  in  red  and  the 
decanoyl moiety in green; (A, B, C) Adapted from [126]; (D) The conformation adopted by the butyryl-ACP 
after delivering the substrate into the active site of a partner enzyme. The phosphopantetheine-binding serine-36 
(E. coli nomenclature) and the thioester bond is shown in orange. Adapted from [112].  
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Figure 1.8  Structural formula for the pantetheine-4´-phosphate-ACP 
The  pantetheine-4´-phosphate  (PP)  group  is  composed  of  the  pantoic  acid,  -alanine  and  -
mercaptoethylamine. The PP is covalently bound from the side of pantoic acid to the conserved serine residue 
of the ACP protein over the phosphodiester bond (highlighted in blue) and on the side of -mercaptoethylamine 
to the acyl chain over the thioester bond (highlighted in yellow). The alkyl group of the acyl chain is denoted 
with –(CH2)n-CH3 and is highlighted in green. Adapted from [116]. 
 
 
1.6.1  Fatty acid synthesis 
Fatty acid synthesis is a central metabolic pathway that entails the iterative elongation of 
fatty  acid  chains  through  a  set  of  chemical  reactions  conserved  in  all  kingdoms  of  life 
(Figure 1.9). Despite the conserved reaction pathway, where ACP plays a central role, the 
molecular architectures of FAS systems differ considerably. Whereas in most plants, bacteria 
and organelles of bacterial origin (plant chloroplasts and mitochondria) synthesis is carried 
out by sets of individual enzymes known as the FAS type II [127-129], eukaryotes have 
evolved large, architecturally diverse, multifunctional synthases referred to as FAS type I 
[130;131]. The FAS type I complex is present in the cytosol of eukaryotes [132;133] and is 
composed of one or two giant polypeptides [134] containing all necessary enzymes for fatty 
acid synthesis (Figure 1.9).  In this type of FAS the ACP-like domain is bound to other 
enzymes by means of two flexible protein linkers (Figure 1.10B). All enzymes of FAS are 
nuclear coded, with the exception of two ACPs from Cryptomonas algae and a -Keto-Acyl-
ACP-synthase from red algae, which are encoded by the plastidal genome [135;136].       INTRODUCTION 
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Figure 1.9  Reaction sequence in fatty acid synthesis  
All catalytic domains necessary for de novo fatty acid synthesis are found on one multidomain polypeptide 
chains in mammals or on twoinfungi. FAS involves the transfer of activated acetyl and malonyl substrates 
from coenzyme A (CoA) to the pantetheine-4‟-phosphate prosthetic group of acyl carrier protein (ACP) via 
acetyl transferase (AT) and malonyl/palmitoyl transferase (MPT). Ketoacyl synthase (KS) condenses them by 
malonyl decarboxylation to acetoacetyl-ACP, which is further modified at the -carbon position by ketoacyl 
reductase (KR), dehydratase (DH), and enoyl reductase (ER) to yield butyryl-ACP. These reactions are repeated 
six  times,  resulting in  the  sequential  incorporation  of  seven  two-carbon  units.  In  fungi,  the  palmitoyl  end 
product is transferred back from ACP to CoA by MPT [137], whereas in the mammalian system, the fatty acid 
is released from ACP by a thioesterase [131]. 
 
The  fungal  and  mammalian  FAS,  although  both  are  classified  as  type  I  are 
structurally  highly  diverse.  Fungal  FAS  is  a  huge,  barrel-shaped,  2.6-megadalton  66 
heterododecameric  complex  (Figure  1.10A)  [138]  with  two  reaction  chambers,  each 
containing three full sets of active sites (Figure 1.10B). In contrast, mammalian fatty acid 
synthase is a 540 kDa x-shaped 2 homodimer containing a full set of catalytic sites present 
in  each  of  two  semicircular  reaction  chambers  on  both  sides  of  the  molecule  [131;139] 
(Figure 1.10C).   
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Figure 1.10  Structure of type I fatty acid synthase complexes  
(A) Overall structure of fungal FAS I contain six complete sets of active sites distributed on 6 and 6 chains: 
KR (yellow), KS (orange), ER (dark green), AT (magenta), DH (light green), PTT (red). Reprinted from [138]; 
(B) Cross section of a reaction chamber of the fungal FAS I complex. ACP (cyan) guided by elastic protein 
linkers (yellow) is channelled into circular path, which increases the concentration of the ACP in the area where 
active  sites  (red)  are  distributed.  Reprinted  from  [140];  (C)  Homodimer  structure  of  mammalian  FAS  I 
complex. White stars indicate the suggested attachment regions for ACP and thioesterase (TE). Reprinted from 
[139]; 
 
 
FAS I is usually considered to be a more efficient biosynthetic machine because the 
enzymatic activities are fused into a single polypeptide template and the intermediates do not 
diffuse away from the complex. However, FAS I can only synthesize a narrow spectrum of 
fatty acids, predominantly palmitate, destined for membrane
 biogenesis and energy storage 
[130].  In  contrast,  FAS  II  is  capable  of  producing  a  diversity  of  products  for  cellular 
metabolism. Not only different chain lengths are produced, but also unsaturated fatty acids, 
iso- and anteisobranched-chain fatty acids, and hydroxyl fatty acids. This enormous diversity 
of products is possible because the ACP intermediates in the pathway are diffusible entities 
that can be diverted into other biosynthetic pathways [128]. 
       INTRODUCTION 
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1.6.2  Significance of ACPs in biosynthetic pathways other than FAS 
 
In  addition  to  fatty  acid synthesis,  ACPs  are  also  involved  in many other  reactions  that 
require  acyl  transfer  steps  such  as  synthesis  of  polyketide  [141]  and  peptide  antibiotics 
[142;143], biotin precursor [144], membrane-derived oligosaccharides [145], acyl transfer to 
glycerol-3-phosphate  and  monoacylglycerol-3-phosphate  [146],  acylation  of  toxins  [147]. 
ACPs also function as essential cofactor in the lipoylation of pyruvate and -ketoglutarate 
dehydrogenase complexes [148].  
Moreover, ACP from Mycobacterium tuberculosis (Figure 1.11A) is able to produce 
mycolic  acids  that  are  extremely  long-chain  (C70  -  C90)  -alkyl,  -hydroxy  fatty  acids 
[149](Figure  1.11B).  This  bacterium  has  developed  an  ACP  with  a  unique  C-terminal 
extension consisting of more than 50% of hydrophobic residues, which can fold and guide 
very long-chain acyl intermediates during biosynthesis [149].  
 
   
 
Figure 1.11  Superimposed NMR structures of ACP from Mycobacterium tuberculosis 
(A)  M.  tuberculosis  ACP  shuttles  very  long-chain hydrophobic  substrates,  which are  stabilised  during  the 
synthesis and transport by an unfolded C-terminal protein extension (grey). M. tuberculosis possesses such an 
extension in addition to the typical ACP four-helix core structure (blue and green). Adapted from [128]; (B) An 
example  of  a  long-chain  -mycolic  acid  -  a  structural  component  of  the  cell  wall  of  the  bacterium  M. 
tuberculosis. Adapted from [149]. 
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1.6.3  Mitochondrial acyl carrier proteins 
 
One or several ACPs of the bacterial FAS type II have been found in mitochondria of several 
species,  including  N.  crassa  [150;151],  bovine heart  [152]  and  A.  thaliana  [153].  These 
proteins are denoted ACPM for “Acyl Carrier Protein, Mitochondrial”. Mitochondria of N. 
crassa were found to contain a protein which was labelled with [
14C] pantothenic acid and 
carried an acyl group [150]. Evidence for a covalently attached pantetheine-4´-phosphate in 
bovine  ACPM  [152]  was  obtained  by  electrospray  mass  spectrometry,  before  and  after 
incubation  of  the  protein  at  alkaline  pH  conditions.  So  far,  only  two  ACPM  structures, 
structurally highly related to their bacterial counterparts are available: The human structure 
solved by NMR [154] (Figure 1.12A) and a structure from parasitic protozoan Toxoplasma 
gondii solved by x-ray crystallography [155] (Figure 1.12B). 
 
 
Figure 1.12  Structures of the mitochondrial acyl carrier proteins 
Mitochondrial ACPs are highly related to the known bacterial structures. (A) NMR structure of human ACPM 
colored blue to red, corresponding to N to C termini [154]. This figure was prepared using the PDB Protein 
Workshop 3.4 software [156]; (B) An x-ray structure of the apo-ACPM from Toxoplasma gondii (blue) by 
[155] superimposed with bacterial apo-ACP x-ray structure of E. coli (red) [157]. T. gondii does not contain the 
highly conserved pantetheine-4‟phosphate-binding serine residue, which is located at the beginning of the helix 
2 in most organisms including E. coli (green). Instead, T. gondii ACPM possesses two directly neighboring 
serines (cyan) situated on the loop connecting helixes 1 and 2. Structures were superimposed using CCP4 
Molecular Graphics software [158]. 
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1.6.4  Mitochondrial fatty acid synthesis 
 
Following discovery and identification of ACPMs, further studies showed that mitochondria 
contain all necessary enzymes for fatty acid biosynthesis and that they are able to synthesize 
short-chain fatty acids [159;160] (9.4.4, appendix). Yeast deletion mutants lacking one of the 
mitochondrial  FAS  components:  ACPM,  -Ketoacyl-ACP  synthase  or  mitochondrial  -
Ketoacyl-ACP  reductase  develop  a  pleiotropic  respiratory  deficient  phonotype.  These 
mutants are unable to grow on non-fermentable carbon sources, such as glycerol or lactate 
and  switch  from  respiration  to  fermentation  [98;161].  An  explanation  was  provided    by 
postulating that ACPM is involved in the synthesis of octanoic acid as a precursor for lipoic 
acid synthesis (Figure 1.13) in pea [162], A. thaliana [163],  N. crassa  [164;165] and S. 
cerevisiae  [166].  Lipoic  acid is  an  important  sulfur  containing  prosthetic  group of  some 
mitochondrial  enzymes  such  as  the  pyruvate  dehydrogenase  (PDH)  and  -ketoglutarate 
dehydrogenase (KGDH) complexes [148;167].  
 
 
 
Figure 1.13  Reaction sequence of lipoic acid synthesis in mitochondria 
The ACPM was postulated to be involved in the synthesis of octanoic acid, which is further modified by lipoyl 
synthase (lipA) by inserting sulfur atoms at unactivated carbons at position 6 and 8 in the lipoic acid synthesis. 
Subsequently,  the  lipB  and  lplA  lipoyl  ligases  transfer  lipoyl  groups  to  the  E2  subunits  of  the  pyruvate 
dehydrogenase  (PDH)  and  -ketoglutarate  dehydrogenase  (KGDH)  complexes  [168;169].  The  scheme  is 
adapted from a model proposed for the endogenous lipoic acid biosynthesis pathways operating in E. coli [170]. 
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Moreover,  there  is  evidence  for  synthesis  of  longer  fatty  acids  in  mitochondria 
[162;163]. It was speculated that this activity plays a vital role, most likely for repair of 
mitochondrial lipids [159]. 
Recently, two distinct links between mitochondrial FAS and RNA processing have 
been discovered in vertebrates and yeast, respectively. In vertebrates, the mitochondrial 3-
hydroxyacyl-ACP dehydratase and the RPP14 subunit of RNase P are encoded by the same 
bicistronic  transcript  in  an  evolutionarily  conserved  arrangement  that  is  unusual  for 
eukaryotes  [171].  In  yeast,  defects  in  mitochondrial  FAS  result  in  inefficient  RNase  P 
cleavage in the organelle [172]. Hypothetically, the intersection of mitochondrial FAS and 
RNA  processing  has  been  maintained  throughout  evolution  as  a  means  to  regulate 
mitochondrial function relative to the nutritional state of the cell [173].  
 
1.6.5  Mitochondrial acyl carrier protein as complex I subunit 
 
Several groups demonstrated  that mitochondrial ACP is tightly associated with complex I in 
some  species  [152;174],  whereas  in  others,  it  is  found  as  a  free,  soluble  protein  [123]. 
Furthermore,  mitochondrial  ACP  appears  to  be  essential  for  structural  and  functional 
integrity of complex I [175]. The number of mitochondrial acyl carrier proteins in eucaryotes 
ranges from one to three. Typically however two isoforms are found [175].  
In N. crassa, one ACPM has been found that is a subunit of complex I [151]. Its disruption 
results in a defect in assembly of the peripheral arm and improper assembly of the membrane 
part, but no effects on complexes III or IV were observed [98]. The lysophospholipid content 
of mitochondrial membranes was increased. In contrast, the yeast S. cerevisiae lacks complex 
I and its ACPM is located in the mitochondrial matrix. In this yeast, deletion of ACPM leads 
to loss of lipoic acid synthesis and eventually to a pleiotropic respiratory deficient phenotype 
[98].  
Similarly, depletion of ACPM by RNAi in Trypanosoma brucei and in human cell 
lines  lead  to  defect  in  mitochondrial  fatty  acid  and  lipoic  acid  synthesis  [176],  which 
consequently caused reduction of activity of PDH and KGDH complexes. Concomitantly, the 
ACPM depletion lead to a drastic decrease in complex I activity and membrane potential, as       INTRODUCTION 
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well as to changes in mitochondrial morphology  [4]. Furthermore, decreased amounts of 
phosphatidylinositol and phosphatidylethanolamine were reported.   
Of  the  ACPM  from  bovine  heart  mitochondria  identified  originally  as  complex  I 
subunit SDAP [152] only a small fraction is associated with complex I. Most of the ACPM is 
found as a soluble (matrix) protein and is therefore available to carry the intermediates of 
type II fatty acid synthesis [124]. In A. thaliana, which expresses three mitochondrial ACPs 
[123], no significant amount of ACPM is found in complex I as determined by BN-PAGE, 
instead, as in bovine mitochondria, the proteins appear to exist predominantly as soluble 
matrix proteins.   
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1.7  Thiosulfate sulfurtransferase (rhodanese)  
 
Sulfurtransferases are ubiquitous enzymes found in all living organisms, from bacteria to 
man [177]. In mammals, two closely related enzymes are present, namely thiosulfate:cyanide 
sulfurtransferase  (TST,  EC  2.8.1.1),  also  referred  to  as  rhodanese,  and  3-
mercaptopyruvate:cyanide  sulfurtransferase  (MST,  EC  2.8.1.2).  Both  are  located 
predominantly in mitochondria [178]. In vitro, thiosulfate sulfurtransferase (TST) catalyses 
the transfer of a sulfane sulfur atom from thiosulfate to cyanide yielding thiocyanate and 
sulfite (Figure 1.14). 
 
 
 
 
Figure 1.14  Scheme representing the sulfur-transfer reaction catalyzed by rhodanese 
The  thiosulfate  sulfurtransferase  (TST)  catalyses  the  transfer  of  a  sulfane  sulfur  atom  from  thiosulfate  to 
cyanide yielding thiocyanate and sulfite. The catalysis occurs via a double displacement mechanism involving 
the transient formation of a persulfide-containing intermediate (Rhod-S), in which the transferring sulfur is 
bound to the invariant catalytic cystein residue. Reprinted from [177]. 
 
 
 3-Mercaptopyruvate sulfurtransferase (MST) is able to catalyse the same reaction but 
shows higher affinity for 3-mercaptopyruvate as sulfur donor [179]. Substrate specificities 
seem to correlate with characteristic active site loop motifs: the five amino acids immediately 
downstream of the active site cysteine comprise one or two positively charged residues in 
TSTs, but not in MSTs [177]. Sulfur transfer occurs by a double displacement mechanism 
that involves formation of a persulfide containing intermediate with an invariant catalytic 
cysteine residue [177]. 
X-ray structures have been solved for TST from bovine liver [180] and Azotobacter 
vinelandii (Figure 1.15) [181]. Comparative studies have revealed a large superfamily that       INTRODUCTION 
             
25 
includes proteins with a single rhodanese domain (e.g., many bacterial and plant enzymes), 
proteins with tandem repeats of rhodanese domains where only the C-terminal domain is 
catalytically active (e.g. A. vinelandii and mammalian TST and MST) and proteins in which 
a rhodanese domain, typically lacking the active site cysteine, is fused to other domains (e.g., 
the dual specific phosphatase Cdc25) [177] (Figure 9.6 and Figure 9.7, appendix). While it is 
generally  assumed  that  tandem  domain  repeat  enzymes  make  the  most  significant 
contribution to cellular sulfurtransferase activity, it has been demonstrated that GlpE from E. 
coli, a  representative of the single domain enzymes, is active in vitro [182;183]. Multiple 
copies of sulfurtransferase are found in the genome of some archaebacteria, eubacteria, plants 
and vertebrates, including mammals and birds. Only a subset of them is predicted to be 
targeted to mitochondria using the MitoProtII [184] algorithm (Table 3.3, results). 
 
 
Figure 1.15 Overall structure of A. vinelandii rhodanese 
Ribbon representation of RhdA. The N- and C-terminal domains (brown and green, respectively), the linker 
peptide (blue). The secondary structure elements of each domain are labelled with letters following the scheme 
proposed for bovine rhodanese [180]. A single quote indicates elements of the C-terminal domains. The active-
site loop is shown in red; the catalytic residue, Cys230, is represented in ball and stick. The drawings were 
prepared with the programs MOLSCRIPT [185] and Raster3D [186]. Reprinted from [181].  
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The biological roles of TST and MST are largely speculative, because their in vivo 
substrates  remain  unknown.  Proposed  functions  include  cyanide  detoxification  [187], 
maintenance of the sulfane pool [188], selenium metabolism [189] and thiamine biosynthesis 
[190]. Due to its ability to transfer sulfur atoms and its mitochondrial localization it has also 
been suggested that rhodanese may be involved in the formation of iron-sulfur clusters [191]. 
It  has  been  reported  that  rhodanese  can  form  complexes  through  disulfide  bonds  with 
membrane-bound enzymes and it was speculated that rhodanese may regulate mitochondrial 
oxidative phosphorylation by controlling the status of iron-sulfur clusters of respiratory chain 
enzymes [191].  In vitro,  rhodanese has been shown to catalyse sulfur transfer to bovine 
kidney succinate dehydrogenase  [192], to spinach ferredoxin  [193] and to the iron-sulfur 
protein fragment of bovine heart complex I, thereby promoting its NADH dehydrogenase 
activity  [194].  The  activity  of  bovine  rhodanese  may  be  regulated  by  protein 
kinases/phosphatases  [195].  According  to  this  model,  phosphorylation  leads  to  loss  of 
rhodanese  activity  and  converts  the  enzyme  into  a  protein  sulfurase,  which  may  extract 
„labile‟ sulfur from iron-sulfur clusters of the respiratory chain. 
       INTRODUCTION 
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1.8  Goals of the study   
 
NADH:ubiquinone  oxidoreductase  (complex  I)  from  Y.  lipolytica  contains  at  least  26 
“accessory” subunits however the significance of most of them remains unknown. The aim of 
this study was to characterize the role of three accessory subunits of complex I recently 
identified:  two  mitochondrial  acyl  carrier  proteins,  ACPM1  and  ACPM2  and  a 
sulfurtransferase (st1) subunit. 
      Significance of both ACPMs in the structural integrity and activity of complex I was 
evaluated.  In  order  to  distinguish  whether  the  activity  of  ACPMs  or  their  presence  as 
structural components of complex I is important for proper complex I assembly and function, 
the  phosphopantetheine-binding  serine  residues  of  ACPMs  were  mutated.  Furthermore, 
effects of the deletion and the point mutation on the respiratory chain complexes assembly 
and  activity  were  checked.  Since  ACPMs  has  been  postulated  to  take  part  in  the 
mitochondrial fatty acid synthesis, mitochondrial lipid composition of the strain lacking the 
pantetheine-4‟-phosphate  cofactor  and  completely  deprived  of  ACPM  was  determined. 
Previous  reports  suggested  localization  of  ACPMs  in  the  mitochondrial  matrix,  which 
triggered  the  idea  of  verification  of  the  submitochondrial  distribution  of  ACPMs  in  Y. 
lipolytica.  
A  protein  exhibiting  rhodanese  (thiosulfate:cyanide  sulfurtransferase)  activity 
associated with a homogeneous complex I preparation was suspected to play a role in the 
iron-sulfur cluster assembly. Complex I assembly and activity, whereas assembly of its iron-
sulfur clusters in Y. lipolytica strain deprived of rhodanese was assayed.       MATERIALS AND METHODS 
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2  MATERIALS AND METHODS 
 
2.1  Materials 
2.1.1  Chemicals 
Chemiluminescent  Peroxidase  Substrate-1  (Sigma),  Ethanol  (J.T.  Baker,  Deventer-
Netherlands);  bovine  serum  albumin  (BSA)  (Biolabs,  New  England);  n-dodecyl-β-D-
maltoside (Biomol Feinchemikalien GmbH, Hamburg- Germany); DEAE Bio-Gel A Agarose 
(Biorad Laboratories GmbH, München- Germany); Chelating Sepharose (Pharmacia Biotech 
AB,  Uppsala-Sweden);  Agar;  bactoPTMP  yeast  extract,  Trypton,  selected  peptone  140 
(Gibco  BRL  Life  Technologies,  Paisley-United  Kingdom);  YNB  (Difco  Laboratories, 
Sparks, MD, USA); boric acid, phenol, developer, fixing and developing solutions and X-ray 
films  (Kodak  BioMax  MR,  Rochester,  New  York);  acetone,  ammonium  peroxosulfate, 
chloroform acetic acid, Folin-Ciocalteus-Phenol reagent, isoamyl alcohol, isopropanol, HCl, 
trichlorine acetic acid (Merck, Darmstadt-Germany); ammonium sulphate, EDTA, glas perls 
(0.25 – 0.5 mm), KCl, KOH, KH2PO4, sodium acetate, sodium citrate, NaCl, NaOH, NiSO4, 
NaH2PO4, saccharose, nucleotides, Ni-NTA Fast Flow Sepharose (Pharmacia); acrylamide, 
bisacrylamide,  Coomassie-Blue  G-250,  urea,  polyethylene  glycol  (PEG)  4000, 
dodecylsulphate  Na-salt  (SDS),  Tricine,  agarose,  amino  caproic  acid,  amino  acids, 
ampicilline,  DMSO,  ethidium  bromide,  glucose,  glycerol  (Pharmacia);  hexaammine 
ruthenuim(III)  chloride  (HAR),  Hepes,  KCN,  lithium  acetate,  mercaptoethanol,  Mops, 
methanol, d-NADH, NADH, NaN3, nystatine, PMSF, Taq DNA polymerase, TEMED, Tris, 
asolectin, oligonucleotides (Sigma Chemie GmbH, Deisenhofen- Germany), Bio-Beads SM-
2  (Bio-Rad),  asolectin  (Fluka);  oligonucleotides  (ARK  Scientific  GmbH  Biosystems, 
Darmstadt-Germany)  or  (MWG-Biotech  Ebersberg-  Germany),  potassium  thiosulfate, 
potassium,  thiosulfate  cyanide,  nitroblue  tertazolium  (Sigma),  zymolyase  20T  (ICN 
Biomedicals), bovine rhodanese (Sigma). 
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2.1.2  Phospholipid standards (Sigma) 
1,1‟,2,2‟-tetraoleoyl cardiolipin              (CL) 
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine         (PE) 
L--phosphatidylinositol (soy bean)              (PI) 
1,2-dipalmitoyl-sn -glycero-3-phosphocholine          (PC) 
1,2-dipalmitoyl-sn-glycero-3-phosphate             (PA) 
L-α-lysophosphatidylethanolamine (egg, chicken)          (LPE)  
L-α-lysophosphatidylinositol (soy bean)             (LPI)  
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine         (LPC) 
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate           (LPA)  
2.1.3  Inhibitors 
 
2-decyl-4-quinazolinyl  amine  (DQA)  was  a  generous  gift  from  Aventis  CropScience, 
Biochemical Research, Frankfurt am Main, Germany; rotenone was purchased from Sigma 
Chemie GmbH, Deisenhofen, Germany. 
 
2.1.4  Media and solutions 
Media for Escherichia coli:  
 
LB-media: 1 % NaCl, 0.5 % Yeast Extract, 1 % Bactotryptone, pH 7.5 (1.5 % agar for plates) 
 
SOC-media: 0.5 % Yeast Extract, 2 % Bactotryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4, 20 mM glucose 
  
Media for Yarrowia lipolytica:  
 
Sporulation  (minimal)  medium  (CSM):  0.7  %  Yeast  Nitrogen  Base  w/o  (NH4)2SO4  and 
amino acids, 0.5 % (NH4)2SO4, 50 mM sodium citrate  
       MATERIALS AND METHODS 
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YPD-complete medium: 2 % Bacto™Pepton, 1 % Yeast Extract, 2 % glucose  
 
Permanent culture medium: YPD-media + 40 % glycerol  
 
Minimal synthetic defined  medium  (S):  1.7 % Yeast  Nitrogen  Base  w/o  (NH4)2SO4  and 
amino acids, 5 % (NH4)2SO4, pH 5.0 were prepared as a 10 X stock solution and sterile 
filtrated. Carbon source (0.4 % acetate or 2 % glucose) were prepared as 2 Χ stock solution, 
autoclaved and added to 10 Χ S-media. Depending on the type of selection one or several of 
the following components were added: 130 μM histidine, 200 μM lysine, 460 μM leucine, 
180 μM uracil.  
 
Buffers and solutions:  
 
10 Χ TAE-buffer: 400 mM Tris / acetate, 10 mM EDTA, pH 8.3  
 
TE: 10 mM Tris / HCl, 1 mM EDTA, pH 8.0  
 
20 Χ SSC-buffer: 3 M NaCl. 0.3 M sodium citrate, pH 7.0  
 
One step buffer (freshly prepared): 45 % PEG4000, 0.1 M lithium acetate pH 6.0, 100 mM 
dithiothreitol, 250 μg/ml salmon sperm DNA as carrier  
 
IPG buffer (Sigma)  
 
Rehydratation buffer: 8 M urea, 1.5 % Triton X-100, 10 mg/ml DTE 0.5 % IPG Buffer and a 
trace of bromphenol blue  
 
SDS equilibration buffer: containing 50 mM Tris-HCl pH 8.8, 6M urea, 30 % glycerol, 4 % 
SDS, 10 mg/ml DTE and a trace of bromphenol blue 
 
Molybdenum Blue Spray Reagent (Sigma)  
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2.1.5  Strains 
 
Escherichia coli competent cells 
 
Strain  Genotype 
XL1-Blue 
recA1 endA1yrA96 thi-1 hsdR17 supE44 
relA1 lac [F‟proAB lacl
qZM15 Tn10 (Tet
r)] 
XL10-Gold 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F‟proAB lacI
qZM15 Tn10 (Tet
r)] 
 
 
Yarrowia lipolytica 
Strain  Genotype 
PIPO  30Htg pop-in-pop-out MatA, ura3-302, leu2-270, lys11-23 
GB10  30Htg2 MatB NDH2i ura3-302 leu2-270 lys11-23 
GB14  NUCM-Htg2, NDH2i, ura3-302, leu2-270, lys11-23/+, his1/+ 
 acpm1 
acpm1 
pACPM1-stepII 
30Htg2 MatA ndh2i acpm1:URA3-302, pACPM1-stepII  
leu2-270 lys11-23 
acpm2acpm2

pACPM2-flag 
30Htg2 MatB ndh2i acpm2:URA3-302, pACPM2-flag leu2-270 lys11-23 
acpm1  lethal 
acpm2  30Htg2 MatB ndh2i acpm2:URA3-302 leu2-270 lys11-23       MATERIALS AND METHODS 
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acpm1 
acpm1 
pACPM1 
30Htg2 MatA ndh2i acpm1:URA3-302, pACPM1 leu2-270 lys11-23 
acpm2acpm2

pACPM2 
30Htg2 MatB ndh2i acpm2:URA3-302, pACPM2 leu2-270 lys11-23 
acpm1 
acpm1 
pACPM1-S66A 
lethal 
acpm2acpm2
 pACPM2-
S88A 
30Htg2 MatA ndh2i acpm2:URA3-302, pACPM2-S88A  
leu2-270 lys11-23 
st1pst1-strepII  30Htg2 MatB ndh2i st1:URA3-302,pst1-strepII leu2-270 lys11-23 
st1  30Htg2 MatB ndh2i st1:URA3-302 leu2-270 lys11-23 
st1 st1 pst1  30Htg2 MatA ndh2i st1:URA3-302,pst1 leu2-270 lys11-23 
nubm  30Htg2 MatB ndh2i nubm:URA3-302 leu2-270 lys11-23 
E129  MatA, URA3-302, leu2-270, lys11-23 
 
  
 
 
34 
2.1.6  Plasmids 
 
 
 
See next page for description.       MATERIALS AND METHODS 
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Figure 2.1  Maps of plasmids  
(previous page) The pUC19 vector was constructed by replacing the AatII/HindIII fragment of pBluescript 
SK- (marked in green) with the AatII/HindIII fragment of pBR322 (magenta), thereby replacing the polylinker 
with region that contains the unique EcoRI and ClaI sites of pUC19. Vector pUB44  was  constructed by 
cloning the hygromycin B resistance gene into the HindIII site (marked in red) of pUC19, and introducing a 
NotI site by site-directed mutagenesis, immediately adjacent to the EcoRI site. The pUB4 vector was derived 
from the pINA443 vector [105] as described in [196]. The representations of vectors pUB4 and pUB44 were 
prepared  by  Dr.  Stefan  Kerscher  using  software  VectorNTI  Advance  9.0;  pUC19  using  Clone  Manager 
Professional  9.0;  pCR2.1  was  adapted  from  Invitrogen  (Groningen,  The  Netherlands);  pBR322  and 
pBluescriptSK- were reprinted from Fermentas Life Sciences (St. Leon-Rot, Germany). Indicated locations of 
genes: ampicilin (Ap
R), hygromycin (Hyg
R) kanamycin, tetracycline (Tc
R) resistance genes, origin of replication 
(ori,  rep),  lac  promoter  (Plac),  -galactosidase  encoding  fragment  used  for  blue-white  screening  (lacZ, 
multiple  cloning  site  (MCS),  the  autonomous  replication  sequence  (ARS68/CEN),  the  upstream  activating 
sequence (4xUAS1) and gene coding for the Rop protein promoting conversion of the unstable RNA I - RNA II 
complex  to  a  stable  complex  and  serving  to  decrease  copy  number  (rop).  Recognition  sites  of  restriction 
enzymes  are  indicated  on  most  plasmids.  Additionally,  a  PstI  restriction  site  was  introduced  into  plasmid 
pCR2.1 by site-directed mutagenesis. 
2.1.7  Enzymes 
 
Taq DNA polymerase (Sigma), Phusion DNA polymerase (Finnzymes), T4-ligase 
(Invitrogen), restriction enzymes (New England BioLabs) 
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2.1.8  Antibodies 
Primary antibodies 
Secondary antibody 
Anti-Maus IgG (Fc Specific) Peroxidase conjugate developed in goat (Sigma, Germany) 
antibody  Specificity  provenience 
30C10 G1  NUBM (51-kDa) 
Dr. Volker 
Zickermann 
Frankfurt am 
Main 
Germany 
42A10 G1 
NUCM (49-kDa), internal epitop  
31 PIPSGALGQKVPHV 45 
37G12 G1 
NUEM (39-kDa), internal epitop  
263 VRHIELPKALYQAYTKATQAI 284 
30C12 G1  NESM 
Monoclonal  ANTI-
FLAG
® M2
  
1 DYKDDDDK 8  Sigma 
Germany 
Monoclonal 
QIexpress
® Strep-
tag
® 
1 SAWSHPQFEK 10  QIAGEN, 
Germany 
StrepMAB-Classic 
conjugated to 
horseradish 
peroxidase 
1 SAWSHPQFEK 10   
IBA, Germany 
Aco1C-3 
rabbit antiserum 
yeast aconitase 
Prof. Dr. Roland 
Lill, 
Marburg, 
Germany 
-hexokinase  rabbit 
antiserum 
SRKGSMADVPRDLLC  Sigma-Genosys, 
USA       MATERIALS AND METHODS 
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2.1.9  Instruments 
Centrifuges: 
Heraeus Biofuge A (Osterode, Germany) 
Heraeus Labofuge 400 (Osterode, Germany) 
Heraeus Minifuge GL (Osterode, Germany) 
Heraeus Cryofuge 8500i (Osterode, Germany) 
Heraeus Megafuge 1.0 RS (Osterode, Germany) 
Cooled centrifuge J2-21, Beckman Instruments GmbH (München, Germany) 
Ultracentrifuge L7-65 and L8-70M, Beckman Instruments GmbH (Germany) 
Spectrophotometer: 
UV 300 Shimadzu (Düsseldorf, Germany) 
U-3210 Hitachi (Düsseldorf, Germany) 
MultiSpec-1501, Shimadzu (Düsseldorf, Germany) 
SPECTRAmax PLUS
384, Molecular Devices GmbH (Ismaning, Germany) 
Thermocycler: 
DNA Thermal Cycler 480, Perkin Elmer (Weiterstadt, Germany) 
GeneAmp
 PCR System 2400, Perkin Elmer (Weiterstadt, Germany) 
cyclone
 gradient, Peqlab, Biotechnologie GmbH (Erlangen, Germany) 
Electroporation: 
E. coli Pulser Bio-Rad (Hercules, USA) 
DNA Sequencer: 
ABI PRISM
TM 310 Genetic Analyzer, Perkin-Elmer (Weiterstadt, Germany) 
Sonifier: 
B 15 Sonifier / Cell Disrupter, Branson (Danbury, UK) 
EPR-Spectrometer: 
ESP 300 E, Bruker (Germany) with continuous flow cryostat ESR 900, 
Tubney Woods Abingdon (Oxon, UK)  
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EPR-tubes: 
Quartz glass Nr: 707-SQ-250M (length: 250 mm, diameter: 4 mm), Rototec Spintec  
(Biebesheim, Germany) 
Phospholipid HPLC system: 
Inline solvent degasser L-7612,VWR International GmbH (Darmstadt, Germany) 
pump L-7100 (with low pressure dosing unit), VWR 
high pressure active mixer for L-7100, VWR 
autosampler L-7200 (100 μL loop; 500 μL syringe), VWR 
column oven L-7360 (coolable), VWR 
diode array detector L-7455, VWR 
evaporative light scattering detector Sedex 75, Sedere (Alfortville, France)   
fraction collector SF-3120 Advantec, (Dublin, USA) 
controlling interface D-7000 VWR 
controlling software D-7000 HSM VWR 
Protein HPLC system: 
119UV/UV-Vis Detector, L-4000/L-4200 eguipped with  Intellligent Inert Pump L-
6210 and D-2500 Chromato-Integrator, Merck, Germany. 
Columns 
TSKgel G 4000 SW filtration column (210.5 mm × 600 mm), TosoHaas GmbH (Stuttgart, 
Germany) 
TSKgel 3000 SW filtration column (75 mm x 600 mm), TosoHaas GmbH (Stuttgart, 
Germany) 
RP-HPLC column: Hibar RT 250-4, LiChospher 100, RP 18 (5 µm), with pre-column 
LiChrospher 100 RP-18 (5µm), (Merck, Germany) 
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Other instruments: 
10 l Fermenter, Biostat E; Braun (Melsungen, Germany) 
Bead-Beater glass pearls mill, Biospec (Bartlesville, USA) 
Cell-Desintegrator-C, Bernd Euler (Frankfurt/Main, Germany) 
BioLogic HR Workstation, Bio-Rad Laboratories GmbH (München, Germany)  
Photo camera MP4 land camera, Polaroid 
Hybridisations oven HB-1D, Techne (Wertheim, Germany) 
Microscope, Leitz (Wetzlar, Germany) 
Membrane, Millipore GmbH (Eschborn, Germany) 
Rotary concentrator Rotavapor-R (Büchi Glasapparatefabrik, Flawil, Switzerland) 
ChemiDoc XRS System, Bio-rad labolatories (Milan, Ityly) 
MALDI-TOF mass spectrometer Voyager De Pro (Applied Biosystems, USA) 
Isoelectric focussing Rotofor
 System, Bio-Rad Laboratories GmbH (Germany) 
2.1.10 Software 
DNA and protein analysis software: 
Mac Vector 3.5, IBI 
VectorNTI Advance 9.0 (InfosMax, USA) 
Clone Manager Professional 9.0 (Scientific & Educational Software, USA) 
HIBIO DNASIS
™ for Windows
® Version 2, Hitachi Software Engineering Co., Ltd 
Husar (DKFZ, Heidelberg, Germany)  
CLUSTALW (EMBL-EBI, Heidelberg, Germany) 
MitoProt II (http://ihg2.helmholtz-muenchen.de/ihg/mitoprot.html) 
Hydrophobicity plots, Molecular toolkit, Colorado State University, USA 
(http://www.vivo.colostate.edu/molkit/hydropathy/index.html) 
Transmembrane helices prediction software HMMTOP (http://www.enzim.hu/ 
hmmtop/) and TMHMM (http://www.cbs.dtu.dk/services/TMHMM/). 
Sequence Navigator (Applied Biosystems, USA) 
Sequencing Analysis (Applied Biosystems, USA) 
BCM Search Launcher (Baylor College of Medicine, USA)  
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Mascot (Matrix Science Ltd., London) 
Protein Prospector (Mirrors at UCL-Ludwig, UK / Ludwig Institute Melbourne 
(Australia)) 
PROWL (ProteoMetrics, USA)  
SOFTmax PRO, Molecular Devices GmbH (Ismaning, Germany) 
Other software: 
Microsoft Office Package 
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2.2  Methods of Molecular Biology 
2.2.1  Deletion strains  
The haploid deletion strains of the st1 and ACPM subunits of complex I from Y. lipolytica 
were generated using the one-step transformation method as described in [197]. The open 
reading frame (ORF) of the gene was replaced by URA3 reporter gene. A fragment of the 
gene in which the ORF had been replaced by URA3 gene was transformed into the haploid 
GB strain. Subsequently a strain carrying the appropriate markers on minimal media plates 
was selected. Finally, the selected clones were checked by PCR and Southern Blotting. 
2.2.2  DNA gel electrophoresis 
The DNA was separated according to standard procedures [198] in the presence of 0.5 µg/ml 
ethiduim bromide. Depending on the expected DNA fragment length agarose concentrations 
from 0.6 – 2.0 % in 1TAE buffer were used. If the DNA fragments were extracted from the 
gel, TEA buffer with extra additive was used (UV-safe TAE, MWG-Biotech, Ebersberg). 
DNA molecular weight standards: 1 kb Ladder, 100 bp Ladder plus (MBI Fermentas, St. 
Leon-Rot). 
2.2.3  Fill-in reaction of 5`-overhang 
The  DNA  blunt-ends  were  made  with  large  fragments  of  E.  coli  DNA-polymerase  I 
(Klenow-polymerase,  New  England  Biolabs  GmbH,  Schwalbach/Taunus)  as described  in 
[198]. 
2.2.4  DNA-vector dephosphorylation 
To avoid self-ligation of empty vectors the DNA ends were dephosphorylated with SAP 
(Shrimp Alkaline Phosphatase, Boeringer Mannheim, Mannheim).  
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2.2.5  Phosphorylation of PCR-products 
To  allow  for  ligation  of  PCR  products  it  was  necessary  that  both  fragment  ends  were 
phosphorylated.  For  this  puprpose  T4  polynucleotide  kinase  (New  England  Biolabs)  as 
described  by  Ausubel  [199].  Alternatively,  primers  rather  than  DNA  fragments  were 
phosphorylated before PCR. 
2.2.6  DNA extraction from agarose gels 
The DNA extractions from agarose gels were performed using the “Easy Pure Kit” (Biozym 
Diagnostic GmbH, Hess. Oldendorf) or the QIAprep® Gel Extraction Kit (Qiagen). 
2.2.7  Ligation 
The T4 DNA-ligase (Gibco BRL Life Technologies) was used in the provided buffer to ligate 
DNA fragments. Usually ligation was carried out over night at 14°C. 
2.2.8  Preparation of electro-competent Escherichia coli cells 
The electro-competent E. coli cells were made according the procedure described in “Current 
Protocols  in  Molecular  Biology”  [199].  Transformation  efficiency  was  up  to  710
9 
colonies/µg DNA. 
2.2.9  Transformation into Escherichia coli (electro-competent cells) 
The transformation of plasmids (with Amp
R gene) into E. coli electro competent cells took 
place in an E. coli Pulser (Biorad) as described in “Current protocols in Molecular Biology” 
[199]. Transformants were then streaked out and grown over night on LB solid medium in 
the presence of ampicillin (50 µg/ml). 
2.2.10 Preparation of plasmid-DNA from Escherichia coli 
The  plasmid-DNA  was  prepared  according  to  [200]  from  a  small  volume  of  over  night 
cultures (1.5-3 ml). Plasmid DNA for sequencing was prepared using the QIAprep
® Spin 
Miniprep Kit (Qiagen).       MATERIALS AND METHODS 
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2.2.11 DNA sequencing 
The double-strand DNA was used as template for sequencing. The sequencing reaction was 
run using the “ABI Prism dye terminator cycle sequencing kit” (Perkin Elmer, Weiterstadt). 
Sequencing was performed with an ABI Prism Automated Sequencer type ABI 310. 
2.2.12 Polymerase chain reaction (PCR) 
10 ng of plasmid-DNA resp. 100 ng of genomic DNA, 5 µl of both oligonucleotides (5 µM), 
5 µl of 10X reaction buffer provided by the manufacturer were combined in a total reaction 
volume of 50 µl. To avoid dimerisation of oligonucleotides as well as non-specific binding of 
oliogonucleotides to matrix DNA manual “hot-start” was applied. Used polymerases were: 
Taq  DNA  polymerase,  Taq2000TM  DNA  polymerase,  Pfu  DNA  polymerase  and 
PfuTurboTM  DNA  polymerase  from  Stratagene  (Heidelberg)  as  well  as  Taq  DNA 
polymerase from Sigma Chemie GmbH (Deisenhofen). 
2.2.13 Generation of point mutations 
The shuttle-vector pUB4 (Figure 2.1) carrying a 4.91 kb insert coding for the NUEM gene 
was used as template for site directed mutagenesis. Point mutation was introduced by PCR 
with  the  “QuikChange
TM  site-directed  mutagenesis  kit”  (Stratagene,  Heidelberg).  After 
amplification  of  the  insert-containing  plasmid  using  phosphorylated  primers  the  reaction 
mixture was digested with DpnI to eliminate methylated template plasmid. Phosphorylated 
PCR  products  were  ligated  and  transformed  into  electro-competent  cells.  To  check  the 
presence  of  the  desired  mutation  and  the  absence  of  inadvertent  sequence  changes,  the 
complete ORF of the mutagenised gene was sequenced and compared to the wild type ORF. 
2.2.14 Southern blot 
The digested  DNA  (genomic  DNA:  500 ng;  plasmid  DNA:  50 ng)  was  separated using 
agarose gel electrophoresis (1 %). The DNA was transferred over night onto Hybond N
+-
membrane (Amersham, Braunschweig). Covalent crosslink of DNA to the membrane was 
achieved by UV-light irradiation (Stratalinker, Stratagene, Heidelberg).  
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2.2.15 
32P DNA labelling 
The DNA fragments were labelled with [-
32P] dCTP (25 µCi for 25 ng DNA) using the 
“Random  primer  labelling  –  Prime-It
®II”  Kit  (Stratagene,  Heidelberg).  The  rate  of 
radioactive labelling was checked by pipetting 3 µl of 1:100 diluted reaction mixtures onto 
two  filter  sheets  (Whatman  DE  81  ion  exchange  paper,  Whatman  International  Ltd., 
Maidstone, England). One of the filters was washed two times for 5 minutes with 2  SSC 
buffer and subsequently washed for 5 minutes in cold ethanol. To estimate incorporation of 
the radioactive label, count rates of both filters were controlled after drying using a Geiger 
counter. 
2.2.16 Hybridisation of radio actively labelled DNA probes 
The hybridisation took place in a rotating glass tube using a thermostatted hybridisation oven 
(HB-1D, Techne). The membranes were pre-hybridised for 15 minutes at 68°C followed by a 
main  hybridisation  period  of  60  min  at  68°C  in  “QuikHyb
®”  hybridisation  solution 
(Stratagene, Heidelberg). For the main hybridisation, 
32P-labelled DNA fragment was added 
together with 100 µl (10 mg/ml) salmon sperm DNA. Subsequently, blots were washed four 
times (2  15 min with 2  SSC, 0.1 % SDS; 2  15 min with 0.1  SSC, 0.1 % SDS) to 
remove non-specifically bound radioactive probe. Blots were exposed to Kodak X-Omat AR 
films with an amplifier-sheet over night at –80°C. 
2.2.17 Transformation of Y. lipolytica 
The Y. lipolytica cells were transformed according to the method of [197]. A single colony 
was taken from a fresh plate. Alternatively, cells from 0.5 ml of an over night culture in 
complete medium were spun down. The cells were dispersed by vortexing for 1 min in 100 
µl of freshly prepared one step buffer (45 % PEG4000, 0.1 M lithium acetate pH 6.0, 100 
mM dithiothreitol, 250 µg/ml salmon sperm DNA as carrier). Subsequently the mixture was 
incubated for 1 h at 39°C and was spread on well dried selection plates. Transformants could 
be observed after 3 days incubation at 28°C.       MATERIALS AND METHODS 
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2.2.18 Isolation of total DNA of Y. lipolytica 
The  total  DNA  isolation  was  performed  according  to  the  “rapid  isolation  of  yeast 
chromosomal DNA” protocol described in “Current Protocols in Molecular Biology” [199]. 
Plasmid DNA was obtained by transformation of 100 ng of total DNA into E. coli competent 
cells. 
2.2.19 Sporulation 
The cells were grown in the minimal synthetic medium (2.1.4) complemented with leucine 
and  lysine  for  4  days  at  23°C.  Isolated  spores  were  treated  with  nystatin  (1  mg/ml); 
subsequently, selection of haploid organisms was carried out. Finally, obtained clones were 
checked by PCR. 
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2.3  Methods of Protein Chemistry 
2.3.1  Growth of Y. lipolytica 
The Y. lipolytica parental strains were grown in YPD medium at 28°C in rotatory flasks. One 
colony of Y. lipolytica from an agarose YPD plate was taken for a 1 l pre-culture and shaken 
in a flask  for 18  - 24 hours. Subsequently, the pre-culture was used to inoculate a 10 l 
fermenter (Biostat E; Braun, Melsungen). The fermentation lasted 14 - 18 hours. The yield 
was up to 90 g cells / l l (wet weight). 
The mutant strains were grown by fermentation in 10 l of YPD medium. The medium of the 
pre-culture  depended  on  the  plasmid.  In  the  case  of  pUB4  YPD  containing  100  mg/l 
hygromycin B
 was used. The fermentation was inoculated in a 10 l fermenter with 1 l of pre-
culture. The pre-cultures were shaken in flask for 24 hours and fermentation took another 24 
hours. Even in the absence of selective pressure during fermentation, no substantial loss of 
plasmid was observed. 
2.3.2  Preparation of intact mitochondria 
The  intact  mitochondria  from  Y.  lipolytica  were  prepared  essentially  by  the  enzymatic 
digestion method described in [201]. Y. lipolytica cells were harvested at early logarithmic 
stage (OD~3-4), washed twice in ice cold water, resuspended (0.1 g wet cells/ml) at room 
temperature in 50 mM Tris-HCl buffer (pH 8.6) supplemented with 5 mM dithiothreitol and 
incubated for 10 min, diluted with water and washed twice again. After the last centrifugation 
the weakened cells were resuspended (0.1 g wet cells/ml) in 1.2 M sorbitol and 10 mM 
Hepes-KOH,  pH  7.5  and  3-4  mg/ml  zymolyase  20T  (from  Arthrobacter  luteus,  ICN 
Biomedicals) was added to digest the cell wall. The formation of spheroplasts was monitored 
spectrophotometrically and usually 10-15 min of incubation at 30°C was enough to complete 
the digestion. After that, 0.2 mM Pefablock SC was added, the spheroblast suspension was 
rapidly cooled, centrifuged at 500-600 g for 10 min and the pellet was resuspended and 
washed twice in the same buffer containing 4 mg/ml fatty acid free BSA. The pellet of the 
last centrifugation was resuspended in grinding buffer  (20 mM Tris-HCl, pH 7.3, 0.4 M       MATERIALS AND METHODS 
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mannitol, 0.5 mM EDTA and 4 mg/ml BSA, fatty acid free). Spheroblasts were disrupted by 
20 gentle strokes in a loosely fitting Dounce homogenizer. The suspension was diluted twice 
with isolation buffer (20 mM Tris-HCl, pH 7.3, 0.6 M mannitol, 0.5 mM EDTA and 4 mg/ml 
BSA) and centrifuged at 2000g for 10 min. The supernatant was collected and centrifuged 
once  more  at  7000g  for  20  min,  the  pellet  was  resuspended  with  a  smaller  volume  of 
isolation buffer and centrifuged again. The mitochondria were resuspended in 500-700 μl of 
isolation buffer. 
2.3.3  Preparation of mitochondrial membranes in small amounts 
The freshly harvested cells (4 - 8 g) were used at a 1:1:1 cells to buffer to glass beads ratio 
(same as in 2.3.2). Cell breakage was achieved by vortexing in a Falcon tube for 10  1 min 
and intermittent cooling in ice for one minute. Centrifugations and further steps were the 
same as in 2.3.2. 
2.3.4  Protein quantification 
The protein determination was done according to the procedure in [202], as  modified in 
[203]. Calibration was carried out with 0.1 – 2.0 mg/ml bovine serum albumin (BSA). 
2.3.5  Mitochondrial fractionation 
The intact mitochondria corresponding to 500 µg of protein determined according to a 
standard protocol [202] were suspended in 170 µl 1 mM EDTA, 20 mM Na
+/Mops pH 7.2, 
subjected to 3 cycles of freezing and thawing using liquid nitrogen and centrifuged for 1 h at 
100,000 g. The supernatant was transferred to another tube and 80 µl of gel loading buffer I 
(0.03 % Serva Blue G, freshly added 6 % 2-mercaptoethanol, 30 % glycerol, 12 % SDS, 150 
mM Tris-Cl pH 7.0) was added. The pellet was resuspended in 250 µl gel loading buffer I/3 
(buffer I diluted 3 times in water). The final protein concentration of the supernatant and 
pellet samples was 2 mg/ml. Also a sample of total mitochondria with the same protein 
concentration was prepared.   
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2.3.6  Localization of ACPM1-strepII and ACPM2-flag in mitochondria by 
western blot analysis  
To investigate protein expression and localization of ACPMs, solubilized fractions of soluble 
and membranous parts of mitochondria were resolved on a Tricine-SDS-PAGE  [204]. A 
semidry immunoblotting procedure was applied using polyvinylidendifluoride membranes 
(Immobilon TMP, Millipore). Gel-blotting paper was incubated in blotting-buffer (cathode 
buffer: 300 mM 6-aminocaproic acid, 30 mM Tris, pH 9.2; anode buffer: 300 mM Tris, 100 
mM Tricine, pH 8.7). Gels were blotted over night at 50  mA and 20 V. After blotting, 
membranes were incubated for 30 minutes in PBS buffer containing 0.5% (w/v) Tween20. 
After washing in PBS (270 mM NaCl, 5 mM KCl, 15 mM Na2HPO4,  3 mM KH2PO4, pH 
7.5)  with  0.1%  (w/v)  Tween20  buffer  once  for  15  minutes  and  twice  for  5  minutes, 
membranes were incubated with antiserum diluted in PBS buffer with 0.1% (w/v) Tween20. 
For  ACPM1-strepII  protein  detection  membrane  was  probed  for  40  min  with  mouse 
monoclonal strepII-tag antibody (Qiagen) diluted 1:5,000. Secondary antibodies anti-mouse 
IgG peroxidase conjugated were diluted 1:500,000 and incubated for 30 min; ACPM2-flag 
was  detected  with  anti-flag  polyclonal  antibodies.  All  secondary  antibodies  subsequently 
used were anti-rabbit IgG peroxidase conjugated, diluted 1:500,000 and incubated for 30 
min.  Antiserum  against  aconitase  was  diluted  1:4,000  and  incubated  for  2.5  hours; 
hexokinase antiserum was diluted 1:10,000 and incubated for 20 h; NESM antiserum was 
diluted 1:15 and incubated for 20 min. All antibodies were purchased from Sigma unless 
indicated  otherwise.  Proteins  were  detected  by  enhanced  chemiluminescent  peroxidase 
substrate (ECL) from Sigma. The washed membrane was incubated for 1 minute with a 1:1, 
(v/v) mixture of ECL-1 solution, containing 2.5 mM luminol, 450 µM coumaric acid, and 
ECL-2 solution, containing 0.03% hydrogen peroxide. The peroxidase oxidises luminol in 
the presence of hydrogen peroxide. Light emission occurring during luminol oxidation was 
detected by placing the blot in contact with an X-ray film (Kodak BioMax MR Film).  
2.3.7  StrepII-tag detection with streptavidin 
The transfer of proteins from the polyacrylamide gel to the blotting membrane was carried 
out according to the procedure described in 2.3.6. After blotting, membranes were incubated       MATERIALS AND METHODS 
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for 60 minutes in room temperature in PBS buffer containing 0.5% (w/v) Tween20 and 2 
g/ml avidin. After washing in PBS (270 mM NaCl, 5 mM KCl, 15 mM Na2HPO4, 3 mM 
KH2PO4, pH 7.5) with 0.1% (w/v) Tween20 buffer once for 15 minutes and twice for 5 
minutes,  membranes  were  incubated  for  60  min  at  room  temperature  with  streptavidin 
conjugated  with  alkaline  phosphatase  diluted  1:1000  in  PBS  buffer  with  0.1%  (w/v) 
Tween20. After another three 5 min washing cycles in PBS with 0.1% (w/v) Tween20 buffer 
membranes were rinsed with water and developed in a solution of one tablet of 5-bromo-4-
chloro-3-indolyl phosphate/ nitro blue tetrazolium (BCIP/ NBT) freshly dissolved in 10 ml 
water. Membranes were incubated until bands were visible and the reaction was stopped 
either with water or 100 mM EDTA pH 7.2. Avidin, streptavidin and BCIP/ NBT tablets 
were purchased at Sigma. 
2.3.8  Doubled SDS-polyacrylamide gel electrophoresis (dSDS-PAGE) 
Tricine dSDS-PAGE was used to separate the subunits of complex I from Y. lipolytica and 
was performed as described [205]. Briefly, lanes from 1D-gels (10% polyacrylamide, 6M 
urea) were incubated in acidic solution containing 100 mM Tris, 150 mM HCl, pH 2 for 30 
min and analysed by SDS-PAGE as a second dimension using 16% polyacrylamide. The 2D-
gels were stained with Coomassie blue G 250 or silver. 
2.3.9  Two-dimensional blue-native SDS polyacrylamide gel electrophoresis (2D-
BN/SDS PAGE) 
Native protein complexes were separated in the first dimension using BN-PAGE [206]. 500 
µg of total protein was solubilised with 3 g/g digitonin and 500 mM amino caproic acid. The 
resulting solubilised mitochondrial membranes were put on 4-13% gradient gels. Gel stripes 
containing proteins were excised and incubated in 1% SDS solution for 30 min. Proteins 
were separated in the second dimension using 16% polyacrylamide SDS-PAGE.  
2.3.10 Silver-staining of 2D-SDS gels 
After  electrophoresis  the  gel  was  incubated  for  15  minutes  in  fixation  solution,  which 
consisted of 50% methanol and 10% acetic acid. Subsequently the gel was incubated in  
 
 
50 
0,005% sodiumthiosulfate-pentahydrate. The gel was washed in H2O and incubated in 0.1% 
silver nitrate (w/v) for 30 minutes. Subsequently the gel was briefly washed in H2O and 
developed in freshly prepared developer: 2% (w/v) sodium bicarbonate in 100 ml H2O plus 
100 µL 36.5% formaldehyde. The development reaction was stopped by adding 100 ml of 50 
mM EDTA solution. 
2.3.11 Staining with nitro blue tetrazolium (NBT) 
NBT-staining was used to detect the NADH activity of complex I in BN-PAGE. The non-
fixed gel was incubated in a solution containing 3 mM NBT and 120 µM NADH for 5 
minutes. In order to stop the reaction, the gel was incubated in 50 % methanol and 10 % 
acetic acid. 
2.3.12 Measurement of NADH:HAR oxidoreductase activity 
Detergent-  and  inhibitor-insensitive  NADH:HAR  [HAR:  hexa-ammine-ruthenium(III) 
chloride]  oxidoreductase  activity  was  measured  using  a  Shimadzu  MultiSpec-1501  or  a 
Molecular  Devices  SPECTRAmax  PLUS
384  spectrophotometer  by  following  NADH-
oxidation at 340 minus 400 nm (=6.22 mM
-1cm
-1). Assays were performed in the presence 
of 200 µM NADH and 2 mM HAR, in 20 mM Na
+/Hepes, pH 8.0, 2 mM NaN3 at 30°C 
[207]. This activity depends only on the presence of FMN and probably FeS cluster N3 
[208].  The  reaction  was  started  by  the  addition  of  50  µg  (total  protein)  of  unsealed 
mitochondrial membranes. 
2.3.13 Measurement of complex I catalytic activity 
For  measurement  of  complex  I  activity,  dNADH  was  used  as  electron  donor,  and  the 
ubiquinone  analogue  DBQ  was  used  as  electron  acceptor.  dNADH:DBQ  oxidoreductase 
activity at 60 µM DBQ and 100 µM dNADH was measured using a Shimadzu MultiSpec-
1501  or  a  Molecular  Devices  SPECTRAmax  PLUS
384  spectrophotometer  by  following 
dNADH-oxidation at 340 minus 400 nm (=6.22 mM
-1cm
-1) at 30°C in 20 mM Na-MOPS 
pH 7.2 buffer containing 50 mM NaCl and 2 mM KCN. The reaction was started by adding 
mitochondrial membranes equivalent to a final concentration of 30 to 50 µg of protein/ml.       MATERIALS AND METHODS 
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2.3.14 Measurement of rhodanese activity 
Rhodanese activity was assayed according to the procedure reported by Sörbo [209;209] and 
Westley [210;210], with minor modifications. The reaction mixture contained 50 mM KCN, 
50 mM sodium thiosulfate, 50mM Bis/Tris buffer, pH 7.0 and 1 µg/µl of purified complex I. 
An equal amount of enzyme inactivated by addition of 15% formaldehyde was used as blank. 
The reaction was followed for up to 70 min at 25°C. 70 µl aliquots of the reaction mixture 
were taken every 10 min and stopped by the addition of 32,5 µl 15% formaldehyde and 97,5 
µl ferric nitrate, Fe(NO3)3. The final volume was 200 µl. The resulting thiocyanate complex 
was  measured  at  460  nm  using  a  Molecular  Devices  SPECTRAmax  PLUS
384 
spectrophotometer.  One  unit  of  rhodanese  was  defined  as  the  amount  of  enzyme  that 
catalyses transfer of one micromole sulfur from cyanide onto thiocyanate per minute under 
these conditions. Specific activity (mU/mg) was calculated using an 460 of 1600 6.22 mM
-
1cm
-1 per mole of SCN
-.  
2.3.15 Purification of complex I 
Complex I was purified from isolated mitochondrial membranes that were solubilised with n-
dodecyl--D-maltoside  as  described  [211]  with  slight  modifications.  Purification  was 
achieved  by  Ni
2+-affinity  chromatography  with  a  modest  reduction  of  the  imidazole 
concentration from 60 mM to 55 mM in the equilibration and washing buffer and subsequent 
gel filtration using a TSK4000 column.  
2.3.16 Reactivation of purified complex I 
In its natural environment, complex I is embedded in a lipid bilayer. Most of these lipids are 
lost during protein purification, resulting in significant loss of catalytic activity. To reactivate 
dNADH:DBQ oxidoreductase activity of complex  I, asolectin was added (total soy bean 
extract with 20 % lecithin) in a 1:1 (w/w) protein-to-lipid ratio. The asolectin solution was 10 
mg/ml solubilised by 1.6 % OG in 1 mM KPi and 25 mM K2SO4 pH 7.2.  
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2.3.17 EPR-spectra 
Low temperature EPR spectra were obtained with a Bruker ESP 300E spectrometer equipped 
with a liquid helium continuous flow cryostat, ESR 900 from Oxford Instruments. Samples 
were mixed with NADH in the EPR tube and frozen in liquid nitrogen after 30 seconds 
reaction  time.  Spectra  were  recorded  at 12  K or  at  40  K  with  the  following  instrument 
settings: microwave frequency 9.475 GHz, microwave power 1 mW, modulation amplitude 
0.64 mT. Under these conditions spectra show contributions from clusters N1, N2, N3 and 
N4. Spectra were recorded and analyzed by Dr. Klaus Zwicker. 
2.3.18 Protein analysis with the matrix assisted laser desorption ionization time 
of flight mass spectrometry (MALDI-TOF-MS)  
Stained  protein  spots  were  excised  from  dSDS  polyacrylamide  gels  and  treated 
following  the  protocol  of  [212].  The  proteins  were  cleaved  with  trypsin  (12.5  ng/µl)  in 
digestion buffer containing 25 mM ammonium hydrogen carbonate, 5 mM CaCl2
 at 37°C 
over night.  
Spectra were recorded in the positive ion mode with a Voyager De Pro MALDI-TOF 
mass  spectrometer  (Applied  Biosystems,  Germany).  The  samples  were  deposited  on 
preparative  plates  by  the  fast  evaporation  method.  DHB  (2,5-dihydroxybenzoic  acid)  or 
HCCA (4-hydroxy--cyano-cinnamic acid) from Sigma were used as a matrix. Spectra were 
calibrated internally using bovine trypsin autolysis products (m/z 805.4167 and 2163.0567) 
or, if necessary, externally using a reference peptide mixture of bradykinin, angiotensin II, 
insulin (oxidized B chain), adrenocorticotropic hormone (ProteoMass Peptide MALDI-MS 
Calibration Kit, Sigma) covering the m/z 757.3997-3494.6513 range. MALDI spectra were 
analysed by the Mascot software package (Matrix Science Ltd., London), Prowl software 
package (ProteoMetrics, LLC, New York, USA). Mass spectrometric analysis of the proteins 
was performed by Dr. Albina Abdrakhmanova.       MATERIALS AND METHODS 
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2.3.19 Sequence analysis 
DNA and protein sequences were analyzed using the Vector NTI (Informax) software. 
Homology searches of mammalian and fungal databases were done using the BLAST server 
at  http://www.ncbi.nlm.nih.gov/BLAST/.  Alignments  of  fungal  and  mammalian  proteins 
were generated using the program CLUSTALW at http://www.ebi.ac.uk/clustalw/index.html. 
Searches of the NCBI conserved domains database [213] were performed at the NCBI server 
(www.ncbi.nlm.nih.gov/ structure/cdd/wrpsb.cgi).  
 
2.4  The phospholipid composition of mitochondria   
Mitochondrial  lipids  were  analyzed  using  thin  layer  chromatography  (TLC)  and  high 
performance  liquid  chromatography  (HPLC)  and  subsequently  identified  with  mass 
spectrometry  (MALDI-TOF).  The  HPLC  and  MALDI-TOF  phospholipid  analysis  was 
performed by Sebastian Richers, Max-Planck-Institute for Biophysics, Frankfurt am Main. 
2.4.1  Extraction of phospholipids for the TLC analysis  
Mitochondrial membrane (prepared as described in 2.3.3) extracts from strain GB10, acpm2 
and acpm2pS88A were used for TLC analysis. Extraction was carried out according to the 
method of [214]. An equivalent of 100 µg protein was mixed with 2.5 ml methanol and 1.25 
ml  chloroform  in  a  glass  tube,  vortexed  for  2  min  and  incubated  on  ice  for  15  min. 
Following, 1.25 ml chloroform and 1.25 ml water was added and mixed. The organic (lower) 
and water (upper) phase separate and precipitated proteins and nucleic acids gather between 
the phases. To accelerate the separation process, centrifugation at 1000 rpm for 10 min in 
Heraeus Megafuge 1.0 RS (Osterode, Germany) was applied. The organic phase, containing 
extracted  phospholipids,  was  transferred  to  another  glass  tube  and  removed  on  a  rotary 
concentrator  Rotavapor-R  (Büchi  Glasapparatefabrik,  Flawil,  Switzerland)  under  reduced 
pressure at 30°C. After evaporation the total lipid sample was taken up in a small volume of 
approx. 100 µl chloroform-methanol 2 : 1.   
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2.4.2  Thin layer chromatography (TLC) 
Extracted phospholipids (25 µl) were applied to the TLC sheets covered with silica gel 60 
F254 (Merck, Darmstadt, Germany) step wise 5 x 5 µl dried in between steps.  TLC sheets 
were developed with a liquid phase containing 190 ml chloroform, 70 ml methanol, 18 ml 
water, 20 ml acetic acid, 80 ml acetone and visualised either with Molybdenum Blue Spray 
Reagent  (Sigma)  or  by  means  of  Typhoon  9400  Variable  Mode  Imager  (Amersham 
Biosciences, Little Chalfont, UK). Images of the TLC sheets containing fluorescent dye F254 
were recorded in the fluorescent mode PMT 300V, at normal sensitivity 520 BP40 in the blue 
laser light at 488 nm. 
2.4.3  Extraction of phospholipids for HPLC analysis  
For  the  phospholipids  extraction  four  different  starting  materials:  Y.  lipolytica  cells, 
mitochondrial  membranes,  intact  mitochondria  and  sucrose  gradient  purified  intact 
mitochondria [215] from strains GB10, acpm2 and acpm2pS88A and the nubm were 
used.    Phospholipid  composition  of  extracted  samples  was  determined  using  a  High 
Performance Liquid Chromatography (HPLC) analysis lipids were extracted according to the 
method  of  [216]  with  two  modifications.  After  mixing  the  50  µl  sample  with  950  µl 
chloroform/methanol (2/1, v/v), the phase separation was induced by the addition of 200 µl 
HCl(aq)  (0.1  M)  instead  of  the  original  recommended  salt  solutions.  Furthermore  two 
additional cycles of washing of the aqueous phase with the organic phase increased the yield. 
The combined organic phases were dried and redissolved in chloroform/methanol (4/1, v/v). 
2.4.4  Phospholipid analysis of acpm2 and acpm2pS88A with HPLC 
The phospholipids were separated by normal phase chromatography with a solvent system of 
chloroform/methanol/water/ammonia  based  on  the  method  described  by  [217].  An 
evaporative light scattering detector Sedex 75 (Sedere, France) supplied with 3.3 bar nitrogen 
and heated to 80 ºC detected the phospholipids. Phospholipids were quantified by external 
calibration with commercially available standards: 1,1‟,2,2‟-tetraoleoyl cardiolipin (CL); 1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine  (PE);  L-α-phosphatidylinositol  (PI),  (soy 
bean);  1,2-dipalmitoyl-sn-glycero-3-phosphate  (PA);  1,2-dipalmitoyl-sn-glycero-3-      MATERIALS AND METHODS 
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phosphocholine  (PC);  L-α-lysophosphatidylethanolamine  (egg,  chicken),  (LPE);  L-α-
lysophosphatidylinositol (soy bean),  (LPI); 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate 
(LPA); 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (LPC), (all from Sigma).  
2.4.5  Mass spectrometry of phospholipids 
Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry 
was used to identify the type of phospholipid headgroup and the fatty acid composition. 
Samples of phospholipid extracts were used directly, while the collected HPLC fractions 
were dried in a speed vac and redissolved in 4 μL 19:1 (v/v) chloroform-methanol solution to 
change the solvent and increase the concentration. About 2 μL of the sample were slowly 
added to MALDI target spots. The fast evaporation of the organic solution under the air 
stream of the fume hood allowed the addition of this relative large volume compared to the 
spot size.  Despite  the chloroform  content of  the  solutions, plastic  tips  were used  with  a 
Gilson  pipette  to  avoid  scratching  the  target  with  glass.  After  the  samples  had  dried 
completely, 0.3 μL of matrix solution (0.5 M 2,5-dihydroxybenzoic acid in methanol with 
2%  (v/v)  formic  acid)  were  added  to  the  spots.  The  dried  target  was  inserted  into  the 
MALDI-TOF mass spectrometer and samples were analyzed in the range of 0-2000 m/z. 
Using the negative charged mode greatly simplifies the spectrum and allows the detection of 
other  phospholipids  even  in  the  presence  of  phosphatidyl  choline.  Detectability  of 
phospholipids and quality of spectra was largely depending on the laser energy which was 
optimal at around 55 %. Typically the resulting spectra of 200 laser shots were acquired and 
summed  up.  Phospholipid  mixtures  containing  Dipalmitoyl-Glycero-Phosphate  and 
Tetraoleoyl-Cardiolipin 0.1 g/L were used as external calibration standards in close vicinity 
to the sample spots. The monoisotopic masses of their single deprotonated ions containing 
over all a single negative charge were used for linear calibration. The [M-H+]− masses are 
647.47 m/z for Dipalmitoyl-Glycero-Phosphate and 1456.03 m/z for Tetraoleoyl-Cardiolipin. 
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3  RESULTS 
3.1  Acyl carrier proteins  
3.1.1  Generation of ACPM deletion strains 
Using  the  sequences  from  the  Genolevures  website  (http://cbi.labri.fr/Genolevures/ 
index.php),  the  ACPM  homologues  YALI0D14850g  (ACPM1)  and  YALI0D24629g 
(ACPM2) were identified. 2.70 kb of genomic DNA comprising the complete ACPM1 open 
reading frame (two exons) and 0.97 kb of 5‟ and 0.96 kb of 3‟ flanking DNA was amplified 
with primers
3 acpm1f and acpm1r (Figure 3.1a). 3.60 kb of genomic DNA, comprising the 
complete ACPM2 open reading frame (three exons) and 1.20 kb of 5‟ and 0.66 kb of 3‟ 
flanking DNA, was amplified using primers acpm2f and acpm2r (Figure 3.1b). Both PCR 
products were made using Taq DNA polymerase and genomic DNA from Y. lipolytica strain
4 
E129 and cloned into plasmid
5  pCR2.1 (Figure  3.1a).  Deletion  strains  for  the  ACPM 
subunits of complex I from Y. lipolytica were generated by homologous recombination using 
the one-step transformation method as described [197]. Deletion alleles in which the ACPM 
ORFs are replaced with the URA3 marker gene were created as follows: First, genomic DNA 
fragments were transferred into the single EcoRI site of vector pUC19 (Figure 3.1d, e). 
Then,  the  ACPM1  construct  was  gapped  by  PCR,  using  primers  acpm1SalI  and 
acpm1BamHI, thereby removing the ORF together with 143 bp of 5‟ flanking sequence and 
22 bp of 3‟ flanking sequence. Similarly, the ACPM2 construct was gapped by PCR, using 
primers acpm2SalI and acpm2BamHI, thereby removing the ORF together with 16 bp of 5‟ 
flanking sequence and 4 bp of 3‟ flanking sequence. The PCR products were digested with 
BamHI and SalI and ligated with the Y. lipolytica URA3 marker gene as a 1.7 kb BamHI/ SalI 
fragment, such that the orientation of the marker was opposite to the original ORFs (Figure 
3.1c, f, g). Then, the hygromycin B resistance gene was cloned into the HindIII site and the 
NotI site, immediately adjacent to the EcoRI site was introduced by site-directed mutagenesis 
                                                    
3 For gene maps see 9.1.2 and 9.1.3, appendix and for the list of primers see 9.2.2 and 9.2.3, appendix. 
4 Genotypes of all strains are listed in 2.1.5, materials and methods. 
5 See maps of plasmids in 2.1.6, materials and methods.  
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in both vectors (Figure 3.1i, j). Thereby, vectors pUB44 containing deletion constructs of 
each ACPM gene were created. 
 
 
 
 
 Figure 3.1  Generation of ACPM deletion constructs 
(a) The pCR2.1 vector of 3.9 kb containing the acpm1 insert of 2.7 kb digested with EcoRI restriction enzyme. 
(b) The acpm2 fragment of 3.6 kb produced by PCR using primers acpm2f and acpm2r. (c) The URA3 ORF 
insert of 1.7 kb excised from pBlueScript SK- vector of 2.7 kb using BamHI and SalI restriction enzymes. (d) 
The empty pUC19 vector of 2.3 kb containing (e) the acpm1 insert of 2.7 kb, (f) the acpm1 deletion construct 
(acpm1::URA3) of 3.4 kb and (g) the acpm2 deletion construct (acpm2::URA3) of 3.5 kb, all digested with 
EcoRI. (h) The empty pUB44 vector of 3.9 kb digested with HindIII into hygromicin B resistance gene (HygB
R) 
of  1.6  kb  and  2.3  kb  fragment.  (i)  The  pUB44  vector  of  3.9  kb  containing  an  acpm1  deletion  construct 
(acpm1::URA3) of 3.4 kb digested with HindIII yielding HygB
R of 1.6 kb and 5.8 kb restriction fragment. (j) 
The pUB44 vector of 3.9 kb containing an acpm2 deletion construct (acpm1::URA3) of 3.5 kb cut with HindIII 
yielding HygB
R of 1.6 kb and fragment of 5.9 kb. Size of the fragments of the molecular weight marker (M) is 
indicated on the left side of the figure in kilobase pairs (kb).  
 
To  exclude  ligation  of  multiple  inserts  and  assure  proper  orientation  of  cloned 
fragments, plasmids were test digested with a number of restriction enzymes. The resulting 
final constructs were linearized with NotI and transformed into the diploid Y. lipolytica strain 
GB14 (Figure 3.2). Heterozygous deletion strains in which one of the chromosomal copies of 
either ACPM1 or ACPM2 had been replaced with the URA3 marker by double homologous 
recombination  were  selected  for  their  ability  to  grow  in  the  absence  of  uracil  and  their 
inability to grow in the presence of hygromycin B. Sporulation, followed by random spore 
selection was performed both in the presence and absence of 10 µg/ml lipoic acid (see 2.2.19,       RESULTS 
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materials and methods). Deletion strains transformed with a functional copy of the respective 
ACPM genes on replicative plasmid pUB4 [196] were used as controls and will be referred to 
as parental strains here. 
  
 
Figure 3.2  Deletion strategy for ACPMs  
A NotI linearized construct containing the URA3-marked ACPM deletion allele (orange), the hygromycin B 
resistance gene (HygB
R), grey and the rest of the pUC19 plasmid with ampicillin resistance gene (AP
R), yellow 
used for deletion of ACPM genes by double homologous recombination (indicated by crosses). The ACPM 
deletion (ACPM/acpm strains were selected for their ability to grow in the absence of uracil and their inability 
to grow in the presence of hygromycin B. Protein coding regions are represented by thick arrows, flanking 
DNA from the Y. lipolytica ACPM locus by green lines. The location of primers is indicated by black thin 
arrows above the construct. The following restriction sites are shown: E, EcoRI; H, HindIII; N, NotI; S, SalI; B, 
BamHI.  
 
   
To ensure proper integration of the deletion constructs into genomic locus of ACPM 
genes, Y. lipolytica transformants were tested in a PCR reaction using primers: acpmckf/ 
acpmchkr that bind to the chromosomal gene locus outside of the  ACPM gene; ura3ds2/ 
ura3us2 binding to the deletion construct and acpmseq3/acpmseq4 binding to the ACPM gene 
(Figure 3.3).   
Proper integration of the acpm1 construct into the chromosomal locus of the acpm1 
gene was confirmed using primer pairs acpm1chkf/ura3ds2 and acpm1chkr/ ura3us2, since 
products of 1.080 kb and 1.075 kb, respectively were obtained. This indicated presence of the 
URA3  gene  on  the  chromosome  in  the  genomic  locus  of  ACPM1  in  the  acpm1strain 
(Figure 3.3a, b). In case of acpm2strain presence of the ACPM2 gene was excluded in a 
PCR  reaction  using  primers  acpm2seq3/  acpm2seq4,  in  which  no  product  was  formed  
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(Figure 3.3c). Presence of the URA3 gene in the acpm2strain was confirmed using primers 
acpm2chkr/ura3us2, which resulted in a product of 1.050 kb (Figure 3.3f).  
As control strains, carrying wild-type copies of the ACPM2 gene, GB14 and a diploid 
acpm2strain, complemented with the plasmid version of a functional copy of the ACPM2 
gene (2n acpm2/ ACPM2) were used.  Presence of the ACPM2 gene in the GB14 and the 
acpm2/ ACPM2 was confirmed in a PCR reaction using primers acpm2seq3/acpm2seq4, 
which yielded a product of 1.000 kb in both strains (Figure 3.3d, e). Absence of the URA3 
gene in the acpm2/ ACPM2 strain was confirmed using primers acpm2chkf/ ura3ds2, since 
no product was obtained (Figure 3.3g). Presence of the URA3 gene in the acpm2/ ACPM2 
strain was confirmed using primers acpm2chkr/ura3us2, since a 1.050 kb band was observed 
(Figure 3.3h).  
 
 
 
Figure 3.3 The PCR test for the deletion of ACPM genes 
The localization of primers in the deletion construct (acpm::URA3) and in the genomic locus of the ACPM gene 
are indicated with arrows (left panel). The transformants carrying a properly integrated URA3 gene into the 
chromosome of the diploid GB14 strain of Y. lipolytica were isolated and checked by PCR (right panel). The 
acpm1 strain was tested using primers acpm1chkf/ ura3ds2 (magenta) and acpm1chkr/ ura3us2 (green) that 
yielded products of (a) 1.080 kb and (b) 1.075 kb, respectively, which confirmed presence of the URA3 gene in 
this strain. The acpm2strain was verified using primers (c) acpm2seq3/ acpm2seq4 (black) that yielded no 
product thus excluded presence of the ACPM2 gene and (f) acpm2chkr/ ura3us2 (green) that yielded a product 
of 1.050 kb, which confirmed presence of the URA3 gene in acpm2. (d) The GB14 and (e) the acpm2/ 
ACPM2 strains were both checked using primers acpm2seq3/ acpm2seq4 (black). In both strains, the PCR 
reaction yielded a product of 1.000 kb, which confirmed presence of ACPM2 in both strains. (g) The GB14 
strain was also confirmed to lack the URA3 gene using primers acpm2chkf/ ura3ds2 (magenta), since no PCR 
product was obtained. (h) The acpm2/ ACPM2 strain was confirmed to contain the URA3 gene using primers 
acpm2chkr/ ura3us2 (green) since a 1.050 kb band was observed. Size of the fragments of the molecular weight 
marker (M) is indicated on the left side of the agarose gel in kilobase pairs (kb).  
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3.1.2  Generation of strains with exchanged serines binding the phosphopantethein 
moiety  
Open reading frames (ORFs) together with flanking regions of ACPM genes were amplified 
in the pCR2.1 vector as described in 3.1.1 and cloned into the EcoRI site of the vector pUB4 
(Figure 3.4A). Mutations leading to the exchange of the phosphopantethein binding serines 
for  alanines  were  carried  out  by  PCR  using  primer  pairs  acpm1S66Af/  acpm1S66Ar, 
acpm2S88Af/  acpm2S88Ar  for  ACPM1-S66A  and  ACPM2-S88A,  respectively.  The 
resulting  products  were  test  digested  with  EcoRI  restriction  enzyme  (Figure  3.4B)  and 
sequenced on an Applied Biosystems 310 genetic analyzer  (Figure 3.5). Plasmids pUB4 
carrying the mutated genes were transformed into ACPM1/ acpm1 and acpm2 strains, 
respectively and checked by PCR (Figure 3.6). 
 
 
 
Figure 3.4 Plasmid pUB4 containing mutated versions of ACPMs 
(A) The localization of mutagenesis primers (violet arrows) used for exchange of serines to alanines in ACPM1-
S66A and ACPM2-S88A proteins indicated on the ACPM protein coding region (orange). The ACPM ORFs 
were cloned, including their flanking DNA (green lines), into the EcoRI site of the pUB4 vector (black).  NN 
denotes in primer names position of the serine, 66 in case of ACPM1 and 88 in case of ACPM2. The following 
restriction sites are shown: E, EcoRI; S, SalI; B, BamHI. (B) EcoRI restriction cut of (a) an empty pUB4 
plasmid, (b) the plasmid containing a 2.7 kb insert of ACPM1-S66A and (c) a 3.6 kb insert of ACPM2-S88A. 
Size of the fragments of the molecular weight marker (M) is indicated on the left side of the agarose gel in 
kilobase pairs (kb).   
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Figure 3.5 Sections of DNA sequence pherogramms from ACPM point mutants  
Mutations  leading  to  the  exchange  of  the  phosphopantethein  binding  serines  for  alanines  in  (A) 
acpm1,pACPM1-S66A  and (B) acpm2,pACPM2-S88A strains were verified by sequencing using primers 
acpm1seq1 and acpm2seq1, respectively on an Applied Biosystems 310 genetic analyzer. 
 
While the acpm2,pACPM2-S88A strain could be generated no acpm1,pACPM1-
S66A  spores  were obtained. The  acpm2,pACPM2-S88A  transformants  and  three  control 
strains, the GB 14, the acpm2 and a diploid acpm2strain, complemented with the plasmid 
version of a functional copy of the ACPM2 gene (2n acpm2pACPM2) were checked by 
PCR  using  two  primer  pairs  acpm2chkf/acpm2S88Ar  and  acpm2f/acpm2S88Ar,  here 
referred to as (1) and (2), respectively. Localisation of the primers is indicated in (Figure 3.6, 
left panel). The acpm2chkf primer binds outside of the ACPM2 gene, acpm2f binds on the 
flanking DNA of ACPM2 gene and acpm2S88Ar binds on the ORF of the  ACPM2. The 
diploid GB14 strain was confirmed in a PCR reaction using primer pairs (1) and (2) to carry 
two  alleles  of  ACPM2  gene,  since  products  of  1.48  kb  (magenta)  and  1.46  kb  (green) 
respectively, were obtained (Figure 3.6a). The diploid acpm2pACPM2 was confirmed to 
lack  a  chromosomal  copy  of  the  ACPM2,  since  no  product  with  primers  (1)  could  be 
generated, and it was shown to contain a plasmid-borne copy of the ACPM2, since a product 
of 1.46 kb (green) was obtained with primers (2) (Figure 3.6b). The acpm2strain was 
proven to lack both chromosomal and plasmid versions of the ACPM2 gene using primer 
pairs  (1)  and  (2),  since no  PCR products could  be obtained  (Figure  3.6c).    Finally,  the 
acpm2pS88A strain was confirmed to lack the chromosomal copy of the ACPM2 gene,       RESULTS 
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since no product with primers (1) were formed and it was proved to carry a plasmid-borne 
copy of the ACPM2-S88A gene, since a product of 1.46 kb (green) was obtained with primers 
(2) (Figure 3.6d).  
 
 
 
Figure 3.6  PCR test for presence of ACPM2-S88A gene 
In the PCR test for the presence of the ACPM2-S88A gene using two primer pairs: (1) acpm2chkf/ acpm2S88Ar 
(magenta) and (2) acpm2f/ acpm2S88Ar (green) strains (a) GB14, (b) acpm2,pACPM2, (c) acpm2 and (d) 
acpm2,pS88A were checked. In these PCR reactions using primers (1) and (2) the following products were 
obtained, respectively: (a) 1.48 kb and 1.46 kb; (b) no product, 1.46 kb; (c) no product for both primer pairs; (d) 
no product, 1.46 kb. Size of the fragments of the molecular weight marker (M) is indicated on the left side of 
the agarose gel in kilobase pairs (kb).   
 
 
3.1.3  The tagged versions of ACPMs 
Open reading frames (ORFs) of ACPM genes together with flanking regions were amplified 
in the pCR2.1 vector as described in 3.1.1 and cloned into the  EcoRI site of the vector 
pUC19  For  generation  of  the  ACPM1-strepII  and  ACPM2-flag  strains  primer  pairs 
acpm1strepIIf/  acpm1strepIIr  and  acpm2flagf/  acpm2flagr,  respectively  were  used.  As  a 
result  ACPM  ORFs  were  extended  by  8  amino  acids  at  the  C-termini:  ACPM1  by 
WSHPQFEK  and  ACPM2  by  DYKDDDDK.  Tagged  versions  of  ACPM  genes  were 
transferred  to  the  EcoRI  site  of  the  pUB4  vector  and  checked  by  test  digestion  with 
restriction enzymes EcoRI, and following with NheI and NdeI to assure cloning of only one 
insert  of  tagged  ACPM  gene  (Figure  3.7).  Subsequently,  plasmids  were  confirmed  by 
sequencing (Figure 3.8) and transformed into diploid strains carrying one wild-type (ACPM) 
and one acpm::URA3 allele (ACPM/ acpm (Figure 3.7). Complemented haploid deletion  
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strains  were  obtained  by  sporulation  and  random  spore  selection  (2.2.19,  materials  and 
methods). 
 
 
Figure 3.7 Test digest of pUB4 plasmid containing tagged versions of ACPMs 
The 8.0 kb pUB4 plasmid digested with EcoRI containing (a) a 3.6 kb ACPM1-strepII insert and (b) a 2.7 kb 
ACPM2-flag insert. To assure presence of only one copy of ACPM insert per pUB4 plasmid (c, f) the empty 
plasmid and (d, g) the plasmid containing the ACPM1-strepII and (e, h) the ACPM2-flag insert was digested 
with NheI and NdeI, respectively resulting in two restriction fragments each. The only exception is (e) the pUB4 
vector  containing  the  ACPM2-S88A  insert,  which  harbours  an  additional  NheI  site  in  the  ACPM2-S88A 
fragment. As a result, three restriction fragments (3.6, 3.7 and 4.5 kb) are formed, although on the gel 3.5 kb 
and 3.6 kb are visible as one thick band. Size of the fragments of the molecular weight marker (M) is indicated 
on the left side of the agarose gel in kilobase pairs (kb). 
 
 
 
 
 
Figure 3.8 Sections of DNA sequence pherogramms from ACPM tagged versions  
ACPM ORFs were extended by 8 amino acids at the C-termini: (A) ACPM1 by WSHPQFEK (StrepII-tag) and 
(B)  ACPM2  by  DYKDDDDK  (Flag-tag)  as  verified  by  sequencing  using  primers  (A)  acpm1seq4  and  (B) 
acpm2seq4, respectively. For localization of primers see 9.1, appendix.       RESULTS 
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3.1.4  Consequence of the deletion of ACPM1 and ACPM2 genes 
In order to investigate the function of the ACPMs the two homologues of the S. cerevisiae 
gene for the mitochondrial acyl carrier protein (YKL192c) that had been identified in the Y. 
lipolytica genome as YALI0D14850g (ACPM1) and YALI0D24629g (ACPM2) were deleted 
as described in 3.1.1. To minimize the risk of selection for second site repressors during 
homologous  recombination,  the  linearized  deletion  constructs  were  transformed  into  the 
diploid Y. lipolytica strain GB14 (Figure 3.2). In the case of ACPM2, the desired diploid 
strain that was confirmed to be heterozygous for the deletion allele could be sporulated to 
yield the desired haploid acpm2::URA3 deletion strain. 
While  a diploid  ACPM1/  acpm1::URA3 deletion strain  was successfully  generated, 
subsequent  extensive  sporulation  attempts  failed  to  generate  haploid  strains  carrying  the 
ACPM1 deletion allele. However, when a plasmid-borne, functional copy of the ACPM1 
gene was introduced into the ACPM1/ acpm1::URA3 strain prior to the sporulation, haploid 
acpm1,pACPM1 strains could be isolated. This demonstrated successful complementation 
of  the  deletion  allele  and  excluded  that  second-site  genetic  defects  in  the  diploid 
heterozygous deletion strain had prevented formation of viable haploid deletion spores. This 
experiment  indicates  that  ACPM1  is  an  essential  gene  in  Y.  lipolytica.  To  discriminate 
whether the ACPM1 protein as a whole or just its functional group was required for survival 
serine-66 of ACPM1 with alanine was exchanged. This serine is conserved in all acyl-carrier 
proteins  and  known  to  bind  the  phosphopantethein  moiety.  A  plasmid-borne  copy  of 
ACPM1-S66A was transformed into the heterozygous ACPM1/ acpm1::URA3 strain, but in 
contrast  to  the  wild-type  copy  it  failed  to  complement  the  deletion  phenotype  and  no 
acpm1,pACPM1-S66A spores were obtained. Thus the single amino acid exchange seemed 
to have the same effect as complete removal of the ACPM1 gene.  
In  contrast,  ACPM2  was  found  to  be  not  essential  in  a  strain  carrying  NDH2i  to 
complement for complex I deficiency and a haploid ACPM2 deletion strain (acpm2) was 
obtained. To test whether complex I was affected by deletion of the ACPM2 gene, first its 
activities in mitochondrial membranes prepared from the deletion strain were measured and 
compared to the parental strain (Table 3.1). 
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  parental   acpm2  acpm2,pS88A  ACPM1-strepII  ACPM2-flag 
  µmol min
-1mg
-1 
Mitochondrial membranes           
NADH:HAR oxidoreductase  0.75  0.18  0.17  0.81  0.77 
dNADH:DBQ 
oxidoreductase  0.27  <0.1  <0.1  0.31  0.30 
           
Purified complex I           
NADH:HAR oxidoreductase  45.2  n.d
6  n.d  49.5  48.0 
dNADH:DBQ 
oxidoreductase  3.4  n.d  n.d  3.1  3.0 
                
Table 3.1  Catalytic activities of mitochondrial membranes and complex I 
 
Specific  inhibitor  sensitive  dNADH:DBQ  oxidoreductase  activity  was  lost 
completely. A strong decrease in dNADH:HAR oxidoreductase activity down almost to a 
level typically observed with other complex I deficient strains suggested that the loss of 
complex I activity was due to a very low content of complex I. Remarkably, essentially the 
same loss in activity was observed when a mutated copy of the ACPM2 gene was introduced 
on a plasmid in which the phosphopantethein binding serine-88 was replaced by alanine. The 
loss of complex I was confirmed when mitochondrial membranes from the acpm2 strain 
and the parental strain were analyzed by two-dimensional BN/SDS-PAGE (Figure 3.9A, B). 
In contrast to the parental strain no complex I could be detected by silver staining in the 
ACPM2 deletion strain (Figure 3.9B). The same result was obtained with the mutant version 
lacking serine-88 (Figure 3.9C). The pattern of the other respiratory chain complexes VD, 
VM, III, IV, II and the presence of small amounts of subcomplex F1, corresponding to the 
matrix part of complex V [218] were not affected by the deletion (Figure 3.9). 
                                                    
6 Not determined    
 
 
 
 
Figure 3.9  2D-BN/SDS PAGE analysis of Y. lipolytica mitochondrial membranes 
Protein complexes were resolved by BN-PAGE in the first and by 16 % SDS-PAGE in the second dimension. (A) A typical pattern of the parental strain 
respiratory chain complexes visible from left to right with decreasing molecular weight: ATP synthase dimer (VD), complex I, complex V monomer (VM), 
complex III, complex IV and complex II. (B) acpm2 strain and (C) acpm2pACPM2-S88A strain exhibit lack of complex I assembly. Other respiratory 
complexes appear to assemble normally.                          
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For higher sensitivity and to detect low amounts of possible subcomplexes of complex I 
mitochondrial membranes from the acpm2 strain were further analyzed by Western blotting 
of  two  dimensional  (Blue  Native/SDS)  gels  with  different  antibodies  directed  against 
subunits of complex I (Figure 3.10). In membranes from the parental strain fully assembled 
complex  I  was  found  to  be  the  dominant  form.  In  addition,  several  supercomplexes 
containing  complex  I  together  with  complexes  III  and/or  complex  IV  were  detected  as 
described recently [219]. Most likely these are (from left to right with decreasing molecular 
weight):  complex  I  dimer;  I1III2IV2,  I1III2IV1,  I1III2,  I1IV2,  I1IV1.  Some disintegration of 
complex I into subcomplexes was also observed with monoclonal antibodies directed against 
the 51-kDa and 49-kDa subunits of the peripheral arm and the accessory NESM subunit of 
the membrane arm. With mitochondria from the ACPM2 deletion and the S88A mutant strain 
a very small amount of fully assembled complex I was detected with all three antibodies. 
However, only with the antibody directed against the NESM subunit pronounced signals of 
two  putative  subcomplexes  were  observed.  These  subcomplexes  migrated  in  a  similar 
position as the disintegration products observed with the parental strain at about 700 (marked 
with 1) and 300 kDa (marked with 2), but the fact that they were not detectable by the 
anti-51-kDa and anti-49-kDa antibodies in the ACPM2-mutant strains suggested a different 
composition. Rather, the antibodies directed against the 51-kDa and 49-kDa subunits gave 
strong signals over a broad range of molecular masses that were even more pronounced in 
the ACPM2-mutants. These signals probably reflected the individual subunits and/or small 
subcomplexes  (up  to  about  100  kDa  in  size)  containing  the  respective  subunits. 
Unfortunately, due to the very small amounts available, it was not possible to analyze the 
subunit composition of the subcomplexes any further. 
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Figure 3.10 Complex I subcomplexes in acpm2 and the acpm2,pACPM2-S88A strains 
Western Blot analysis of mitochondrial membranes from the parental strain and strains acpm2 and acpm2, 
pACPM2-S88A is shown. Subcomplexes were detected at positions marked above the picture with 1 and 2  
by antibodies against the 51-kDa, the 49-kDa and the NESM subunit in the parental strain. In strains acpm2 
and pACPM2-S88A only the antibody against the membrane arm subunit NESM indicated subcomplexes in 
these positions suggesting that different subcomplexes of similar size but different composition were detected. 
In strains acpm2 and pACPM2-S88A the majority of the 49-kDa and 51-kDa subunits of the peripheral arm 
were detected close to the front of the gel and only minute amounts of fully assembled complex I denoted with 
(I) were identified. Several supercomplexes (S) of complex I associated with complex III and complex IV as 
described recently in [219] were detected as indicated (S). Positions of the respiratory chain complexes are 
denoted from left to right with decreasing molecular weight: ATP synthase dimer (VD), complex V monomer 
(VM), complex III2, complex IV and complex II.  
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3.1.5  The mitochondrial lipid composition analysed by thin layer chromatography 
To see whether deletion and mutagenesis of ACPM2 had affected the lipid composition, the 
phospholipid content of extracts (2.4.1, materials and methods) from intact mitochondria of 
parental,  acpm2  and  acpm2,pACPM2-S88A  strains  were  analyzed  by  the  thin  layer 
chromatography  (TLC),  (2.4.2,  materials  and  methods).  Phospholipids  separated  in  the 
chromatography run were visualized either by molybdenum dye staining or by scanning the 
TLC sheets containing fluorescent dye F254 with Typhoon Imager.  Regardless of the staining 
method only limited number of phospholipids, phosphatidyl-choline (PC) and phosphatidyl-
ethanolamine (PE) (Figure 3.11A) or PC, PE and cardiolipin (CL) (Figure 3.11B) could be 
identified,  respectively.  Also,  no  difference  in  the  phospholipid  composition  could  be 
observed among the analyzed strains. 
 
 
 
Figure 3.11  Thin layer chromatography (TLC) of lipids extracted from intact 
mitochondria 
The TLC analysis of mitochondrial lipids extracted from the (1) parental, (2) acpm2 and (3) acpm2pS88A 
strains. The following reference phospholipids were used: CL, cardiolipin; PC, phosphatidyl-choline and PE, 
phosphatidyl-ethanolamine.  (A)  Two  bands  corresponding  to  phospholipids  PE  and  PC,  as  well  as  one 
unidentified band were detected by visualisation of the TLC sheet with Molybdenum Blue Spray Reagent; (B) 
Bands corresponding to all reference phospholipids CL, PC and PE, as well as several unidentified bands were 
detected in the TLC sheet containing a fluorescent dye F254 scanned with Typhoon Imager in the blue laser light 
at  488  nm.  No  difference  in  the  lipid  composition  among  analysed  strains  both  in  (A)  and  (B)  could  be 
observed.  
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3.1.6  The mitochondrial lipid composition analysed by HPLC 
The analysis was performed by Dr. Sebastian Richers.  
In order to detect and compare greater spectrum of mitochondrial phospholipids, extracts 
(2.4.3,  materials  and  methods)  from  intact,  sucrose  gradient-purified  mitochondria  of 
parental, acpm2, acpm2,pACPM2-S88A and the nubm strains were analyzed by HPLC. 
The  nubm  strain  carrying  a  deletion  of  the  central  51-kDa  subunit  of  complex  I  was 
included as additional control because of its severe complex I assembly defect  [220].  In 
addition  to  phospholipids  identified  in  the  TLC  (3.1.5),  phosphatidyl-inositol  (PI),  lyso-
phosphatidyl-ethanolamine (LPE) and lyso-phosphatidyl-choline (LPC) were identified in the 
HPLC by comparison to the commercially available standards (Figure 3.12). All lipids were 
detected at very similar ratios in mitochondria  from all strains, such that PC constituted 
almost a half, PE and CL roughly 20% each, whereas PI, LPE and LPC less than 10 % each 
(Figure 3.13). Also the protein to phospholipid ratio was nearly identical in mitochondria 
from all strains (Figure 3.14).  In addition, the analysis was performed with  whole cells, 
mitochondrial membranes and crude intact mitochondria yielding very similar results. 
 
 
Figure 3.12 HPLC profiles of phospholipids extracted from Y. lipolytica mitochondria 
(See the next page) The extracts from intact, sucrose gradient-purified mitochondria (0.5 mg/ml) of the parental, 
acpm2 acpm2,pACPM2-S88A and nubmstrains were analyzed. No significant difference in phospholipid 
composition among analysed strains was found. Two different HPLC profiles for two different analyzed batches 
are  shown.  (A)  Profile  of  a  lower  magnification.  (B)  Chromatogram  of  another  extract  shown  in  higher 
magnification revealed additional unidentified peaks (*), though their amounts did not vary among analyzed 
samples. The  first  prominent  peak,  which  elutes  after  approximately  2  minutes  contains  the  pass  through.  
Abbreviations  used:  CL,  cardiolipin;  PE,  phosphatidyl-ethanolamine;  PI,  phosphatidyl-inositol;  LPE,  lyso-
phosphatidyl-ethanolamine;  LPI,  lyso-phosphatidyl-inositol;  PA,  phosphatidic  acid;  LPA,  lyso-phosphatidic 
acid; PC, phosphatidyl-choline; LPC, lyso-phosphatidyl-choline.                          
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Figure 3.13 The phospholipid composition of purified intact mitochondria 
The relative amount (w/w) of individual phospholipids to the total mass of all phospholipids isolated from the 
intact, sucrose gradient-purified mitochondria of the parental, acpm2, acpm2,pS88A and the nubm strains 
were  determined  by  HPLC  analysis.  The  detected  phospholipids  are:  CL,  cardiolipin;  PE,  phosphatidyl-
ethanolamine; PI, phosphatidyl-inositol; LPE, lyso-phosphatidyl-ethanolamine; PC, phosphatidyl-choline; LPC, 
lyso-phosphatidyl-choline.                         
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Figure 3.14 The phospholipid to protein ratio in intact mitochondria 
The concentration of individual phospholipids relative to the protein concentration in intact mitochondria is 
nearly  constant  as determined in the  HPLC  analysis.  The  detected  phospholipids  are:  CL,  cardiolipin;  PE, 
phosphatidyl-ethanolamine; PI, phosphatidyl-inositol; LPE, lyso-phosphatidyl-ethanolamine; PC, phosphatidyl-
choline; LPC, lyso-phosphatidyl-choline. 
 
3.1.7  Identification of mitochondrial phospholipids with MALDI-TOF-MS 
The analysis was performed by Dr. Sebastian Richers.  
Phospholipids extracted from intact, sucrose gradient-purified mitochondria of Y. lipolytica 
strains were separated on the HPLC column using the standard run as described in 2.4.4, 
materials and methods. Fractions were collected every 30 seconds beginning with time 0 
seconds and were analysed with the matrix-assisted laser desorption ionization time-of-flight       RESULTS 
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mass spectrometry (MALDI-TOF-MS) (2.4.5, materials and methods). All prominent peaks 
of the HPLC chromatogram (Figure 3.13) were identified using MS (for spectra see 9.5, 
appendix). It has been shown that CL was found to be present in fraction (fr) 18 (Figure 9.14, 
appendix) and fr 19 (Figure 9.15, appendix), PE in fr 24 (Figure 9.16, appendix), PI in fr 28 
(Figure 9.17, appendix), LPE in fr 28 (Figure 3.15), phosphatidic acid (PA) in fr 30 (Figure 
9.18, appendix), LPC in fr 52 (Figure 9.19, appendix). It should be noted that the peak for 
LPE was found at a mass of 454.33 Da indicating substitution with a palmitoyl-chain (16:0; 
theoretical  mass  454.29  Da)  rather  than  an  unsaturated  acyl-chain  (Figure  3.15).  All 
phospholipids were measured in the negative charged mode with an exception of LPE and 
LPC, which were measured in the positive mode.  
 
 
Figure 3.15 The MALDI-MS spectrum of lyso-phosphatidyl-ethanolamine identified in 
fraction 28 
Phospholipids isolated from intact mitochondria and separated with HPLC (fraction 28) were identified using 
MALDI-MS. The peak corresponding to LPE obtained in the positive charged mode was found at a mass of 
454.33 Da indicating substitution with a palmitoyl-chain (16:0; theoretical mass 454.29 Da) rather than an 
unsaturated acyl-chain. Masses of the phospholipids determined experimentally are indicated above the spectra 
in black, whereas the theoretical values in violet. Numbers in brackets separated by a colon indicate the number 
of carbon atoms in the acyl-chains (first number) and the number of carbon atoms involved in the double bond 
formation in unsaturated chains (second number).  
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3.1.8  ACPM1 and ACPM2 are bona fide subunits of Y. lipolytica complex I  
The next addressed question was whether one or both of the ACPM-proteins in Y. lipolytica 
were bound to complex I as accessory subunits. In a previous proteomic approach aimed at 
the identification of the accessory subunits of Y. lipolytica complex I ACPM1 had already 
been identified as a component of the purified enzyme by MALDI-TOF mass spectrometry 
[37]. However, the almost complete loss of fully assembled complex I caused by the deletion 
of the ACPM2-gene suggested a tight link between complex I and ACPM2 as well. Indeed, 
thorough analysis of the double-spot in dSDS-PAGE that had previously been shown to 
contain ACPM1 (Figure 3.17A) allowed the unambiguous identification of both ACPM1 and 
ACPM2 by MALDI-MS/MS sequencing of peptides from both proteins (Figure 3.16). 
To confirm this assignment we introduced tagged versions of the two proteins into the 
ACPM deletion strains. Both constructs appeared to be functional, since ACPM1-strepII per-
mitted survival of strain acpm1 (Figure 3.17A) and ACPM2-flag restored normal assembly 
of  complex  I  (Figure  3.17C).  Also  NADH:HAR  oxidoreductase  and  dNADH:DBQ 
oxidoreductase activities of mitochondrial membranes from both complemented strains were 
restored to parental strain levels (Table 3.1). Moreover, also the purified complexes from 
both tagged strains exhibited wild-type catalytic activities indicating normal stability of the 
multiprotein  complex.  This  allowed  dSDS-PAGE  analysis  of  the  tagged  complexes. 
Molecular mass shifts of ACPM1-strepII (Figure 3.17B, red arrow) and ACPM2-flag (Figure 
3.17C,  blue  arrow)  subunits  as compared  to  the  untagged parental  strain  (Figure  3.17A) 
confirmed the assignment of the two proteins that thus have both to be considered bona fide 
subunits of complex I from Y. lipolytica.   
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Figure 3.16  Mass Spectra of ACPM subunits 
MALDI-post-source decay spectra of peptides identified by using y- and b-ions. Identification of (A) the C-
terminal peptide (position 94-109) SVNQAVEYILAQPDAK (MH+ 1745.907) of the ACPM1 protein (Mascot 
Score 42) and (B) the peptide (position 59-73) IVALLESFDKVNDAK (MH+ 1661.911) of the ACPM2 protein 
(Mascot Score 76).  
 
 
 
 
 
 
Figure 3.17  Analysis of tagged versions of ACPMs in dSDS-PAGE 
Both ACPM genes were deleted and replaced with plasmid-borne copies encoding tagged versions of the two proteins. Molecular mass shifts as compared to the 
parental strain (A) are visible in dSDS-PAGE in (B) ACPM1-strepII (red arrow) and (C) ACPM2-flag (blue arrow) complex I.       RESULTS 
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3.1.9  Sub-mitochondrial localization of ACPM1 and ACPM2  
The  next  open  question  was  whether  the  two  ACPMs  were  exclusively  present  as 
complex  I  subunits  in  Y.  lipolytica  mitochondria.  To  answer  this  question  intact 
mitochondria from the Y. lipolytica strains containing the tagged versions of ACPM1 and 
ACPM2 were isolated and soluble and membrane fractions were analyzed by Western 
blotting (Figure 3.18). As controls for the identity and purity of the individual fractions 
aconitase for the mitochondrial matrix,  hexokinase for the cytosol and the complex I 
subunit  NESM  for  the  mitochondrial  membranes  were  used.  Both  ACPMs  were 
exclusively  detectable  in  the  membrane  fraction  but  absent  in  the  soluble  fraction of 
mitochondria and the cytosolic fraction (PMS). This strongly suggested that all ACPM1 
and  ACPM2  in  mitochondria  were  completely  bound  to  complex  I  in  the  inner 
mitochondrial membrane of Y. lipolytica.  
 
 
 
Figure 3.18 Localization of tagged versions of ACPM in mitochondrial fractions 
Intact mitochondria were fractionated into soluble (ms) and membrane (mm) part and analyzed for ACPM 
presence with antibodies specific to strepII- and flag-tags. Neither of them could be detected in the soluble 
fraction  of  mitochondria  nor  in  the  cytosolic  (PMS)  fraction.  Both  ACPMs  were  detectable  in  the 
membrane fraction. Purified complex I (CI) and whole mitochondria (mt) were used as controls. Antiserum 
specific  to  representative  proteins  of  each  fraction  were  used:  aconitase  (soluble  fraction),  hexokinase 
(cytosol) and NESM (complex I, membrane fraction).        RESULTS 
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3.2  Exploration of the st1 subunit of complex I from Y. lipolytica  
3.2.1  Identification of a rhodanese-like protein in purified complex I 
Upon gel filtration chromatography, His-tagged Y. lipolytica complex I, as Ni
2+-affinity 
purified from n-dodecyl--D-maltoside solubilised mitochondrial membranes, elutes as a 
single, symmetrical peak, indicating excellent purity and homogeneity (Figure 3.19A). A 
protein  with  an  apparent  molecular  mass  of  34.6  kDa  (Figure  3.19B)  previously  not 
detected in complex I from other sources was found to be consistently present even in the 
purest preparations.  
 
 
Figure 3.19 Gel filtration purified complex I contains rhodanese-like protein 
(A) Elution profile of Y. lipolytica complex I purified by Ni
2+ affinity chromatography. The elution profile 
of a TSK4000 column run with purified complex I was monitored by measuring A280 for protein (upper 
trace) and A415 for flavine mononucleotide and iron-sulfur clusters (lower trace). Experimental details 
were as described in [221]. (B) SDS-PAGE of purified Y. lipolytica complex I. Coomassie stained 16% 
tricine-SDS gel with 30 µg of complex I from the parental and the sulfurtransferase deletion (st1) strains. 
The band corresponding to the sulfurtransferase protein is marked with an arrow. The sulfurtransferase 
seems to be present in substoichiometric amounts in the parental strain and is clearly absent in the deletion 
strain.             
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Figure  3.20  MALDI-TOF  mass  spectrum  of  in-gel  digested  34.6 kDa  protein  of  Y. 
lipolytica complex I 
The protein spot was excised from a dSDS gel and digested with trypsin. The peptide mixture was analyzed 
by MALDI-TOF mass spectrometry using peptide mass fingerprinting (PMF). Sequence coverage was 38% 
using 50 ppm error margin. Tryptic peptides identified by MALDI-TOF MS are marked with asterisks. The 
analysis was performed by Dr. Albina Abdrakhmanova.  
 
Peptide 
residues
7  
Expected mass
8 
(MH+) 
Observed 
mass  Sequence 
4 – 12  941.5666  941.5909  LISPAELAK 
21 – 36  1792.9268  1792.9731  IFDATWYLPTPANVGK 
37 – 44  1018.4298  1018.4766  NAYDNYMK 
81 – 102  2280.1506  2280.2307  LGVSSDSPIVVYDTQGVFSGPR 
103 – 108  793.4607  793.4671  LVWTFK 
150 – 158  1015.5094  1015.4961  IDPADPPYK 
169 – 179  1249.6674  1249.7283  SFEDVLAIVEK 
211 – 234  2458.2248  2458.2461  AELSSGHVPGAYSIAFPEVVENGK 
282 – 297  1898.8303  1898.9119  DTNAVYDGSWTEWAQR 
 
Table 3.2 Tryptic peptides of the 34.6 kDa protein identified by MALDI-TOF MS 
Its  content  relative  to  other  complex  I  proteins  seemed  variable  and  appeared 
substoichiometric in most preparations. Using dSDS-PAGE [205], followed by MALDI-
TOF mass spectroscopic analysis (Figure 3.20) of tryptic fragments (Table 3.2) enabled 
identification of this protein.  
                                                    
7 residue numbers refer to the mature amino acid sequence 
8 the monoisotopic single protonated mass of the peptides is shown.       RESULTS 
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Species, enzyme, NCBI accession   Similarity 
 
(%)   Identity (%)  
Probability of 
mitochondrial import 
 
(%)  
E. coli MST (JX0320)   47   39   not applicable  
A. vinelandii MST (ZP_00415650)   45   35   not applicable  
A. vinelandii TST (S62187)   35   26   not applicable  
S. tokodaii TST1 (BAB66874)   38   31   not applicable  
S. tokodaii TST2 (BAB67675)   38   30   not applicable  
Y. lipolytica MST (CAG78604)   (100)   (100)   27  
S. cerevisiae MST (NP_014894)   48   37   5  
N. crassa MST (XP_325872)   50   38   99  
P. anserina MST (CAD60606)   54   42   100  
T. aestivum MST (AAK64575)   48   39   1  
A. thaliana MST1 (AAC17062)   46   37   99  
A. thaliana MST2 (AAM61125)   46   39   1  
C. elegans MST (NP_501461)   38   28   17  
D. rerio MST (AAH74047) 
 
  51  35   91  
G. gallus MST (XP_416283)   53   41   60  
G. gallus TST (XP_416284)   51   42   86  
B. taurus TST (NP_803455)   53   36  83  
B. taurus MST (NP_001029463)   52   34   75  
H. sapiens TST (Q16762)   54  36   82  
H. sapiens MST (P25325)   50   37   75  
Table 3.3.  Similarity and identity scores for pairwise comparisons between Y. lipolytica 
sulfurtransferase and tandem rhodanese domain repeat enzymes from other 
organisms 
The  alignments  were  created  using  the  GAP  programme  from  the  HUSAR  (genius.embnet.dkfz-
heidelberg.de) program package in standard mode. The probability of mitochondrial import was calculated 
using MitoProt II software (http://ihg.gsf.de/ihg/mitoprot.html).  
 
 
The recently identified protein corresponds to NCBI protein data base entry CAG78604, 
TrEMBL entry Q6C0L9_YARLI and to open reading frame YALI0F23551g in the Y. 
lipolytica  genomic  sequence  as  deposited  at  the  Genolevures  site 
(http://cbi.labri.fr/Genolevures/index.php). Sequence coverage was 38% using a 50 ppm 
error margin. Predicted protein CAG78604 exhibits no homology to any other known 
subunit  of  complex  I  from  other  organisms  but  shows  up  to  about  50%  sequence  
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similarity  and  40%  sequence  identity  to  members  of  the  sulfurtransferase  family,  in 
particular  to  tandem  rhodanese  domain  repeat  enzymes  like  thiosulfate:cyanide 
sulfurtransferases  (TSTs)  and  3-mercaptopyruvate:  cyanide  sulfurtransferases  (MSTs) 
from various sources (Table 3.3).  
 
3.2.2  Generation of the st1 deletion strain (st1 
To determine role of the sulfurtransferase (st1) associated with Y. lipolytica complex I the 
corresponding gene was deleted. The intronless open reading frame (ORF) encoding a 
protein of 315 amino acids, together with its flanking DNA was replaced by homologous 
recombination with URA3-marked deletion allele (Figure 3.23).  
First, the region encompassing the entire ORF and roughly 1100 bp of upstream 
and 600 bp of downstream sequence was amplified in the PCR reaction with Taq DNA 
polymerase  using  primers  st1f/  st1r.  Subsequently,  the  fragment  was  cloned  into  the 
pCR2.1 vector (Figure 3.21a, b), amplified in E. coli cells and transferred to EcoRI site of 
the pUC19 vector. 
 
 
 
Figure 3.21  Steps of st1 strain generation 
 (a) A 2.7 kb fragment composed of st1 gene ORF with its flanking regions produced by PCR using primer 
pair st1f/ st1r; (b) A 3.9 kb pCR2.1 plasmid containing the st1 insert excised with EcoRI restriction enzyme; 
(c) A construct of 3.9 kb composed of the plasmid pUC19 and flanking regions of the st1 gene generated 
by  PCR  using  primers  st1SalI/  st1BamHI;  (d)  A  2.7  kb  pUC19  plasmid  containing  a  1.7  kb  URA3 
fragment excised with BamHI and SalI enzymesSize of the fragments of the molecular weight marker (M) 
is indicated on the left side of the agarose gel in kilobase pairs (kb).   
       RESULTS 
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For  generation of  genetically  marked  st1  deletion  allele  a  gap  comprising  the 
entire open reading frame and 55 bp of upstream sequence was created by PCR using 
primers st1SalI/ st1BamHI (Figure 3.21c). The resulting product was digested with SalI 
and BamHI and ligated with a 1.7 kb SalI/ BamHI fragment containing the Y. lipolytica 
URA3 gene, which had been generated by PCR using primers ura3f/ ura3r (Figure 3.21d), 
In the deletion construct, orientation the URA3 was opposite to the orientation of st1 gene. 
  In  order  to  improve  selection  efficiency,  in  addition  to  URA3  gene,  another 
selection marker, the hygromycin B resistance gene (HygB
R) was cloned into the HindIII 
site  of  the  deletion  construct  (pUC19st1::URA3),  (Figure  3.23).  To  assure 
incorporation of a single HygB
R insert, length of the constructed vector was checked by 
linearization  with  BamHI  (Figure  3.22).  The  final  construct  was  sequenced  and 
transformed into haploid Y. lipolytica GB10 cells.  Subsequently, strains were selected on 
minimal plates for their ability to grow in the absence of uracil and their inability to grow 
in the presence of hygromycin B.  
 
 
 
Figure 3.22  Test digest for the number of hygromycin B inserts  
In order to assure incorporation of only one hygromycin B resistance gene (HygB
R) into the HindIII site of 
the st1 deletion construct (pUC19 st1::URA3, HygB
R), the vector was linearized with BamHI enzyme. A 
strain carrying (a) single copy of HygB
R gene was verified by sequencing and transformed into GB10 cells. 
Plasmids that incorporated multiple copies of HygB
R genes: (b) 2, (c) 3 and (d) 4 were discarded. Size of the 
fragments of the molecular weight marker (M) is indicated on the left side of the agarose gel in kilobase 
pairs (kb).   
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To ensure proper integration of the deletion constructs into genomic locus of st1 
gene, transformants were tested by PCR using primers: st1f and st1r, which bind to the 
flanking  DNA  upstream  and  downstream  to  st1  ORF,  respectively;  ura3ds2,  ura3us2 
binding to the deletion construct and st1seq2, st1seq5 binding to the ORF of st1 gene 
(Figure 3.24).  The GB10strain carrying a wild-type copy of the st1 gene was used as a 
control.  Presence of the st1 gene in the GB10 was confirmed in a PCR reaction using 
primer pairs st1f/ st1r and st1seq2/ st1seq5, which yielded products of 2.8 kb and 0.7 kb, 
respectively  (Figure  3.24a,  d).  Absence  of  the  URA3  gene  in  the  GB10  strain  was 
confirmed  using primers  st1f/  ura3ds,  ura3us/ st1r,  since no product  with  any  of  the 
primers was obtained (Figure 3.24b, c).  
Proper integration of the st1 construct into the chromosomal locus of the st1 
gene was confirmed using primer pairs st1f/ st1r, st1f/ ura3ds, ura3us/ st1r and st1seq2/ 
st1seq5,  since  products  of  3.4  kb,  1.2  kb,  0.8  kb  and  no  product,  respectively  were 
obtained. This indicated presence of the URA3 gene on the chromosome in the genomic 
locus of st1 in the st1strain (Figure 3.24e, f, g) and confirmed absence of the st1 gene 
(Figure 3.24h).  
 
 
 
 
 
Figure 3.23  Strategy for generation of the st1 strain 
A  EcoRI  linearized  construct  containing  the  URA3-marked  st1  deletion  allele  and  the  hygromycin  B 
resistance gene (HygB
R) used for deletion of st1 gene by double homologous recombination (indicated by 
crosses). The st1 deletion (st1 strains were selected for their ability to grow in the absence of uracil and 
their inability to grow in the presence of hygromycin B. The location of PCR primers is indicated by violet 
arrows.  
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Figure 3.24 PCR test for deletion of the st1 gene 
PCR test for proper integration of the URA3-marked deletion construct into the genomic locus of the st1 
gene. Genomic DNA isolated from Y. lipolytica GB10 and st1strains was verified in the PCR reaction 
using primers (a, e) st1f/ st1r; (b, f) st1f/ ura3ds; (c, g) ura3us/ st1r and (d, h) st1seq2/ st1seq5. In case of 
GB10 strain containing the st1 gene fragments of (a) 2.8 kb and (d) 0.7 kb were created, whereas in (b) and 
(c) no products were obtained. The st1 strain, containing an integrated URA3 gene replacing the st1 gene 
resulted in PCR products of (e) 3.4 kb, (f) 1.2kb and (g) 0.8 kb, whereas no product in (h) was obtained. For 
localization of primers see Figure 3.23 and 9.1.1, appendix. Size of the fragments of the molecular weight 
marker (M) is indicated on the left side of the agarose gel in kilobase pairs (kb).   
 
 
3.2.3  Complementation of st1 strain with a plasmid carrying st1-strepII  
The st1 strain complemented with a plasmid-borne strepII-tagged version of the st1 gene 
(st1pst1-strepII) was generated by PCR amplification of  the st1 ORF with flanking 
regions  (see  Figure  3.23)  integrated  in  the  pCR2.1  vector  using  primers  st1strepIIf/ 
st1strepIIr. As a result the st1 ORF was extended by 8 amino acids WSHPQFEK at the C-
terminus. The st1-strepII gene was cloned into the EcoRI site of the replicative plasmid 
pUB4 [196] and the orientation and number of incorporated inserts was checked by test 
digestion with EcoRI, NheI and NdeI restriction enzymes (Figure 3.25). Verified vector 
was sequenced (Figure 3.26) and transformed into Y. lipolytica st1cells. Strains were 
selected on minimal plates for their ability to grow in the absence of uracil and their 
inability to grow in the presence of hygromycin B. Furthermore, st1 strain transformed 
with a functional copy of the st1 gene on plasmid pUB4 (st1pst1) was generated and 
will be referred to as parental strain here.  
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Figure 3.25 Test digest of the pUB4 plasmid containing the st1-strepII insert 
The test digest of the pUB4 plasmid carrying the st1-strepII gene with (a) EcoRI results in fragments of 8.0 
kb and 2.7 kb. To assure integration of a single st1-strepII insert the pUB4 plasmids were test digested with 
NheI and NdeI enzymes. The NheI digestion of (b) an empty pUB4 plasmid and (c) the plasmid containing 
the st1-strepII insert, results in (a) 3.5, 4.5 kb and (b) 4.5, 6.2 kb fragments, respectively. Whereas, the NdeI 
digestion of (d) an empty pUB4 plasmid and (e) the plasmid carrying the st1-strepII insert, results in (d) 
3.3, 4.7 kb and (e) 4.7, 6.0 kb fragments, respectively. See also map of pUB4 plasmid in  
See next page for description. 
Figure 2.1, materials and methods. Size of the fragments of the molecular weight marker (M) is indicated 
on the left side of the agarose gel in kilobase pairs (kb).   
  
 
 
 
 
 
Figure 3.26 Section of DNA sequence pherogramm from the st1-strepII strain  
The st1 ORF was extended by 8 amino acids WSHPQFEK (strepII-tag) at the C-terminus as verified by 
sequencing using primer st1seq6. For localization of the primers see 9.1.1, appendix.  
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3.2.4  Purified Y. lipolytica complex I displays rhodanese activity 
To find out whether the rhodanese-homologue present in the complex I preparation was 
functional  thiosulfate:  cyanide  sulfurtransferase  activity  was  measured.  A  specific 
rhodanese activity of 12.1 nmol min
-1 mg
-1 was measured for complex I purified from Y. 
lipolytica strain GB10 (Table 3.4). Assuming that each molecule of Y. lipolytica complex 
I  with  a  molecular  mass of  around 900  kDa  is  associated  with 0.5  molecules of  the 
sulfurtransferase subunit a turnover number of ~27 min
-1 was estimated for the rhodanese 
activity associated with complex I. Negligible rates of thiocyanate formation (<0.1 nmol 
min
-1 mg
-1) were observed when complex I was replaced by bovine serum albumin. Also, 
no rhodanese activity (<0.1 nmol min
-1 mg
-1) was detected with purified complex I from 
bovine heart mitochondria [222]. This is consistent with the fact that no sulfurtransferase 
orthologue was found to be associated with the purified mammalian enzyme [35]. Thus, 
although the observed rate is rather low as compared to rhodanese from bovine heart 
[210], it was clearly specific for the newly identified protein. 
 
3.2.5  The rhodanese deletion strain 
To test whether the sulfurtransferase activity of the newly identified protein was required 
for  complex  I  biogenesis  or  the  synthesis  of  its  iron-sulfur  clusters,  the  entire  open 
reading frame of the corresponding gene was deleted from the Y. lipolytica genome by 
homologous recombination replacing it by the URA3 marker gene. The st1 strain was 
fully viable, moreover yielded considerably higher cell mass than the GB10 wild-type 
strain, regardless whether grown in minimal- or YPD complete-medium (Figure 3.27) . 
The growth rate difference was more pronounce as cells were grown in the complete 
medium (for composition of media see 2.1.4, materials and methods). 
 
  
 
 
90 
 
 
Figure 3.27  Growth curves of the st1strain of Y. lipolytica 
Y. lipolytica strain deprived of rhodanese – st1red traceyielded considerably higher cell mass than the 
GB10  wild-type  strain  (green  trace) regardless  whether  grown  in (A)  minimal  synthetic-  or  (B)  YPD-
medium,  both  supplemented  with  2%  glucose  as  carbon  source.  The  growth  rate  difference  is  more 
pronounce as cells were grown in the YPD, full medium.  
 
 
Mitochondrial membranes of the st1 strain contained fully assembled complex I 
at near wild type expression levels, as judged by BN-PAGE (Figure 3.28). NADH:HAR 
oxidoreductase activities of the membranes also indicated that the deletion did not reduce 
complex I expression (Table 3.4). In fact, we observed a slight tendency for increased 
complex I contents in membranes from the st1 strain, but further studies will be required 
to test whether this difference is significant.  
       RESULTS 
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Figure 3.28 BN-PAGE of mitochondrial membranes from st1 strain 
Mitochondrial membranes isolated from GB10 and st1 strains were solubilised with 1.6 gram n-dodecyl-
-D-maltoside per 1 gram of protein (1.6 g/g DDM) and 3 g/g digitonin and visualized in BN-PAGE. (a) 
GB10  1.6  g/g  DDM,  (b)  st1g/g  DDM,  (c)  GB10  3  g/g  digitonin,  (d)  st1  3  g/g  digitonin. 
Mitochondrial  membranes  of  the  st1  strain  contained  fully  assembled  complex  I  at  near  wild  type 
expression levels. This result could be confirmed regardless of the detergent used for solubilisation of the 
membranes. 
 
Except for the 34.6 kDa band that was missing in the deletion strain, complex I 
purified from the st1 strain exhibited the same subunit pattern in standard tricine SDS-
PAGE  as  the  parental  strain  (Figure  3.19B).  More  detailed  analysis  of  the  subunit 
composition by dSDS-PAGE [205] confirmed this finding suggesting that the stability of 
complex I was not significantly affected.  
Although,  upon  gel  filtration  chromatography  st1  subunit  remained  bound  to 
complex I (Figure 3.19A), association of the subunit to complex I is not strong enough to 
resist  BN-PAGE.  St1  subunit  dissociated  from  complex  I  even  if  the  mild  detergent 
digitonin was used for mitochondrial membrane solubilisation, as demonstrated using the 
tagged version of the protein (st1-strepII) specifically detected with alkaline phosphatase-
conjugated streptavidin (Figure 3.29).   
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Figure 3.29 St1 subunit dissociates from complex I in BN-PAGE 
Mitochondrial membranes isolated from the st1-strepII strain were solubilised with 3 g/g digitonin or 0.8 
g/g n-dodecyl--D-maltoside (DDM) and resolved in two dimensional BN-SDS PAGE (2.3.9, materials and 
methods). After transferring proteins to a  polyvinylidendifluoride membrane and probing with alkaline 
phosphatise-conjugated streptavidin (2.3.7, materials and methods) the st1-strepII protein was detected at 
the front of BN-PAGE indicating migration of dissociated protein.  
 
 
As expected if the deleted gene coded for the sulfurtransferase associated with 
complex I, rhodanese activity was not detectable in purified complex from the deletion 
strain  (Table  3.4).  Inhibitor  sensitive  dNADH:DBQ  activities  in  mitochondrial 
membranes and purified, lipid-reactivated complex I were very similar for the parental 
and the deletion strain (Table 3.4) and were within the range of typical variations between 
preparations. 
  
                                
        NADH:HAR oxidoreductase  dNADH:DBQ oxidoreductase  Rhodanese activity 
        (mol min
-1mg
-1)    (mol min
-1mg
-1)    (nmol min
-1mg
-1) 
                                
                     
Parental strain                   
Mitochondrial membranes      1.1      0.4      See text   
Purified complex I    45      3.5      12.1   
                     
st1 strain                     
Mitochondrial membranes      1.0      0.4      See text   
Purified complex I    53      3.2      <0.1   
                                
 
Table 3.4   Activities of mitochondrial membranes and purified complex I from Y. 
lipolytica 
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EPR spectra of iron sulfur clusters N1, N2, N3 and N4 of purified complex I 
revealed that neither the signal intensities nor the positions of characteristic g values 
differed between the parental and the deletion strain (Figure 3.30). EPR spectra were 
recorded by Dr. Klaus Zwicker. 
 
Figure 3.30  EPR spectra of complex I from the parental and the deletion strains 
Complex I was reduced with NADH and spectra were recorded under the following conditions: microwave 
frequency 9.47 GHz, modulation amplitude 0.64 mT, microwave power 1 mW, sample temperature 12 K. 
Spectra show contributions from clusters N1, N2, N3 and N4 [58]. No changes could be observed in EPR 
spectra of the mutant in comparison with the parental strain enzyme. 
 
To test for the presence of other sulfurtransferases in Y. lipolytica, also rhodanese 
activities  in  mitochondrial  membranes  were  measured.  Activities  were  found  to  vary 
considerably between 3 and 9 nmol min
-1 mg
-1 between different batches of membranes 
from  both  the  parental  and  the  deletion  strain.  By  comparing  the  increase  from 
membranes to purified complex I in NADH:HAR oxidoreductase and rhodanese specific 
activities,  it  can  be  estimated  that  the  sulfurtransferase  associated  with  complex  I 
contributed  no  more  than  about  5%  of  the  total  rhodanese  activity  present  in 
mitochondrial membranes.       DISCUSSION 
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4  DISCUSSION 
4.1  Acyl carrier proteins 
Individual  deletion  of  the  genes  for  the  two  mitochondrial  acyl-carrier  protein 
homologues ACPM1 and ACPM2 revealed that both proteins serve important functions 
in Y. lipolytica. While in the absence of ACPM2 only trace amounts of fully assembled 
complex I could be detected in mitochondrial membranes, ACPM1 even seems to be 
indispensable for survival. This clear difference is quite remarkable considering that the 
mature forms of the two proteins are of very similar size [110] and exhibit a sequence 
similarity  of  81%  with  63%  identical  amino  acids  (Figure  4.1).  Also,  predicted  3D-
structures of both proteins are almost identical (Figure 4.2). Despite of this similarity, no 
or only partial cross-complementation between the two genes was observed. The fact that 
ACPM1 turned out to be essential for survival of Y. lipolytica indicated an important role 
for viability that could not be compensated by ACPM2. In return the role of ACPM2 in 
assembly and stability of mitochondrial complex I could not be taken over by ACPM1. 
Two scenarios could accommodate these findings. On one hand it could be envisioned 
that the two mitochondrial acyl-carrier proteins have entirely different and independent 
functions. However, this seems unlikely considering their very high similarity and the fact 
that neither of the proteins seems to contain functional domains not present in the other.  
 
 
 
Figure 4.1  Sequence alignment of ACPM1 and ACPM2 from Y. lipolytica 
The  protein  sequences  were  aligned  using  the  CLUSTALW  software  (http://www.ebi.ac.uk/clustalw/ 
index.html)  and  adjusted  manually  in the  presequence  region  to reduce  the number  of  large  gaps.  *  - 
identical  amino  acids;    :  -  conservative  substitutions;  .  -  semi-conservative  substitutions.  Small  and 
hydrophobic amino acids are represented in red, acidic residues in blue, basic residues in magenta; hydroxyl 
and  basic  residues  in  green.  The  mitochondrial  presequences  predicted  with  the  MitoProt  II  software 
(http://ihg2.helmholtz-muenchen.de/  ihg/mitoprot.html)  are  underlined  and  the  site  of  processing  is 
indicated by a black triangle. 
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Alternatively,  the  two  proteins  could  operate  together  e.g.  by  forming  a 
heterodimer responsible for both functions. In this case, one would have to postulate that 
in the deletion strains a homodimer of ACPM1 but not of ACPM2 could be formed to 
take over the function essential for survival and that on the other hand, both proteins 
would be necessary for complex I assembly and stability. In agreement with a similar 
function  for  ACPM1  and  ACPM2,  we  also  found  that  removal  of  the  conserved 
phosphopantethein carrying serines in either of the two proteins had the same effect as 
deletion of the complete reading frame. It should be noted here that it has been shown in a 
previous  study  using  laser  induced  liquid  beam  ion  desorption  mass  spectrometry 
(LILBID-MS) that both proteins carry an additional mass of about 560 Da consistent with 
the binding of phosphopantetheine-hydroxy-tetradecanoate [110].  
Before  LILBID-MS  was  used  to  prove  the  post-translational  modification  of 
ACPMs, a modification could be suspected from anomalous migration of both ACPMs in 
the dSDS-PAGE, namely all hydrophilic subunits localize on the diagonal of the dSDS 
gel,  whereas  ACPMs  were  always  present  slightly  underneath  it  (Figure  4.4A). 
Tetradecanoate has been previously detected on N. crassa ACPM [150], moreover the 
same acyl intermediate has been reported to confer a post-translational modification to 
ND5  subunit  of  complex  I  from  this  organism.  Thus,  ACPM  was  postulated  to  be 
involved in the synthesis or delivery of myristic acid [223], which could enhance proper 
assembly  of  complex  I  by  anchoring  the  ND5  subunit  to  the  membrane  and  thus 
stabilizing its interaction with the rest of the complex I. This hypothesis seems to be 
supported  by  the  fact  that  deletion  of  ACPM  from  N.  crassa  indeed  results  in 
destabilization of complex I [98]. Although, no myristoyl post-translational modification 
of  ND5  subunit in  Y.  lipolytica  complex  I  could be predicted9,  lack of  the  ACPM2 
subunit  had  even  more  severe  effects  on  the  complex  assembly,  since  mostly 
subcomplexes and only trace amounts of fully assembled complex I could be detected 
(Figure  3.10,  results).  Another  reason  for  detection  of  3-hydroxytetradecanoate 
modification bound to the ACPM in mass spectrometric analysis could be the fact that 
this  particular  modification  is  one  of  the  most  stable  intermediates  of  the  fatty  acid 
synthetic pathway.  
                                                    
9 N-terminal myristoylation sites could not be predicted with the Expasy Tool Myristoyl CoA:Protein N-
myristoyltransferase        DISCUSSION 
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In  addition  to  the  phosphopantetheine-binding  domain  both  proteins  contain  a 
region, which is similar to the calcium-binding domain, however, it turned out to that it is 
not capable of ion binding. 
 
 
 
Figure 4.2  Predicted structures of ACPMs from Y. lipolytica 
The ribbon representation of mature ACPM1 (red) superimposed with mature ACPM2 subunit (blue). The 
phosphopantetheine-binding serines are represented in sphere models, the Ser66 of ACPM1 (green) and the 
Ser88 of ACPM2 (cyan) in Y. lipolytica nomenclature. Both structures were predicted by comparison to the 
Toxoplasma gondii apicoplastal ACP, which exhibited 39% sequence identity to the ACPM1 and 27% to 
the  ACPM2.  Models  were  prepared  using  QuickPhyre  software  [224]  and  superimposed  with  CCP4 
Molecular graphics software [158]. 
 
The observation that the residue binding the phosphopantethein moiety is of critical 
importance was in line with the postulated role of the ACPMs in the lipid metabolism of 
mitochondria.  Indeed,  it  has  been  reported  that  disruption  of  the  ACPM  subunit  of 
complex  I  from  N.  crassa  results  in  a  four-fold  increase  of  lysophospholipids  in 
mitochondrial membranes [98]. However, in the ACPM2 deletion strain of Y. lipolytica 
no  changes  in  the  phospholipid  composition  of  the  mitochondria  could  be  observed 
(Figure 3.12 and Figure 3.13, results). 
In Y. lipolytica both ACPMs were found to be tightly and exclusively associated 
with complex I and no protein was detected in any mitochondrial compartment other than 
the  mitochondrial  membranes  (Figure  3.18,  results).  This  in  striking  contrast  to  the 
situation  in  other  organisms  analyzed  so  far.  In  mammalian  mitochondria,  where  the 
ACPM protein was first identified as the SDAP subunit of complex I [152], the major  
 
 
98 
portion of this protein is detectable in the mitochondrial matrix  [124]. In Arabidopsis 
none of the three ACPM isoforms seems to bind tightly to complex I [123].  
 
 
Figure 4.3 Hydropathy plots of ACPM subunits 
The  hydrophobicity  plots  of  (A)  the  ACPM1  and  (B)  the  ACPM2  subunits  were  simulated  using  the 
Software  Hydrophobicity  Plots  (Molecular  Toolkit,  Colorado  State  University,  USA; 
http://www.vivo.colostate.edu/  molkit/ hydropathy/index.html).  The  y-axis  represents  the  Kyte-Doolittle 
hydrophobicity  scale,  where  the  positive  values  represent  hydrophobic,  whereas  negative  hydrophilic 
character of the amino acids. On the x-axis the amino acid number is indicated. The window size, which is 
the number of amino acids examined at a time to determine the point of hydrophobic character, was set to 7. 
 
This suggests that the functionality of the ACPMs is independent of their location, 
i.e. whether they are bound as subunits to complex I or reside in the mitochondrial matrix. 
Notably,  ACPM  is  also  found  in  S.  cerevisiae  which does not  contain mitochondrial 
complex I and is devoid of all other complex I genes [83]. 
While ACPM1 seems to be an essential gene in Y. lipolytica, N. crassa carrying a 
disrupted acp-1 gene - the only gene coding for an ACPM protein in this organism [225] - 
is  viable.  The  functional  basis  of  this  observation  remains  unclear.  With  respect  to 
assembly of complex I the effects are similar in both organisms. Disruption of the acp-1       DISCUSSION 
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gene in N. crassa results in lack of assembly of the peripheral arm and improper assembly 
of the membrane part [98] and deletion of the ACPM2 gene in Y. lipolytica results in a 
severe  assembly  defect  of  complex  I  and  generation  of  subcomplexes  (Figure  3.30, 
results). In line with a role in the stabilization of complex I, evidence exists that ACPM1 
and ACPM2 seem to be located at the interface between the peripheral and the membrane 
arm of complex I, because both proteins were not found in either of these fragments that 
can  be  prepared  by  treating  purified  complex  I  with  the  chaotropic  detergent  lauryl-
dimethylamine-oxide [37]. Furthermore, when incubated with this detergent also bovine 
heart complex I splits into subcomplexes I and I (Figure 1.5, introduction) that both 
contain the ACPM homologous subunit SDAP [35]. Additional evidence indicating that 
ACPMs  reside  on  two  different  subcomplexes  is  provided  by  an  experiment,  where 
complex I from Y. lipolytica was deprived of the NUJM subunit. This deletion resulted in 
generation of two subcomplexes roughly corresponding to a300 kDa large distal part 
of the membrane arm anda 700 kDa large remaining part of the complex (Kaiser, 
Krack  et  al,  unpublished).  Purified  analyzed  with  dSDS  was  shown  to  contain 
ACPM1,  however,  it  lacked  among  others  the  ACPM2  subunit  (Figure  4.4).  If  the 
assumption that ACPMs form a dimer is correct, one has to conclude that the interaction 
between these two proteins is not strong enough to hold both subcomplexes together.  
Moreover, lack of predicted transmembrane helices
10 in ACPMs (for hydrophaty 
plots see Figure 4.3), as well as the fact that assembly of complex I was not affected by 
attaching  C-terminal  affinity-tags  to  ACPMs  (Figure  3.17,  results)  may  suggest 
localization of these proteins close to the surface of  the complex. 
                                                    
10 Predicted using servers http://www.enzim.hu/hmmtop/ and http://www.cbs.dtu.dk/services/TMHMM/ 
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Figure 4.4 Deletion of the NUJM complex I subunit leads to formation of 
subcomplexes 
Doubled SDS-PAGE of Y. lipolytica complex I isolated from (A) wild-type and (B) nujm strain. Deletion 
of single transmembrane domain subunits (STDs) – NUJM or NIAM (not shown) results in destabilisation 
of  complex  I  and  formation  of  subcomplexes  of  approximately  300  kDa  and  700  kDa.  The  larger 
subcomplex is composed of complex I lacking the distal part of the membrane embedded arm, whereas the 
smaller    constitute  two  central  hydrophobic  core  subunits  ND4  and  ND5  and  several  neighbouring 
accessory subunits NIAM (STD), NESM (STD), NIDM, NI2M, NB8M and ACPM2. Subunits belonging to 
the 700 kDa complex are denoted in black, to the 300 kDa in red and the NUJM subunit in green (Figure 
provided by Silke Kaiser, unpublished). 
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Following the assumption that ACPMs are involved in the synthesis of octanoic 
acid as a precursor for lipoic acid, sporulation of the ACPM1/acpm1::URA3 strain was 
performed in the presence of 10 µg/ml lipoic acid, but again, no viable acpm1 spores 
could be isolated. However, the significance of this result is unclear since it has been 
reported that N. crassa mitochondria are not able to take up exogenously added lipoic 
acid [166].  
The reason of ACPM association with complex I is not clear, however, many other 
accessory subunits are also involved in various metabolic pathways.  It is possible that 
some of the enzymatic activities are associated to complex I because the corresponding 
proteins use the complex as a tether to the inner membrane.  One may speculate that the 
immobilisation of a soluble FAS component could confer an evolutionary intermediate 
stage of the FAS type I complex, where all enzymatic activities reside on one or two 
polypeptide chains in multi-domain biosynthetic machinery.  
Further studies will be required to better understand why the deletion of the ACPM1 
gene is essential for survival and why the highly similar ACPM2 gene is not. Differences 
between species seem to suggest that the exact role of ACPMs in mitochondrial fatty acid 
metabolism and complex I assembly may vary among species.  
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4.2  Rhodanese 
 
A  protein  associated  with  Y.  lipolytica  complex  I  has  been  identified  as  a  functional 
sulfurtransferase. The additional protein was not only present in complex I purified by Ni
2+ 
affinity  chromatography,  but  a  protein  band  of  the  same  molecular  mass  had  also  been 
detected before in Y. lipolytica complex I purified by ion exchange chromatography [58]. 
This suggests that although the protein was usually found in substoichiometric amounts, it 
may be considered as a bona fide subunit of Y. lipolytica complex I. Specific interaction with 
complex  I  is  also  suggested by  the  fact  that some  mutants of  the 39  kDa  subunit of  Y. 
lipolytica complex I significantly affect sulfurtransferase levels in purified complex I [226], 
(Figure 4.5). Moreover, partial loss of subunits upon purification has also been observed for 
the 42 kDa subunit of bovine complex I [35]. In mammals and probably also in complex I 
from  other  species  that  were subjected to proteomic  analysis  [38;39],  a  sulfurtransferase 
subunit was not identified so far. This may suggest that in these organisms the interaction is 
too weak to detect the protein in the purified complex.  
Deletion of the gene encoding the sulfurtransferase associated with complex I from 
the Y. lipolytica genome had no effect on complex I assembly, catalytic activity and its EPR 
detectable  iron-sulfur  clusters.  This  indicated  that  it  is  not  essential  for  complex  I 
biosynthesis.  
The relatively low sulfurtransferase activity of the st1 subunit of Y. lipolytica complex 
I (Table 3.4, results), can be explained by comparison of its active site-loop sequence to the 
typical active-site of TSTs and MSTs enzymes (Figure 4.6), (Figure 9.6, appendix). The st1 
subunit  sequence  exhibits  a  classic  MST  active-site  loop,  whereas  the  sulfurtransferase 
activity  of  the  st1  subunit  was  assayed  using  thiosulfate  as  substrate,  against  which  the 
enzyme could have had lower affinity.   
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Figure 4.5  Doubled SDS-PAGE of complex I isolated from 39kDa subunit mutant strains 
Coomassie stained dSDS-gels with 70-80µg complex I isolated from 39kDa subunit mutant strains. All complex 
I subunits, with the exception of st1, are present in stoichiometric amounts. Variations in the amount of the st1 
subunit from normal in the parental strain to completely missing subunit in the R65D strain are indicated with 
red arrows. Reprinted form [227]. 
 
 
 
TST      CR X     GX[R/T] 
MST      CG[S/T]GV T 
ST1       CG S     GV T 
 
Figure 4.6 Sequence comparison of the st1 active-site loop with typical TST and MST 
loops  
The  st1  subunit  represents  a  typical  3-mercaptopyruvate:cyanide  sulfurtransferase  (MST)  active-site  loop. 
Typical MSTs are able to catalyse the same reaction as thiosulfate:cyanide sulfurtransferases (TSTs) but show 
higher affinity for 3-mercaptopyruvate as sulfur donor. Small and hydrophobic amino acids are represented in 
red; acidic in blue; basic in magenta; hydroxyl, amine and basic in green. 
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Other sulfurtransferase activities were detectable in mitochondrial membranes from Y. 
lipolytica and may have complemented the loss of the enzyme associated with complex I. No 
second tandem rhodanese domain-type sulfurtransferase (Figure 4.6) could be identified in 
the Y. lipolytica or the genomes of other yeasts or fungi suggesting that the additional activity 
was due to the presence of single rhodanese domain-type enzymes of which two candidate 
open  reading  frames  (CAG82611.1  and  CAG78833),  referred  here  as  to  st2  and  st3, 
respectively,  could  be  identified  in  the  Y.  lipolytica  genome  (Figure  9.6,  appendix).  An 
alternative explanation for the absence of a deletion phenotype for the complex I associated 
sulfurtransferase may be the fact that rather than being involved in iron-sulfur biosynthesis, 
this enzyme may be important for the repair, regulation or quality control [191] of the iron-
sulfur proteins of complex I.  
It is tempting to speculate that st1 subunit functions as a sort of „molecular break‟ of 
the cell growth rate since a strain deprived of the protein yields higher cell mass then the GB 
10 wild-type strain (Figure 3.27, results). On the other hand, the  st1 strain possess the 
URA3  gene  encoding  orotidine  5-phosphate  decarboxylase,  an  enzyme  involved  in  the 
synthesis of uracil, which replaced the st1 gene by homologous recombination in the deletion 
strategy. The more feasible explanation for the increased growth rate seems to be the fact that 
URA3 selection marker allows the st1 strain to reach higher OD values, whereas the GB10 
wild-type strain ceases to grow at the time point where all the uracil available in the growth 
medium is expended. Verification of the growth curves by supplementation of the media with 
sufficient amount of uracil or comparing growth rates of the st1 strain and the st1 strain 
complemented with a plasmid version of the st1 gene is to be assayed. 
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Figure 4.7  Predicted structure of the st1 sulfurtransferase from Y. lipolytica 
(A) Predicted structure of the st1 subunit of Y. lipolytica complex I was predicted by comparison to the x-ray 
structure of 3-mercaptopyruvate sulfotransferase from E. coli that share 35% sequence identity. In this ribbon 
representation N- and C-terminal domains are represented in grey and purple, respectively; the linker peptide in 
blue; the active-site loop in red; the catalytic residue, Cys260 (Y. lipolytica nomenclature) is represented in 
sphere  model  (yellow);  (B)  The  predicted  structure  of  the  st1  subunit  of  Y.  lipolytica  complex  I  (orange) 
superimposed with an x-ray structure of sulfurtransferase RhdA from A. vinelandii (grey). Y. lipolytica active-
site loop and the catalytic cysteine residue is shown in red (sphere model). The catalytic cysteine residue of A. 
vinelandii is represented in sphere model (dark blue). The structure prediction was performed with QuickPhyre 
[224] and models were superimposed using CCP4 Molecular graphics [158].  
 
Although  st1  was  predicted
1  to lack transmembrane helices, its exact position in 
complex I is not known (for the hydropathy plot of the st1 see Figure 4.8). Weak association 
of the st1 subunit with complex I was shown not only by investigation of the 39kDa subunit 
mutants (Figure 4.5), but also st1 is known to dissociate from the complex in BN-PAGE 
even  if  the  mild  detergent  digitonin  is  used  for  mitochondrial  membrane  solubilisation 
(Figure 3.29, results).  
 
 
                                                    
1 Predicted using servers http://www.enzim.hu/hmmtop/ and http://www.cbs.dtu.dk/services/TMHMM/.  
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Figure 4.8 Hydropathy plots of st1 and ND6 subunits 
The hydrophobicity plots of (A) the st1 subunit and (B) the ND6 subunit, the most hydrophobic of all complex I 
subunits  were  simulated  using  the  Software  Hydrophobicity  Plots  (Molecular  Toolkit,  Colorado  State 
University,  USA;  http://www.vivo.colostate.edu/  molkit/  hydropathy/index.html).  The  y-axis  represents  the 
Kyte-Doolittle  hydrophobicity  scale,  where  the  positive  values  represent  hydrophobic,  whereas  negative 
hydrophilic character of the amino acids. On the x-axis the amino acid number is indicated. The window size, 
which is the number of amino acids examined at a time to determine the point of hydrophobic character, was set 
to 7. 
 
4.3  Biosynthetic module of complex I - link between ACPMs and st1 subunit 
 
It is tempting to speculate that one or both ACPM subunits operate together with the st1 
sulfurtransferase in a functional biosynthetic domain. Also, the 39 kDa subunit of complex I, 
a member of the short-chain dehydrogenase/ reductase (SDR) family was postulated to be a     DISCUSSION 
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part of the same biosynthetic module [35]. Furthermore, two homologes of the SDR family 
the    enoyl-acyl  carrier  protein  reductase  (mENR1  and  mENR2)  closely  related  to 
mitochondrial FASII component the trans-2-enoyl-CoA, were recently identified in addition 
to the ACPM as complex I subunits in Trypanosoma brucei [228].  
ACPMs from several organisms are known to provide octanoic acid as a precursor for 
the lipoic acid synthesis. Although, it is known that in octanoic acid synthesis pathway the 
sulfur insertion is usually catalyzed by lipoic acid synthase it cannot be ruled out that the st1 
subunit could take over or support this function, especially, as sulfurtransferase has been 
shown to bind lipoate at its active site [229]. Therefore, lipoic acid levels of the parental, 
acpm2 and the acpm2,pS88A and st1 strains were determined in a turbidimetric assay 
using  suspensions  of  lipoic  acid-deficient  E.  coli  strain  [230].  Unfortunately,  it  was  not 
possible to assess significance of these enzymes in the lipoic acid synthetic pathway due to 
the high variability in the measured values (data not shown).  
Possibly,  the  biosynthetic  module  could  also  play  a  regulatory  role  within  the 
respiratory chain by managing the production of specialized fatty acids, as well as managing 
sulfur supply for iron-sulfur and lipoic acid biosynthesis, as well as control of the lipoylation 
status  of  Krebs  cycle  enzymes.  The  possible  localization  of  the  biosynthetic  module  in 
complex I is the speculated localization of ACPMs, which is the interface between domains 
I and I. The st1 protein is predicted to lack transmembrane helices (Figure 4.7, Figure 4.8) 
and is known to dissociate from the complex I, if the 39-kDa (NUEM) subunit is absent, 
therefore one could speculate that these two subunits remain in contact in complex I.  
Modules  associated  with complex  I  that  are  organism  specific  and confer  certain 
functions were described before. A plant complex I contains additional subunits -carbonic 
anhydrases, associated with specific plant function of reversible interconversion of CO2 and 
HCO3  [76;77].  The  theoretical  biosynthetic  module  of  Y.  lipolytica  may  be  functionally 
linked to certain specialized function of Yarrowia in a similar way, for instance with unusual 
lipid metabolism [3]. Further studies will be needed to elucidate possible interactions among 
sulfurtransferase and ACPMs associated with Y. lipolytica complex I. 
     SUMMARY 
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5  SUMMARY 
 
The  nicotinamide-adenine-dinucleotide  (NADH):ubiquinone  oxidoreductase  (complex  I) 
from the strictly aerobic yeast Y. lipolytica contains at least 26 “accessory” subunits however 
the significance of most of them remains unknown. The aim of this study was to characterize 
the role of three accessory subunits of complex I, recently identified: two mitochondrial acyl 
carrier proteins, ACPM1 and ACPM2 and a sulfurtransferase (st1) subunit.  
ACPMs  are  small  (approx.  10  kDa)  acidic  proteins  that  are  homologous  to  the 
corresponding central components of prokaryotic fatty acid synthase complexes. Genomic 
deletions of the two genes ACPM1 and ACPM2 resulted in strains that were not viable or 
retained only trace amounts of assembled mitochondrial complex I, respectively, as assessed 
using  two-dimensional  blue  native/sodium  dodecyl  sulfate  polyacrylamide  gel 
electrophoresis (BN/SDS) PAGE.  This suggested different functions for the two proteins 
that despite high similarity could not be complemented by the respective other homolog still 
expressed in the deletion strains. To test whether complex I was affected by deletion of the 
ACPM2  gene,  its  activities  in  mitochondrial  membranes  were  measured.  Consequently, 
specific inhibitor sensitive dNADH: decylubiquinone (DBQ) oxidoreductase activity was lost 
completely  and  a  strong  decrease  in  dNADH:  hexa-ammine-ruthenium  (HAR) 
oxidoreductase activity was measured.  
Remarkably, the same phenotypes were observed if just the conserved serine carrying 
the  phosphopantethein  moiety  was  exchanged  with  alanine.  Although  this  suggested  a 
functional link to the lipid metabolism of mitochondria,  using HPLC chromatography no 
changes in the lipid composition of the organelles were found. Proteomic analysis revealed 
that both  ACPMs  were  tightly  bound to purified  mitochondrial complex  I.  Western blot 
analysis revealed that the affinity tagged ACPM1 and ACPM2 proteins were exclusively 
detectable in mitochondrial membranes but not in the mitochondrial matrix as reported for 
other organisms. Hence it has been concluded that the ACPMs can serve all their possible 
functions in mitochondrial lipid metabolism and complex I assembly and stabilization as 
subunits bound to complex I.  
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A  protein  exhibiting  rhodanese  (thiosulfate:cyanide  sulfurtransferase)  activity  was 
found  to  be  associated  with  homogenous  preparation  of  complex  I.  From  a  rhodanese 
deletion  strain,  functional  complex  I  that  lacked  the  additional  protein  but  was  fully 
assembled and displayed no functional defects or changes in EPR signature was purified. In 
contrast to previous suggestions, this indicated that the sulfurtransferase associated with Y. 
lipolytica complex I is not required for assembly of its iron–sulfur clusters.     OUTLOOK 
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6  OUTLOOK 
 
In the future, it is expected that the tagged versions of ACPMs will facilitate their isolation 
from purified complex I and analysis of the acyl rests attached to them, thus providing better 
insight to the role of ACPMs. Mutagenesis studies of regions with significant differences in 
the amino acid sequence between ACPM1 and ACPM2 can indicate regions responsible for 
specific  functions  (Figure  4.1,  discussion),  for  instance  dimerization  regions,  the  ACP-
binding motif,  which was shown to interact strongly and specifically to allow using it as a 
bait in the affinity purification of partner FAS components [118]. Moreover, a strategy has 
been developed to swap larger fragments of the ACPM proteins and to assign specific parts 
of the protein sequence to their functions. The most notable difference between ACPMs of Y. 
lipolytica is with the organelle targeting sequences. Although both presequences direct these 
proteins  to  mitochondria,  the  ACPM1
1  presequence  is considerably shorter ( Figure  4.1, 
discussion) and it is predicted to direct the protein also to other cellular compartments, where 
ACPM1 might confer additional functions. Performed Western-blot analysis does not support 
the view that the tagged versions of ACPMs are present in other compartments than in the 
inner mitochondrial membrane (Figure 3.18, results). However, concentration of the strepII-
tagged version of ACPM1 in fractions used for analysis could have been below the antibody 
detection sensitivity, therefore isolation of individual cellular compartments will be required 
to confirm this statement. 
It is already known that the ACPM2 cannot complement the function of the ACPM1. 
A remaining open question is whether the presequence of ACPM1 fused with the ACPM2 
protein can rescue the vital function of ACPM1. Potentially interesting effects on complex I 
might be observed with a double deletion mutant deprived of both ACPM1 and ACPM2. 
Since  ACPMs  were  postulated  to  be  an  important  link  in  the  lipoic  acid  biosynthetic 
pathway, it would be important to perform activity assays of Krebs cycle enzymes (pyruvate 
and -ketoglutarate dehydrogenase), which utilise lipoate as a cofactor. 
Tagged versions of ACPMs and st1 subunit make it possible to label these subunits 
by immuno-gold and localize them using electron microscopy. Alternatively, an immune- 
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fluorescent-dye  labelling can be  applied  to determine distances  among  these  subunits by 
means  of  the  FRET  method.  Complex  I  deprived  of  ACPM2  subunit  dissociates  into 
subcomplexes, whose composition could be analysed using the newly developed and highly 
sensitive LILBID mass spectrometry [110].  
Rhodanese activity of the st1 subunit has been measured with the thiosulfate as a 
sulfur donor. It would be interesting to check if st1, which possesses a typical MST catalytic 
loop,  exhibits  higher  sulfurtransferase  activity,  when  3-mercaptopyruvate  is  used  as 
substrate.  
 
                                                                                                                                                                  
1 The protein is recognized as a secretory protein, which might be directed to Endoplasmic reticulum or 
microsomes                                     AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
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7  AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMEN-
FASSUNG 
 
7.1  Komplex I 
 
Komplex  I  (NADH:  Ubichinon  Oxidoreduktase)  ist  der  erste  elektronentransferierende 
Proteinkomplex  der  mitochondralen  Atmungskette,  und  stellt  einen  der  größten  und 
kompliziertesten membrangebundenen Proteinkomplexe dar [25].  Das L-förmige Molekül 
besteht  aus  einem  Segment,  das  sich  in  der  Lipiddoppelschicht  der  inneren  Membran 
befindet, sowie einem peripheren Teil, der in den Matrix-Raum hineinragt und alle bekannten 
Resdoxzentren enthält. Die atomare Struktur des hydrophilen Teils des homologen Enzyms 
aus Thermus thermophilus wurde gelöst [17]. Der genaue, katalytische Mechanismus von 
Komplex I ist jedoch noch nicht verstanden. Komplex I katalysiert die Übertragung von zwei 
Elektronen  von  reduziertem  Nicotinamidadenindinucleotid  (NADH)  über  Flavin 
mononucleotid (FMN) und acht Eisen-Schwefel-Cluster auf Ubichinon. An diesen Transfer 
ist die Translokation von vier Protonen über die innere mitochondrielle Membran gekoppelt. 
Die minimale Anzahl von 14 zentralen Untereinheiten, aus denen sich das prokaryotische 
Enzym  zusammensetzt,  ist  in  Eukaryonten  um  bis  zu  31  akzessorische  Untereinheiten 
erweitert, was sich auf eine Masse von 1 MDa summiert [35;36].  
 
7.2  Acyl-Carrier-Proteine 
 
Acyl-Carrier-Proteine (ACPs) sind kleine (~10 kDa), saure Proteine mit hochkonservierten 
Sequenzbereichen. Sie sind zentrale Bestandteile der prokaryotischen und mitochondrialen 
sowie der Chloroplasten-Fettsäure-Synthase (FAS II) Komplexe. ACPs enthalten ein zentral 
lokalisiertes, an Serin gebundenes Pantethein-4'-Phosphat als prosthetische Gruppe, die post-
translational angefügt wird und als Plattform für die Acyl Zwischenprodukte während der 
Fettsäure-Synthese dient. Zusätzlich wird für die bakteriellen ACPs eine Beteiligung an der 
Synthese  von  Polyketiden  [141],  von  Peptid-Antibiotika  [143]  und  der  Acylierung  von 
Toxinen [147] postuliert. In der Regel werden ein oder mehrere ACPs vom Typ II FAS in 
den  Mitochondrien  verschiedener  Spezies  gefunden,  und  aufgrund  ihrer  Lokalisation  als  
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ACPM (M=Mitochondrial) bezeichnet. Seit der Entdeckung und Identifizierung von ACPMs 
haben  weitere  Studien  angedeutet, dass  Mitochondrien  alle notwendigen  Enzyme  für  die 
Fettsäure-Biosynthese enthalten. Sie sind in der Lage, kurze [159;160] und möglicherweise 
sogar langkettige [162;163] Fettsäuren zu synthetisieren. Es wird ihnen außerdem eine Rolle 
bei der Herstellung von Oktansäure zugeschrieben, einem Vorläufer der Liponsäure. Letzere 
ist die prosthetische Gruppe einiger mitochondrialer Enzyme, die an wichtigen zellulären 
Prozessen beteiligt sind [162];[163];[164;165]; [166];[176], wie die Pyruvat-Dehydrogenase- 
und 2-Oxoglutarat-Dehydrogenase-Komplexe [148;167]. Es wurde auch spekuliert, dass die 
Aktivität der ACPMs eine wesentliche Rolle bei der Reparatur von mitochondrialen Lipiden 
spielt [159]. 
 
7.3  Rhodanese (Thiosulfat:Cyanid Sulfurtransferase) 
 
Sulfurtransferasen  sind  ubiquitäre  Enzyme,  die  in  allen  lebenden  Organismen  gefunden 
wurden,  von  Bakterien  bis  zum  Menschen  [177].  Bei  Säugetieren  sind  dies  zwei  eng 
miteinander verwandte Enzyme, die Thiosulfat: Cyanid Sulfurtransferase, auch bezeichnet 
als Rhodanese, und die 3-Mercaptopyruvat: Cyanid Sulfurtransferase. Beide sind vorwiegend 
in den Mitochondrien lokalisiert [178]. In vitro katalysiert Thiosulfatsulfurtransferase (TST) 
die  Übertragung  eines  Sulfan-Schwefelatoms  von  Thiosulfat  auf  Cyanid,  wodurch 
Thiocyanat und Sulfit entstehen. 3-Mercaptopyruvat Sulfurtransferase (MST) ist in der Lage, 
die gleiche Reaktion zu katalysieren, zeigt aber eine höhere Affinität für 3-Mercaptopyruvat 
als  Schwefeldonor  [179].  Der  Schwefel-Transfer  findet  durch  einen  doppelten 
Verdrängungsmechanismus statt, der die Bildung eines persulfidhaltigen Zwischenproduktes 
mit einem invarianten katalytischen Cystein beinhaltet [177]. Die tatsächliche biologische 
Rolle von TST und MST ist allerdings weitgehend unklar, da ihre in vivo Substrate immer 
noch  nicht  bekannt  sind.  Vorgeschlagene  Funktionen  beinhalten  die  Cyanid-Entgiftung 
[187], die Erhaltung des Sulfan Pools [188], den Selen-Stoffwechsel [189] und die Thiamin-
Biosynthese  [190].  Aufgrund  ihrer  Eigenschaft,  Schwefelatome  zu  übertragen,  und  ihrer 
mitochondrialen Lokalisation  wurde  vorgeschlagen,  dass die  Rhodanese die  Bildung  von 
Eisen-Schwefel-Zentren katalysieren könnte. 
                                     AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
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7.4  Zielsetzungen 
 
Das  Ziel  dieser  Studie  war  es,  die  Funktion  von  drei  kürzlich  charakterisierten 
akzessorischen Untereinheiten von Komplex I der strikt aeroben Hefe Yarrowia lipolytica zu 
charakterisieren. Es handelt sich um  zwei mitochondriale Acyl-Carrier-Proteine, ACPM1 
und ACPM2, sowie um die Sulfurtransferase (St1) Untereinheit.  
Die Bedeutung der beiden ACPMs für die strukturelle Integrität und die Aktivität von 
Komplex  I  wurde  untersucht.  Der  Phosphopantetheine-bindende  Serin-Rest  der  ACPMs 
wurde  mutiert,  um  feststellen  zu  können,  ob  die  Bedeutung  der  ACPMs  in  ihrer 
enzymatischen Aktivität begründet ist oder ob ihre Anwesenheit als strukturelle Komponente 
von  Komplex  I  von  Bedeutung  ist.  Außerdem  wurden  die  Auswirkungen  der  ACPM-
Deletion  und  des  Serinaustauschs  auf  die  Atmungsketten-Komplex  Assemblierung  und 
Aktivität  überprüft.  Da  postuliert  wird,  dass  ACPMs  an  der  mitochondriellen  Fettsäure-
Synthese  beteiligt  sind,  wurde  die  mitochondriale  Lipid-Zusammensetzung  der  Yarrowia 
Stämme, in denen der Pantethein-4'-Phosphat-Kofaktor fehlte bzw. in dem das Acyl Carrier 
Protein komplett entfernt worden war, bestimmt. Da ACPMs in anderen Organismen sowohl 
in der  Mitochondrien-Matrix  als  auch  assembliert  mit  Komplex  I  nachgewiesen  wurden, 
wurde die submitochondriale Verteilung der ACPMs in Y. lipolytica überprüft.  
Einem  Protein,  das  Rhodanese  -(Thiosulfat:  Cyanid  Sulfurtransferase)  Aktivität 
aufwies  und  mit  einer  homogenen  Komplex  I  Präparation  assoziiert  war,  wurde  eine 
mögliche Rolle in der Eisen-Schwefel-Zentren Assemblierung zugesprochen. Daher wurde in 
einem Rhodanese-negativen Y. lipolytica Stamm sowohl die Assemblierung und Aktivität 
von Komplex I als auch die Assemblierung der Eisen-Schwefel-Cluster untersucht.     
 
7.5  Ergebnisse 
 
Neueste  massenspektrometrische  Analysen  von  Y.  lipolytica  Komplex  I  hatten  die 
Anwesenheit von zwei mitochondrialen Acylcarrierproteinen, ACPM1 und ACPM2, gezeigt. 
Um  die  Funktion  der  ACPMs  zu  untersuchen,  wurden  die  entsprechenden  Gene  durch 
homologe Rekombination deletiert. 
Die  Deletion  des  als  ACPM1  bezeichneten  Gens  in  einem  diploiden  Stamm 
(ACPM1/acpm1::URA3) und die anschließende Sporulation ergab keine haploiden Deletions- 
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Stämme. Wurde jedoch eine Plasmid-kodierte, funktionsfähige Kopie des ACPM1 Gens in 
den ACPM1/acpm1::URA3 Stamm eingeführt, konnten haploide acpm1, pACPM1 Stämme 
isoliert werden. Somit wurde festgestellt, dass es sich bei ACPM1 um ein essentielles Gen in 
Y. lipolytica handelt. Um zu unterscheiden, ob das ACPM1 Protein als Ganzes oder nur seine 
funktionelle Gruppe für das Überleben erforderlich sind, wurde das Serin-66 von ACPM1 
durch  Alanin  ausgetauscht.  Dieses  konservierte  Serin  ist  in  allen  Acyl-Carrier-Proteinen 
enthalten  und  bindet  kovalent  die  prosthetische  Gruppe,  das  Phosphopantethein.  Im 
Unterschied zur wildtypischen ACPM1 Kopie konnte diese mutierte Version des ACPM1 
Gens  den  Deletions-Phänotyp  nicht  komplementieren.  Folgerichtig  konnten  keine 
acpm1,pACPM1-S66A Sporen erhalten werden. Somit scheint der Austausch einer einzigen 
Aminosäure die  gleiche  Wirkung zu haben  wie  die  vollständige Entfernung des ACPM1 
Gens. 
Im Gegensatz dazu ist das zweite ACPM2 Protein, ACPM2, nicht essentiell für das 
Überleben, da haploide ACPM2 Deletions-Stämme (acpm2) mit derselben Strategie wie für 
ACPM1 angewandt hergestellt werden konnten. Um zu überprüfen, ob Komplex I von der 
Deletion des ACPM2 Gens beeinträchtigt wird, wurde zuerst die Aktivität in mitochondrialen 
Membranen aus Deletions-Stämmen gemessen und mit den Werten des Wildtyps verglichen. 
Die  spezifische,  Inhibitor-sensitive  dNADH:DBQ  Oxidoreduktase  Aktivität  war  völlig 
verschwunden. Ein starker Rückgang der dNADH:HAR Oxidoreduktase Aktivität auf ein 
Niveau,  das  häufig  bei  anderen  Komplex  I-defizienten  Stämmen  beobachtet  wurde,  ließ 
darauf schließen, dass der Verlust der Komplex I-Aktivität auf einen sehr geringen Anteil an 
intaktem  Komplex  I  zurückzuführen  ist.  Bemerkenswert  ist,  dass  ähnlich  reduzierte 
Aktivitäten  beobachtet  wurden,  wenn  ein  Plasmid  mit  mutiertem  ACPM2  in  die  Zellen 
eingeführt  worden  war.  Dieses  ACPM2  enthielt  eine  Mutation,  durch  die  das 
Phosphopantethein-bindende Serin-88 im ACPM2 durch Alanin ersetzt wurde. Der Verlust 
von  Komplex  I  wurde  durch  zwei-dimensionale  BN/SDS-PAGE  bestätigt,  in  der 
mitochondriale Membranen aus dem  acpm2 Stamm und dem Wildtyp-Stamm analysiert 
wurden. Im Gegensatz zum Wildtyp konnte im ACPM2 Deletions-Stamm kein Komplex I 
durch Silberfärbung nachgewiesen. Das gleiche Ergebnis wurde mit dem Stamm erzielt, der 
die mutierte Version von ACPM2 exprimierte, in der Serin-88 durch Alanin ersetzt worden 
war.                                     AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
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Mitochondriale Membranen aus dem  acpm2 Stamm wurden durch Western Blot 
Analyse  von  nativen  Gelen  untersucht,  um  etwaige  geringe  Mengen  von  Komplex  I-
Subkomplexen  zu  detektieren.  Während  in  den  Membranen  aus  dem  parentalen  Stamm 
komplett assemblierter Komplex I als die vorherrschende Form gefunden wurde, war in den 
Mitochondrien der acpm2 und S88A Mutanten nur eine sehr kleine Menge an vollständig 
assembliertem Komplex I zu finden. Stattdessen wurden zwei Subkomplexe von etwa 700 
und  300  kDa  erkannt.  die  leider  aufgrund  der  sehr  geringen  verfügbaren  Menge  an 
Probenmaterial  nicht  weiter  bezüglich  ihrer  Untereinheiten-Zusammensetzung  analysiert 
werden konnten. 
Um  zu  sehen,  ob  die  Deletion  bzw.  die  Mutagenese  von  ACPM2  die  Lipid- 
Zusammensetzung  der  mitochondriellen  Membranen  beeinflusst  hatte,  wurden 
mitochondriale Membranen des Wildtyp Stammes und der Stämme acpm2 sowie acpm2, 
pACPM2-S88A auf ihren Phospholipidgehalt untersucht. Alle Lipide waren in sehr ähnliche 
Verhältnissen in den intakten, mittels Saccharose Gradient gereinigten Mitochondrien aus 
allen Stämmen vorhanden. Prominente Peaks wurden mittels MALDI-MS als Cardiolipin, 
Phosphatidyl-Ethanolamin,  Phosphatidyl-Inositol,  Lyso-Phosphatidyl-Ethanolamin,  und 
Phosphatidyl-Cholin identifiziert. 
In früheren Berichten wurde eine Lokalisierung der ACPMs in der mitochondrialen 
Matrix vorgeschlagen. Um die submitochondriale Verteilung der ACPMs in Y. lipolytica zu 
untersuchen, wurden die lösliche und die Membran-Fraktion der Mitochondrien analysiert. 
Die Fraktionierung wurde mit Yarrowia Stämmen durchgeführt, die die getaggten Versionen 
der ACPMs, ACPM1-strepII und ACPM2-flag, exprimierten, um sie nach der SDS-PAGE im 
Western-Blot  nachweisen  zu  können.  Beide  ACPMs  waren  ausschließlich  in  der 
mitochondrialen  Membran-Fraktion  nachweisbar  und  fehlten  sowohl  in  der  löslichen 
Fraktion der Mitochondrien als auch in der cytosolischen Fraktion. 
Ein Rhodanese-ähnliches Protein mit einer molekularen Masse von ca. 34,6 kDa war 
auch in den reinsten Präparationen aus Y. lipolytica dauerhaft vorhanden. Das Protein wies 
Thiosulfat:Cyanid Sulfurtransferase Aktivität auf, die zuvor nie in Komplex I aus anderen 
Quellen aufgetreten war. Der Gehalt des St1 benannten Proteins schien im Vergleich zu 
anderen Komplex I Proteinen variabel zu sein und tauchte substöchiometrisch in den meisten 
Komplex I-Präparationen auf. Um zu testen, ob die Sulfurtransferase Aktivität von St1 für  
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die Komplex I Biogenese oder die Synthese von Eisen-Schwefel-Zentren erforderlich ist, 
wurde  das  Gen  durch  homologe  Rekombination  entfernt.  Der  St1  Stamm  war  voll 
lebensfähig, und durch BN-PAGE konnte nachgewiesen werden, dass seine mitochondrialen 
Membranen vollständig assemblierten Komplex I mit ähnlichem Expressionsmuster wie im 
Wildtyp enthalten  
Die NADH:HAR Oxidoreduktase-Aktivitäten der mitochondrialen St1 Membranen 
deuten  ebenfalls  daraufhin,  dass  die  Deletion  die  Komplex  I  Aktivität  nicht  reduzierte. 
Abgesehen  von  der  34,6  kDa  Bande,  die  in  dem  Deletions-Stamm  fehlte,  zeigte  der 
gereinigte  Komplex  I  aus  dem  St1  Stamm  das  gleiche  Untereinheiten  Muster  wie  der 
Wildtyp unter Standard Tricin-SDS-PAGE Bedingungen. Dies deutet darauf hin, dass die 
Stabilität  von  Komplex  I  nicht  wesentlich  beeinträchtigt  wurde.  Die  Inhibitor-sensitiven 
dNADH:DBQ  Aktivitäten  von  mitochondrialen  Membranen  und  gereinigtem  Komplex  I 
waren  sehr  ähnlich  im  Wildtyp  und  dem  St1  Stamm.  Die  EPR-Spektren  der  Eisen-
Schwefel-Cluster N1, N2, N3 und N4 des gereinigten Komplex I zeigten, dass sich weder die 
Signalintensitäten  noch  die  Positionen  der  charakteristischen  g-Werte  zwischen  dem 
parentalen und dem Deletions-Stamm unterschieden. 
                                     AUSFÜHRLICHE DEUTSCHSPRACHIGE ZUSAMMENFASSUNG 
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7.6  Fazit 
 
Die genomischen Deletionen der beiden Gene ACPM1 and ACPM2 in Y. lipolytica führten 
zu Stämmen, die entweder, wie im Fall von acpm1, nicht lebensfähig waren oder, wie beim 
acpm2 Stamm, nur Spuren von assembliertem mitochondriellen Komplex I enthalten. Dies 
deutete  auf  unterschiedliche  Funktionen  der  beiden  ACPMs  hin.  Denn  trotz  ihrer  hohen 
Sequenz-Ähnlichkeit konnten die Funktionen des jeweiligen deletierten ACPMs nicht durch 
das  andere  ACPM-Homolog,  das  ja  noch  in  den  Deletions-Stämmen  exprimiert  wurde, 
übernommen werden.  
Bemerkenswert  ist,  dass  der  gleiche  Phänotyp  beobachtet  wurde,  wenn  nur  das 
konservierte  Serin,  das  die  Phosphopantethein-Gruppe  trägt,  gegen  Alanin  ausgetauscht 
wurde.  Obwohl  dies  eine  funktionale  Querverbindung  zum  Lipidstoffwechsel  der 
Mitochondrien andeutete, wurden keine Veränderungen in der Lipid-Zusammensetzung der 
Organellen  gefunden.  Die  Proteomanalyse  ergab,  dass  die  beiden  ACPMs  eng  mit  dem 
gereinigten mitochondrialen Komplex I verbunden waren. Die Western-Blot Analyse zeigte, 
dass die affinitätsmarkierten Versionen der ACPM1 und ACPM2 Proteine ausschließlich in 
der mitochondrialen Membran nachweisbar waren und nicht in der mitochondrialen Matrix 
wie  bei  einigen  anderen  Organismen.  Daraus  wurde  gefolgert,  dass  die  ACPMs  ihre 
möglichen Funktionen wie z.B. im mitochondrialen Lipidstoffwechsel und in der Komplex I 
Assemblierung  und  Stabilisierung,  gebunden  als  Untereinheiten  von  Komplex  I  ausüben 
können. 
Der  Rhodanese-Deletions  Stamm  (St1)  enthielt  vollständig  assemblierten, 
funktionsfähigen Komplex I, und zeigte keine funktionellen Defekte oder Veränderungen in 
der EPR Signatur. Im Gegensatz zu früheren Vorschlägen, dass St1 für die Assemblierung 
der Eisen-Schwefel-Zentren des Komplex I erforderlich ist, lassen die Ergebnisse mit dem 
Deletionsstamm  darauf  schließen,  dass  dies  für  die  mit  Komplex  I  assoziierte 
Sulfurtransferase in Y. lipolytica nicht gilt.  
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7.7  Ausblick 
 
Es ist vorstellbar, dass die affinitätsmarkierten Versionen der ACPMs ihre Isolierung aus 
gereinigtem Komplex I ermöglichen. Hierdurch würde die Analyse der mit ihnen verbunden 
Acyl  Reste  erleichtert  werden,  um  einen  besseren  Einblick  in  die  Rolle  der  ACPMs  zu 
bekommen.  
Es ist bereits bekannt, dass  ACPM2 die  Funktion des  ACPM1 nicht  übernehmen 
kann, obwohl die reifen Proteine eine hohe Sequenzähnlichkeit aufweisen. Eine verbleibende 
offene Frage ist, ob die durch die Präsequenz der ACPMs vermittelte Lokalisation eine Rolle 
für die Funktion spielt, da hier die größten Unterschiede zwischen beiden Proteinen bestehen. 
Daher könnte die ACPM1 Präsequenz mit der Sequenz des reifen ACPM2 Proteins fusioniert 
werden, um zu überprüfen, ob  ACPM2  anschließend  die  lebensnotwendige  Funktion des 
ACPM1 übernehmen kann.  
Da  angenommen  wird,  dass  mitochondriale  Acyl  Carrier  Proteine  eventuell  eine 
wichtige Rolle in der Liponsäure Biosynthese spielen, wäre es wichtig, Aktivitäts-Tests von 
Krebs-Zyklus  Enzymen (Pyruvat-  und  -Ketoglutarat-Dehydrogenase)  durchzuführen,  die 
Lipoat als Cofaktor benötigen.  
Die  Rhodanese  Aktivität  der  St1  Untereinheit  wurde  mit  Thiosulfat  als 
Schwefelspender gemessen. Es wäre interessant zu überprüfen, ob St1, das eine für MST 
Enzyme  typische  katalytische  Schleife  besitzt,  eine  höhere  Sulfurtransferase-Aktivität 
aufweist, wenn 3-Mercaptopyruvat als Substrat verwendet wird.      REFERENCES 
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9  APPENDIX 
9.1  Gene maps 
The names and direction of primers used are marked in blue; sequences of the primers are 
highlighted  in  yellow.  The  capital  letters  in  the  primer  sequence  denote  unchanged 
nucleotides; small letters represent mutated nucleotides. The translated exons are shown in 
green capital letters below the genomic sequence.  
9.1.1  The st1 gene encoding the rhodanese, locus CAG78604, ACC No. 
YALI0F23551g, ID 2908766 
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Figure 9.1 The fragment of st1 gene encoding rhodanese 
Primers for generation of the st1 deletion strain, st1-strepII tagged version, BamHI and SalI enzyme cleavage 
sites, PCR check primers and sequencing primers are shown.   
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9.1.2  The ACPM1 gene, locus CAG81024.1, ACC. No. YALI0D14850g, ID 
2911329. 
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Figure 9.2 The ACPM1 gene used for generating the mutants 
Primers for generation of the ACPM1 deletion strain, ACPM1-strepII tagged version, for the swap strategy, for 
generation of BamHI and SalI enzyme cleavage sites, PCR check primers and sequencing primers are shown.   
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9.1.3  The ACPM2 gene, locus CAG81441.2, fusion of loci YALI0D24629g and 
YALI0D24643g, ACC. No. YALI0D24629g, ID 2910510. 
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Figure 9.3 The ACPM2 gene used for generating the mutants 
Primers for generation of the ACPM2 deletion strain, ACPM2-flag tagged version, BamHI and SalI enzyme 
cleavage sites, PCR check primers and sequencing primers are shown.   
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9.2  Oligonucleotides 
 
The capital letters in the primer sequence denote unchanged nucleotides; small letters 
represent mutated nucleotides. Recognition sites of the restriction enzymes are underlined. 
Nucleotides coding for mutated serine are bold. 
9.2.1  Oligonucleotides for the st1 gene 
   
name  sequence  binding site 
st1f  5‟-CGACGATACCGATGCTAGAG-3‟  118-137 
st1BamHI  5‟-GGAGGAtccCTTGAACGAGGCCAACC-3‟  2115-2140 
st1SalI  5‟-aagtcgacGACGATGATGATCCTGC-3‟  1153-1129 
st1r  5‟-TTCACAGGCACCTCTACAGC-3‟  2810-2792 
 
Table 9.1 Oligonucleotides for generation of the st1 deletion strain 
 
name  sequence  binding site 
st1ckf  5‟-GGCAATCGAGGCGATATATG-3‟  30-49 
st1ckr  5‟-TTATGACCATGCGACCAGTG-3‟  2865-2846 
 
Table 9.2 Oligonucleotides for checking of the deletion via PCR  
 
 
name  sequence  binding site 
st1strepIIf  5‟-caatttgaaaaaTAGATAGAATCATACTGTAG-3‟  2134-2165 
st1strepIIr  5‟-aggatgagaccAAGCCCGGTTGGCCTCGTTC-3‟  2157-2127 
 
Table 9.3 Oligonucleotides for creating the strepII-tagged version of st1 gene  
 
 
name  sequence  binding site 
st1seq1  5‟-CACTTCGCTGACTCAGAATG-3‟  733-752 
st1seq2  5‟-AGATCTTCGATGCTACCTGG-3‟  1259-1278 
st1seq3  5‟-GAGGTCACCTTCATTGATGC-3‟  1768-1787 
st1seq4  5‟-CAAGTCGAGGTCCGGAGAAG-3‟  1510-1491 
st1seq5  5‟-GTGACACCGGATCCACACAT-3‟  1994-1975 
 
Table 9.4 Oligonucleotides for sequencing of the st1 gene      APPENDIX 
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9.2.2  Oligonucleotides for ACPM1 gene 
   
name  sequence  binding site 
acpm1f  5‟-TACTCGGCTGAACTGCAAG- 3‟  279-297 
acpm1BamHI  5‟-atggatccAGCGTTAAGGCCACAG-3‟  2036-2059 
acpm1r  5‟-ATCTCACGGCTTCACAACG-3‟  2978-2960 
acpm1SalI  5‟-aagTCGaCACGGACAGGATTCGAAC-3‟  1112-1088 
 
Table 9.5 Oligonucleotides for generation of the ACPM1 deletion strain 
 
name  sequence  binding site 
acpm1chkf  5‟-AAGCCGAGCGACACAAGGAG-3‟  143-162 
acpm1chkr  5‟-AGCCAGTCACAGCCAGAGAG-3‟  3017-2998 
 
Table 9.6 Oligonucleotides for checking of the deletion via PCR  
 
name  sequence  binding site 
acpm1strepIIf  5‟-caatttgaaAAATAAGCAAGCTGTATATAATAG-3‟  2007-2039 
acpm1strepIIr  5‟-aggatgagaccATTTAGCATCGGGCTGG-3‟  2030-2003 
 
Table 9.7 Oligonucleotides for creating the strepII-tagged version of ACPM1 gene  
 
 
name  sequence  binding site 
acpm1seq1  5‟-GTTAGCTGTCAGGCAGTGG-3‟  1054-1072 
acpm1seq2  5‟-GATCCACAGACGCACAATG-3‟  1592-1610 
acpm1seq3  5‟- GAATGCCACAGGTGAATGC-3‟  1689-1671 
acpm1seq4  5‟- GCCTACCTAGAGCTCCAAG-3‟  2185-2165 
 
Table 9.8 Oligonucleotides for sequencing of the ACPM1 gene  
 
name  sequence  binding site 
acpm1S66Af  5‟-gcCTTAGACACCGTCGAGGTTG-3‟  1887-1907 
acpm1S66Ar  5‟-GTCGAGGTTGAGGTCCTTGG-3‟  1886-1867 
 
Table 9.9 Oligonucleotides for mutating the phosphopantetheine-binding serine (S66A)   
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9.2.3  Oligonucleotides for the ACPM2 gene 
   
name  sequence  binding site 
acpm2fnew  5‟-GTACAGAAGTGTCGGCGCAG-3‟  528-547 
acpm2BamHI  5‟-aaggatCCTCAAACAGACTAAAGCCCT-3‟  2949-2975 
acpm2SalI  5‟-aagTCGacAGTGTGGAGGATGGTGTGG-3‟  1193-1167 
acpm2r  5‟-CTCGCTCTAACGCCGTACTC-3‟  3606-3587 
 
Table 9.10 Oligonucleotides for generation of the ACPM2 deletion strain 
 
name  sequence  binding site 
acpm2f  5‟-CACGCACCAGTTACTCTGTC-3‟  1-20 
acpm2chkr  5‟-CGCACTTGGCAGGATGGAAC-3‟  3760-3741 
 
Table 9.11 Oligonucleotides for checking of the deletion via PCR  
 
name  sequence  binding site 
acpm2flagf  5‟-gatgatgataaaTAATCAACCTCAAACAGAC-3‟  2939-2966 
acpm2flagr  5‟-gtctttgtaatcAACGGCTGGGTTAGTAGG-3‟  2959-2930 
 
Table 9.12 Oligonucleotides for creating the flag-tagged version of ACPM2 gene  
 
 
name  sequence  binding site 
acpm2seq1  5‟-CTGAGCAATATCTCCGCACC-3‟  1064-1083 
acpm2seq2  5‟-GTACTAGTGACTGACCGAAG-3‟  1508-1527 
acpm2seq3  5‟-GAGTCTGCATACAGTCTGAG-3‟  2041-2060 
acpm2seq4  5‟-CGACGACGCAGAAGGAGATG-3‟  3034-3015 
 
Table 9.13 Oligonucleotides for sequencing of the ACPM2 gene 
 
 
name  sequence  binding site 
acpm2S88Af  5‟-gcTTTGGATGTCGTCGAGGTG-3‟  1465-1485 
acpm2S88Ar  5‟-GTCCAGACCAAGGTCGGAAG-3‟  1464-1445 
 
Table 9.14 Oligonucleotides for mutating the phosphopantetheine-binding serine (S88A) 
      APPENDIX 
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9.2.4  Oligonucleotides for ACPM1 and ACPM2 genes swap strategy 
 
 
name  sequence  binding site 
acpm1_2-1f1  5‟-CGAATTGCTGCTGTTCTCG-3‟  1351-1369 
acpm1_2-1f2  5‟-CATCACCCCCACCGCTTCC-3‟  1844-1862 
acpm1_2-1f3  5‟-GAGATCCCCGACAAGGAG-3‟  1938-1955 
acpm1_1-2r1  5‟-ATTCGCTTCTCGGCATCG-3‟  1355-1338 
acpm1_1-2r2  5‟-GGTGATGGCAGCGGGGTTG-3‟  1850-1832 
acpm1_1-2r3  5‟-GATCTCGATGCCGAACTC-3‟  1943-1926 
 
Table 9.15 Oligonucleotides for swap strategy of ACPM1 gene 
 
 
 
name  sequence  binding site 
acpm2_1-2f1  5‟-GAATCGTGGCTCTTCTGG-3‟  1373-1390 
acpm2_1-2f2  5‟-GTAGTGGCGGTGGCGGTTGG-3‟  1422-1441 
acpm2_2-1r1  5‟-ATTCGCTCCTGAATCATG-3‟  1376-1359 
acpm2_2-1r2  5‟-GGTGATGTTCTTGGCGTC-3‟  1428-1411 
 
Table 9.16 Oligonucleotides for swap strategy of ACPM2 gene 
 
9.2.5  Oligonucleotides for URA3 gene 
 
name  sequence  binding site 
ura3f  5‟-GTCGACAAAGGCCTGTTTC-3‟  outside of the gene 
ura3r  5‟-GAGGATCCGTCTGACTCGTCATTGC-3‟  outside of the gene 
ura3us2  5‟-CACAGCCTCCAACGAAGAATG-3‟  105-86 
ura3ds2  5‟-CCTGGAGGCAGAAGAACTTG-3‟  1587-1606 
 
Table 9.17 Oligonucleotides for URA3 gene  
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9.3  Complex I subunits of Yarrowia lipolytica 
 
Procaryotes  Eucaryotes 
E. coli 
P. denitrificans 
T. thermophilus 
Y. lipolytica  B. taurus 
Subunit 
NUO 
Subunit 
NQO 
Subunit   Mr
1 [Da]  TMDs
2  Subunit   Mr 
[kDa] 
Remarks 
/modification/ 
Cofactor
3 
               
      Central nuclear coded 
G  3  NUAM   75,198.7  0/0  75-kDa   77.0  1-23/[2Fe-
2S],2x[4Fe-S] 
 
F  1  NUBM   51,660.0  0/0  51-kDa  48.5    1-20/[4Fe-4S], 
FMN 
 
D
4  4  NUCM   49,945.0  0/0  49-kDa   49.2   1-33/[4Fe-4S] 
 
C
4  5  NUGM  30,476.2
5  0/0  30-kDa   26.4   1-38 
 
E  2  NUHM   24,068.6  0/0  24-kDa   23.8   1-32/[2Fe-2S] 
 
I  9  NUIM   22,321.3  1/0  TYKY   20.1   1-36/2x[4Fe-4S] 
B  6  NUKM   20,425.6  0/0  PSST   20.2   1-37/[4Fe-4S] 
               
  Central mitochondrially coded 
H  8  NU1M   38,347.7  10/10   ND1   36  - 
N  14  NU2M   53,331.9  14/13   ND2   39  - 
A  7  NU3M   14,470.5  3/3   ND3   13  - 
M  13  NU4M   54,481.2  13/12   ND4   52  - 
L  12  NU5M   73,705.4  18/16   ND5   67  - 
J  10  NU6M   20,758.3  5/5   ND6   19  - 
K  11  NULM   9810.9  2/2   ND4L   11  - 
               
                   APPENDIX 
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   Accessory nuclear coded 
    NUEM   40,434.0  0/0  39-kDa   39.1  Short-chain 
dehydrogenase, 
NADPH 
    ST1   34,621.2  0/0   n.p.  n.p.  n.p. 
    NESM   23,438.1  1/0  ESSS   14.5  STMD
6, 
phosphorylation 
    NUJM   20,827.6  2/2  B14.7   14.8  TIM17/22  family,  -
Met +Ac 
    NUZM   19,749.6  0/0   n.p.   n.p.  n.p. 
    NUPM   19,196.0  0/0  PGIV   20.0  Cystein-rich  motif,  -
Met 
    NUXM   18,565.2  3/2   n.p.   n.p.  n.p. 
    N7BM   16,153.2  0/0   B17.2   17.1  +Ac, nitration 
    NUYM   15,939.9  0/0  AQDQ   15.3  Phosphorylation 
    NUFM    15,572.7  0/0  B13   13.2  -Met+Ac 
    NIAM   14,642.3  1/1  ASHI   18.7  STMD,1-28 
    NB4M   14,626.7  0/0  B14   15.0  -Met+Ac, nitration 
    NUMM   14,257.0  0/0   13-kDa   10.5  1-28 
    NB6M   13,960.2  1/1  B16.6   16.6  STMD,  proapoptotic 
factor, -Met+Ac  
    NUNM   13,300.9  1/1  n.p.   n.p.  n.p. 
    NI2M   12,879.8  0/0   B22   21.7  -Met+Ac 
    NB8M   11,067.8  0/0  B18   16.5  Cystein-rich  motif  -
Met +Myr 
    NIDM   10,890.1  0/0  PDSW   20.8  Cystein-rich  motif,  -
Met 
    NB5M   10,347.7  1/1  B15   15.1  STMD, -Met+Ac 
    ACPM2
7   9526.7  0/0  SDAP  10.7  Phosphopantetheine
8 
    NIPM   10,018.6  0/0   PFFD   12.5  Cystein-rich  motif,  -
Met  
    NIMM   9662.1  1/1  MWFE  8.1  STMD, 
phosphorylation 
    ACPM1
7   9071.2  0/0  SDAP   10.7  Phosphopantetheine
8  
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    NI8M   9472.8  0/0  B8   11.0  Thioredoxin  fold,  -
Met +Ac 
    NI9M   7704.8  1/1  B9   9.3  STMD, -Met+Ac 
    NB2M   6804.7  1/1  B12   11.1  STMD,  -Met+Ac 
(partial)  
    NEBM
9  7900  1/1  n.p.   n.p.  n.p. 
               
Mammal specific subunits 
          KFYI  5.8  STMD1-27 
          MNLL  7.0  STMD, -Met 
          AGGG  8.5  STMD,1-36  
          MLRQ  9.3  STMD  
          10-kDa  8.4  1-34 
          B14.5a  12.6  -Met+Ac 
          B14.5b  14.1  STMD, +Ac(partial) 
          SGDH  16.7  STMD,1-46 
          B17  15.4  STMD, -Met+Ac 
          42-kDa  36.7  1-23, 
phosphorylation 
 
Table 9.18  Central and accessory subunits of Yarrowia lipolytica complex I 
Nomenclature for subunits NESM (formerly called NUWM), NB5M (formerly called NUVM) and NUNM 
(newly identified, with no significant homology to proteins from other organisms) was introduced in  [71]. 
Information to bovine complex I was adapted from [35]. Abbreviations: n.p: not present; - Met: N-terminal 
methionine is removed post-translationally; + Ac: N-terminal residue is acetylated; + Myr: N-terminal residue is 
myristoylated. a – b: known mitochondrial import sequence (residues a to b) are removed. 
 
1 Average molecular masses of mature proteins, excluding cofactors, calculated using the “compute pI/Mw” 
tool at   http://www.expasy.ch/tools/pi_tool.html. 
2 Predicted using servers http://www.enzim.hu/hmmtop/ and http://www.cbs.dtu.dk/services/TMHMM/. 
3 Y. lipolytica posses the same composition of FeS clusters, a FMN, NADPH and phosphopantetheine as bovine 
complex I 
4 NuoC and NuoD are fused in a single subunit in E. coli 
5 Including hexa-histidine tag and hexa-alanine spacer 
6 Single transmembrane domain (STMD) 
7 Including phosphopantheteine and hydroxy-tetradecanoate 
8 By means of LILBID spectrometry, a phosphopantetheine-hydroxy-tetradecanoate modification to both acyl 
carrier proteins of Y. lipolytica complex I was identified. 
9 Nübel et al, unpublished. Exact mass of the subunit has not been determined yet. 
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9.4   Protein alignments  
 
The  protein  sequences  were  aligned  using  the  CLUSTALW  software 
(http://www.ebi.ac.uk/clustalw/index.html).  *  -  conserved  amino  acids;  :  -  conserved 
substitutions; 
.  -  semi-conserved  substitutions.  Small  and  hydrophobic  amino  acids  are 
represented in red, acidic in blue, basic in magenta; hydroxyl + amine + basic in green. The 
mitochondrial presequences predicted with the MitoProt II software (http://ihg2.helmholtz-
muenchen.de/ihg/mitoprot.html) are underlined. 
9.4.1  Alignment of ACPs from different species 
 
ACP_E.coli              ------------------------------------------------------------ 
ACPM2_A.thaliana        -------------------MAARGAMLRYLRV-NVNPTIQNPRECVLPFSILLRRFSEEV 40 
ACPM1_Y.lipolytica      -------------------MLRN----------VSRLAL---------RSNFARQATMG- 21 
ACPM2_Y.lipolytica      -------------------MLRQSVLRLSRAA-VARPALSRSFVTAVARPQLVRAAPVSF 40 
ACPM_N.crassa           -------------------MFRTAALTAAR---VARPAVASAVRAGVARPAFVQAVPKVA 38 
ACP_S.cerevisiae        -------------------MFRSVCRISSR---VAP----SAYRTIMGRSVMSNTI---- 30 
ACPM_B.taurus           MAVRVLCACVRRLPTAFAPLPRLPTLAAARPLSTTLFAAETRTRPGAPLPALVLAQVPGR 60 
ACPM_H.sapiens          MASRVLSAYVSRLPAAFAPLPRVRMLAVARPLSTALCSAGTQTRLGTLQPALVLAQVPGR 60 
           
                                                
                                                10        20             30              
ACP_E.coli              ---------------MSTIEERVKKIIGEQLGVKQE-----EVTNNASFVEDLGADSLDT 40 
ACPM2_A.thaliana        R---------GSFLDKSEVTDRVLSVVKNFQKVDPS-----KVTPKANFQNDLGLDSLDS 86 
ACPM1_Y.lipolytica      ----QRFYS----VARPDAEKRIAAVLESFDKISNP----AAITPTASFAKDLNLDSLDT 69 
ACPM2_Y.lipolytica      ----IRHYSSAHVLTKDMIQERIVALLESFDKVNDA----KNITATANLTSDLGLDSLDV 92 
ACPM_N.crassa           AFQAVRFYSAGGHLKKDEVFSRIAQVLSGFDKVNDP----KNITETAHFANDLGLDSLDT 94 
ACP_S.cerevisiae        --LAQRFYSAN--LSKDQVSQRVIDVIKAFDK-NSPNIANKQISSDTQFHKDLGLDSLDT 85 
ACPM_B.taurus           VTQLCRQYSDAPPLTLEGIKDRVLYVLKLYDKIDPE-----KLSVNSHFMKDLGLDSLDQ 115 
ACPM_H.sapiens          VTQLCRQYSDMPPLTLEGIQDRVLYVLKLYDKIDPE-----KLSVNSHFMKDLGLDSLDQ 115 
                                            .*:  ::      .        ::  : : .**. ****  
 
           
            
            50        60        70 
ACP_E.coli              VELVMALEEEFDTEIPDEEAEKITTVQAAIDYINGH-QA-- 78 
ACPM2_A.thaliana        VEVVMALEEEFGFEIPDNEADKIQSIDLAVDFIASHPQAK- 126 
ACPM1_Y.lipolytica      VEVVVAIEEEFGIEIPDKEADEIKSVNQAVEYILAQPDAK- 109 
ACPM2_Y.lipolytica      VEVVMAIEEEFGLEIPDHDADEIKTVQQAIDYVSAQPAAV- 132 
ACPM_N.crassa           VEVVMAIEEEFSIEIPDKDADQIHSVDKAVEYILSQPDAN- 134 
ACP_S.cerevisiae        VELLVAIEEEFDIEIPDKVADELRSVGETVDYIASNPDAN- 125 
ACPM_B.taurus           VEIIMAMEDEFGFEIPDIDAEKLMCPQEIVDYIADKKDVYE 156 
ACPM_H.sapiens          VEIIMAMEDEFGFEIPDIDAEKLMCPQEIVDYIADKKDVYE 156 
                        **:::*:*:**. ****  *:::      ::::  :  .   
 
Figure 9.4  Alignment of ACPM1 and ACPM2 subunits with acyl carrier proteins from 
other species 
Four helices (I-IV) denoted in red and positions of amino acids according to E. coli nomenclature are 
indicated  above  the  sequence  alignment.  The  phosphopantetheine-binding  serine  residue  conserved  among 
different species is highlighted in red.  
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9.4.2  Alignment of ACPM1 and ACPM2 subunits from Y. lipolytica 
 
YL_ACPM1       MLRN---------VSRLAL---------RSNFARQATMG-QRFYS----VARPDAEKRIA 37  
YL_ACPM2       MLRQSVLRLSRAAVARPALSRSFVTAVARPQLVRAAPVSFIRHYSSAHVLTKDMIQERIV 60  
               ***:         *:* **         *.::.* *.:.  *.**    :::   ::**.  
        Helix  1         Helix             
YL_ACPM1       AVLESFDKISNPAAITPTASFAKDLNLDSLDTVEVVVAIEEEFGIEIPDKEADEIKSVNQ 97  
YL_ACPM2       ALLESFDKVNDAKNITATANLTSDLGLDSLDVVEVVMAIEEEFGLEIPDHDADEIKTVQQ 
120  
               *:******:.:.  **.**.::.**.*****.****:*******:****::*****:*:*  
             Helix   
YL_ACPM1       AVEYILAQPDAK    109  
YL_ACPM2       AIDYVSAQPAAV    132  
               *::*: *** *  
 
Figure 9.5  Alignment of Y. lipolytica ACPM1 and ACPM2 subunits 
The pantetheine-4‟-phosphate-binding serine residue is highlighted in red. Localisation of four helices (I-
IV) is denoted in red above the aligned sequences. 
 
9.4.3  Alignment of the st1 subunit 
                                                                             
MST_P.anserina     -----------------------------------MASLFILRPLRVSLPRSGSQQLRQP 25 
MST_N.crassa       -----------------------------------MARVGVISPLRAS--------MRST 17 
MST_S.cerevisiae   -----------------------------------MPLFDLISP---------------- 9 
St1_Y.lipolytica   -------------------------------------MSKLISP---------------- 7 
MST_E.coli         ------------------------------------------------------------ 
MST1_A.thaliana    MASTLFSRTFLAASHRLITPSLPQKIFNPATFLSRSLHSQLGSASTAYKSTTWARRAMAS 60 
MST2_A.thaliana    ---------------------------------------------------------MAS 3 
MST_T.aestivum     ------------------------------------------------------------ 
MST_B.taurus       ------------------------------------------------------------ 
MST_H.sapiens      ------------------------------------------------------------ 
MST_G.gallus       ------------------------------------------------------------ 
MST_D.rerio        ------------------------------------------------------------ 
TST_H.sapiens      ------------------------------------------------------------ 
TST_B.taurus       ------------------------------------------------------------ 
TST_G.gallus       ------------------------------------------------------------ 
TST1_S.tokodaii    ------------------------------------------------------------ 
TST2_S.tokodaii    ------------------------------------------------------------ 
MST_A.vinelandii   ------------------------------------------------------------ 
TST_A.vinelandii   ------------------------------------------------------------ 
St2_Y.lipolytica   ------------------------------------------------------------ 
St3_Y.lipolytica   ------------------------------------------------------------ 
MST_C.elegans      ------------------------------------------------------------ 
                                                                                   
MST_P.anserina     AAKAAGVRRSFSSYLVTPQELAEALKKAPPSPISSEPRVIPLCASWFLPNDPEGRT-GID 84 
MST_N.crassa       AAKTGAVR-CFSSYLVTPKELHEALKKAPPSPISSEPRVIPLCASWFLPNDPQKRT-GLD 75 
MST_S.cerevisiae   ----------------------KAFVKLVAS--EKVHRIVPVDATWYLPS-WKLDN-KVD 43 
St1_Y.lipolytica   ----------------------AELAKRLSS-----KETKIFDATWYLPTPANVGKNAYD 40 
MST_E.coli         ------------------------------------------------------------ 
MST1_A.thaliana    TGVETKAGYSTSSVSTSEPVVSVDWLHANLRE----PDLKILDASWYMPDEQRNPI---Q 113 
MST2_A.thaliana    SGSEAKANYAP--ISTNEPVVSVDWLHSNLGD----ADIKVLDASWYMAHEQRNPI---Q 54 
MST_T.aestivum     -------------MAQDDPVVSAQWLQQHLGQ----PDIKILDASWYMPHESRDAW---Q 40 
MST_B.taurus       ----------MASKQLFRALVSAQWVAEALRAPQAGQPLRLLDASWYLAKLGRDAR---R 47     APPENDIX 
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MST_H.sapiens      ----------MASPQLCRALVSAQWVAEALRAPRAGQPLQLLDASWYLPKLGRDAR---R 47 
MST_G.gallus       ----------MSQQLLYRALVSAKWLSEAIKSKQTGQALKVVDASWYLPKMKRDPK---Q 47 
MST_D.rerio        ----------MAAQT--RALVAARWLADAVKSNRVGPNLRILDASWYLPKMKRNPR---A 45 
TST_H.sapiens      ----------MVHQVLYRALVSTKWLAESIRTGKLGPGLRVLDASWYSPGT-REAR---K 46 
TST_B.taurus       ----------MVHQVLYRALVSTKWLAESVRAGKVGPGLRVLDASWYSPGT-REAR---K 46 
TST_G.gallus       ----------MAAQALGRALVSAKWLSEAVRAGRVGAGLRVLDASWYPPQE-RNAR---Q 46 
TST1_S.tokodaii    ------------------MLVSVKWLYENLN------EVKILEIDFDPEIN--------- 27 
TST2_S.tokodaii    ----------MSQTIQQQVVVDTKWLLEHLKD----PNVRIVEVDYDPNTA--------- 37 
MST_A.vinelandii   --------------MSHAQLLDPARLAERLDQ----PDLRILDCRFALEDPAYGAR---- 38 
TST_A.vinelandii   ----------MDDFASLPLVIEPADLQARLSA----PELILVDLTSAAR----------- 35 
St2_Y.lipolytica   ------------------------------------------------------------ 
St3_Y.lipolytica   ------------------------------------------------------------ 
MST_C.elegans      -----MAVDMIVEPKWVVQNFGNIRILDASWTFKPKADIAEYKAKYYNKFGVGMNELKNP 55 
                                                                                   
 
MST_P.anserina     VFREKRIPKARFFDLDKVIDKHSEYPHML-----PTPKGFAAAMSELGIRHEDTVVVYDS 139 
MST_N.crassa       VFIEKRIPKARFFDLDKVIDKRSPYPHML-----PSSKDFAAAMSELGIRREDTVVIYDS 130 
MST_S.cerevisiae   FLTKPRIPNSIFFDIDAISDKKSPYPHMF-----PTKKVFDDAMSNLGVQKDDILVVYDR 98 
St1_Y.lipolytica   NYMKKRIPGALYFDIDAVN-TPSKFPHML-----PSPQTFENELTKLGVSSDSPIVVYDT 94 
MST_E.coli         ---MDIFPAQCFLISKRFLDHTSPLPHML-----PRPETFAVAMLELGVNQDKHLIVYDE 52 
MST1_A.thaliana    EYQVAHIPRALFFDLDGISDRKTSLPHML-----PTEEAFAAGCSALGIDNKDEVVVYDG 168 
MST2_A.thaliana    EYQVAHIPGALFFDLNGIADRKTNLRHML-----PSEEAFAAGCSALGIENNDGVVVYDG 109 
MST_T.aestivum     EYQVAHIPGALYFDIDGISDRTTHLPHML-----PLEEAFAAAVSALGISNHDKVIVYDG 95 
MST_B.taurus       EFEERHIPGAAFFDIDQCSDRTSPYDHML-----PSAAHFSEYAGRLGVGAATHVVVYDA 102 
MST_H.sapiens      EFEERHIPGAAFFDIDQCSDRTSPYDHML-----PGAEHFAEYAGRLGVGAATHVVIYDA 102 
MST_G.gallus       EFEERHIPGAVFFDIDQCSDRTSPYDHMM-----PKANEFAEYVGKLGVGNDSHVVVYDG 102 
MST_D.rerio        EFEQTHIPGASFFDIDECCDKSSEFDHML-----PTKGEFADYVGNLGIGNNTHVVVYDA 100 
TST_H.sapiens      EYLERHVPGASFFDIEECRDTASPYEMML-----PSEAGFAEYVGRLGISNHTHVVVYDG 101 
TST_B.taurus       EYLERHVPGASFFDIEECRDKASPYEVML-----PSEAGFADYVGSLGISNDTHVVVYDG 101 
TST_G.gallus       EFKERHIPGASFFDIEECRDKSSPYDFML-----PSEAHFADYVGRLGVSNDTHVVVYDG 101 
TST1_S.tokodaii    -YYEGHIPSALLLPWKS-LLHDKIRDFAP-----PEK--FSKVLGNLGVKEDDLIVLYSD 78 
TST2_S.tokodaii    -YNVWHIQGAVLIRWREDLRHPVIRDFIE-----PSD--FEKLMESKGISNNTTVVLYGD 89 
MST_A.vinelandii   SYAEAHIPGARFADLERDLSG-PVHKGVTGRHPLPDPVLLTERLRAWGIDNDSQVVLYDD 97 
TST_A.vinelandii   -YAEGHIPGARFVDPKRTQLGQPPAPGLQ-----PPREQLESLFGELGHRPEAVYVVYDD 89 
St2_Y.lipolytica   ------------------------------------------------------------ 
St3_Y.lipolytica   ---------MMFRRITPVARRVIARDASK---------------HALGIRGRALRPIVNS 36 
MST_C.elegans      EYLAEHINGAAHFNFDIAYYPSENERFTLY-----TPEEFSSYVKRLGVFNGDHLVIYGR 110 
                                                                                   
 
MST_P.anserina     K-ELGIFSAPRVGWTLKTFGHPR-VHILNN-FRLWVEQG-LPTE-----------SGNVW 184 
MST_N.crassa       Q-ELGIFSAPRVGWTMKVFGHPK-VHILNN-FKLWIEEG-LPTE-----------SGNVW 175 
MST_S.cerevisiae   ---VGNFSSPRCAWTLGVMGHPK-VYLLNN-FNQYREFK-YPLD-----------SSKVA 141 
St1_Y.lipolytica   ---QGVFSGPRLVWTFKVFGHDN-VQFLNG-FEAYTQLPGIPSRPDA-------YTWGIW 142 
MST_E.coli         ---GNLFSAPRAWWMLRTFGVEK-VSILGGGLAGWQRDDLLLEEG--------------- 93 
MST1_A.thaliana    ---KGIFSAARVWWMFRVFGHEK-VWVLDGGLPRWRASGYDVESSASGDAILKASAASEA 224 
MST2_A.thaliana    ---MGLFSAARVWWMFRVFGHDK-VWVLDGGLPKWRASGYDVESSVSNDAILKASAATEA 165 
MST_T.aestivum     ---KGFYSAPRVWWMFRILGHDK-VWVLDGGFPQWQASGFNIGSSCPDDAVLKSKAANIA 151 
MST_B.taurus       S-DQGLYAAPRVWWMFRVFGHRT-VSLLDGGLRNWLRQGLPLSSGKS------------- 147 
MST_H.sapiens      S-DQGLYSAPRVWWMFRAFGHHA-VSLLDGGLRHWLRQNLPLSSGKS------------- 147 
MST_G.gallus       S-DQGLFSAPRVWWMFRVFGHEA-VSLLDGGLKNWLREGFPLSSGKT------------- 147 
MST_D.rerio        S-DFGSFSAPRVWWMFRVFGHSS-VSVLDGGFKNWLKEGHPVSQQYS------------- 145 
TST_H.sapiens      E-HLGSFYAPRVWWMFRVFGHRT-VSVLNGGFRNWLKEGHPVTSEPS------------- 146 
TST_B.taurus       D-DLGSFYAPRVWWMFRVFGHRT-VSVLNGGFRNWLKEGHPVTSEPS------------- 146 
TST_G.gallus       D-ELGTFYAPRAWWMFRAFGHRE-VSVLNGGFKNWVKEGHPVTAEPS------------- 146 
TST1_S.tokodaii    ---MGNRYAFYTYWLMKAYGHEN-VAILNGGIYKWLKEGYPVENEPT------------- 121 
TST2_S.tokodaii    ---YNNWFAVYTFWLFKAYGHED-VRILNGGRTKWAKENLPTEQGPK------------- 132 
MST_A.vinelandii   ---GPGAFAARAWWLLAWLGKRDGVFLLDGGLNAWRAAGLPLSGEPP------------- 141 
TST_A.vinelandii   ---EGGGWAGRFIWLLDVIGQQR-YHYLNGGLTAWLAEDRPLSRELP------------- 132 
St2_Y.lipolytica   ----------------------MKLSTLFSTFVCVTLG---------------------- 16 
St3_Y.lipolytica   ----------------ITTRKVHSVSQLNSARVALAAVPHNFHTQLL------------- 67 
MST_C.elegans      GKDGGMAAASRAYWTFRYYGYTT-VSVLNGGIEAFKLAQGVVQSGES------------- 156 
                                              * .                                
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MST_P.anserina     TVECG---TYPIPEMDEAK-----VAHFEDVREVALDYNKEGAEG-----VQILDARSYG 231 
MST_N.crassa       TIECG---TYPIPEMNEDK-----VASFEEVRQVAIDSSKEGSKS-----VQILDARSPG 222 
MST_S.cerevisiae   AFSPYPKSHYESSESFQDKE----IVDYEEMFQLVK--SGELAKK-----FNAFDARSLG 190 
St1_Y.lipolytica   DTQVPGKIDPADPPYKVTKARPELVKSFEDVLAIVEKHNGDGAKIRN--EVTFIDARPNG 200 
MST_E.coli         ------AVELPEGEFNAAFN-------PEAVVKVTDVLLASHENT-----AQIIDARPAA 135 
MST1_A.thaliana    IEKIYQGQTVSPITFQTKFQ--------PHLVWTLDQVKNNMEDPT----YQHIDARSKA 272 
MST2_A.thaliana    IEKIYQGQTISPITFQTKFR--------PHLVLALDQVKENIEDKT----YQHIDARSKA 213 
MST_T.aestivum     VETAYNGELANAATFQTEFR--------HQLLWTLEKVKHNVAAKA----HQVVDARVKG 199 
MST_B.taurus       --------RPQPAEFHAVLD--------PAYIKTYEDIKENLESRR----FQVVDARAAG 187 
MST_H.sapiens      --------QPAPAEFRAQLD--------PAFIKTYEDIKENLESRR----FQVVDSRATG 187 
MST_G.gallus       --------QVAPSDFHATLD--------KCMVKTYEDILDNLDSHR----FQVVDARVEG 187 
MST_D.rerio        --------KPAPVDFNASFK--------ESWVKTYEDVLNNIKTKE----FQVVDARANG 185 
TST_H.sapiens      --------RPEPAVFKATLD--------RSLLKTYEQVLENLESKR----FQLVDSRSQG 186 
TST_B.taurus       --------RPEPAIFKATLN--------RSLLKTYEQVLENLESKR----FQLVDSRAQG 186 
TST_G.gallus       --------QPAQAVFKATLD--------KTLLKTFEEMMENVGSKK----FQVVDSRPAG 186 
TST1_S.tokodaii    ------FPSK-KSNYIVKRVD------WSS-RILLWELLSKLN------SIELIDARNRE 161 
TST2_S.tokodaii    ------EPQYPKGSYKVKKVD------WGSHRAFFWEVLQRVTKGEVGKTTILVDVRSPK 180 
MST_A.vinelandii   --------APAAGTFRGQPD--------ASLLVDAQDLLARLGDAR----LTLLDARALP 181 
TST_A.vinelandii   --------APAGGPVALSLH--------DEPTASRDYLLGRLGAAD----LAIWDARSPQ 172 
St2_Y.lipolytica   --------------VASSAK--------EYSYFDVKKLSESLVDGSAPADTILIDVR--- 51 
St3_Y.lipolytica   --------KRRYSALSSECR--------ELTYPDIKALSDNILKGDN-DNVILVDVR--- 107 
MST_C.elegans      --------MISSGNYEAKSVDN------NILAKMADIPFDNLASIK------YLDARSKE 196 
                                                                         * *    
 
MST_P.anserina     RWSGKDPEPRP-----GLSSGHMPGSINIPFDAVLDPQTKAFLPVDKLKQVFKEKG---- 282 
MST_N.crassa       RWSGTEPEPRE-----GLSSGHMPGSINIPFSAVLDSSTKAFLPADKLKEVFARAG---- 273 
MST_S.cerevisiae   RFEGTEPEPRS-----DIPSGHIPGTQPLPYGSLLDPETKTYPEAGEAIHATLEKALKDF 245 
St1_Y.lipolytica   RFTGKDAEPRA-----ELSSGHVPGAYSIAFPEVVE--NGKFKSPEELKALFASKG---- 249 
MST_E.coli         RFNAEVDEPRP-----GLRRGHIPGALNVPWTELVR--EGELKTTDELDAIFFGRG---- 184 
MST1_A.thaliana    RFDGTAPEPRK-----GIRSGHIPGSKCIPFPQMFD-SCNTLLPAEELKKRFDQED---- 322 
MST2_A.thaliana    RFDGIAPEPWK-----GLPSGHIPGSKCVPFPLMFD-SSQTLLPAEELKKQFEQED---- 263 
MST_T.aestivum     RFDGVMPEPRE-----GVRSGHIPGTKCVPFPEMSD-GAQTLLPADELSKKFEQAG---- 249 
MST_B.taurus       RFRGTEPEPRD-----GIEPGHIPGTINIPFTDFLT-EDGLEKSPEEIRRLFQDKK---- 237 
MST_H.sapiens      RFRGTEPEPRD-----GIEPGHIPGTVNIPFTDFLS-QEGLEKSPEEIRHLFQEKK---- 237 
MST_G.gallus       RFRGIEPEPRD-----GIEPGHIPGSLNMPFTSFLT-ESGLEKTPEQIRSLFQEKK---- 237 
MST_D.rerio        RFRGVEPEPRA-----NTEPGHIPASLNMPFPSFMDPESGLERPVEELTKLFQQAG---- 236 
TST_H.sapiens      RFLGTEPEPDAV----GLDSGHIRGAVNMPFMDFLT-EDGFEKGPEELRALFQTKK---- 237 
TST_B.taurus       RYLGTQPEPDAV----GLDSGHIRGSVNMPFMNFLT-EDGFEKSPEELRAMFEAKK---- 237 
TST_G.gallus       RFQGTELDQ-------GLESGHIPGAVNMPFSTFLT-ESGHEKSIEEIQQMFHEKK---- 234 
TST1_S.tokodaii    EYEGLTSAPPEHKCEQTQVSGHIPNAKNIPWTILFN-EDGTLKGREELEKIFSS------ 214 
TST2_S.tokodaii    EYTGEIRAPPEYADEQTQVGGHIPGAISFPWSQAVNPETGEFKPIEELRRLVESSG---- 236 
MST_A.vinelandii   RFRGEVEPLDP-------VAGHIPGARCAPFTDNLG-ADGRFLPADELRARFAGLLG--- 230 
TST_A.vinelandii   EYRGE-KVLAA-------KGGHIPGAVNFEWTAAMD-PSRALRIRTDIAGRLE-ELG--- 219 
St2_Y.lipolytica   -------EPSE------YAAGFIPGAFNMPLKTQSF---ALCKSPEEFETAMGFPK---- 91 
St3_Y.lipolytica   -------EPDE------FKAGHIPGAINIPVKSTPG---ALSLSAEEFEGTFGFPK---- 147 
MST_C.elegans      EFIGKVPIGYP-----DSKAEGVRCKDAIHFPIGEVCAAKGFKKKTDCDQAFAAKG---- 247 
                                         :                       .              
 
MST_P.anserina     ---VDPAKPIISSCGTGVTACVLETALNEAQYGSPETRKVYDGSWTEWAQRVKPSDSLIR 339 
MST_N.crassa       ---VDPSKPIISSCGTGVTACVLETALNEAQFGSPEKSKVYDGSWTEWAQRVKSSESLIE 330 
MST_S.cerevisiae   HCTLDPSKPTICSCGTGVSGVIIKTALELA--GVPNVR-LYDGSWTEWVLKSGP-EWIAE 301 
St1_Y.lipolytica   ---IDGSKPIISMCGSGVTACVIDLALEIAGIGSRDTNAVYDGSWTEWAQRAPTKYIVKE 306 
MST_E.coli         ---VSYDKPIIVSCGSGVTAAVVLLALATLD---VPNVKLYDGAWSEWGARADLPVEPVK 238 
MST1_A.thaliana    ---ISLDKPIMASCGTGVTACILAMGLHRLG---KTDVPIYDGSWTEWATQP--DLPIES 374 
MST2_A.thaliana    ---ISLDSPIAASCGTGVTACILALGLYRLG---KTNVAIYDGSWTEWATAP--NLPIVG 315 
MST_T.aestivum     ---ISLDGPIVLTCASGVTACILALGLYRIG---KHDVPVYDGSWTEWEALPDNDYPIVT 303 
MST_B.taurus       ---VDLSLPLVATCGSGVTACHVALGAYLCG---KPDVPIYDGSWVEWYMRAQPEDIISE 291 
MST_H.sapiens      ---VDLSKPLVATCGSGVTACHVALGAYLCG---KPDVPIYDGSWVEWYMRARPEDVISE 291 
MST_G.gallus       ---VDLSKPLVATCGSGVTACHVALGAYLCG---KPDVAVYDGAWVEWYMRAQPENIISE 291 
MST_D.rerio        ---VDLQKPFWVTCGSGVTACHIALAAHLCG---HPGVSLYDGAWSEWFTKAAPEHIISE 290 
TST_H.sapiens      ---VDLSQPLIATCRKGVTACHVALAAYLCG---KPDVAVYDGSWSEWFRRAPPESRVSQ 291     APPENDIX 
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TST_B.taurus       ---VDLTKPLIATCRKGVTACHIALAAYLCG---KPDVAIYDGSWFEWFHRAPPETWVSQ 291 
TST_G.gallus       ---VDLSKPLTATCRKGVTACHIALAAYLCG---KPDVAVYDGSWSEWFHRAPPQYKVTE 288 
TST1_S.tokodaii    ---INKDKEIVVYCRTGARASAVWYVLKEVLS--YKNVRLYDGSWVEYGNLVGVPIER-- 267 
TST2_S.tokodaii    ---ISQDKEIITYCRIGERAAHTWFVLKYLLG--YPAVRVYDGSWAEWGNIVGAPVKKGN 291 
MST_A.vinelandii   ---ERPVERLVAYCGSGVTACHNLFALSLAG---YPLAPLYAGSWSEWLTDRSRPVATGD 284 
TST_A.vinelandii   ---ITPDKEIVTHCQTHHRSGLTYLIAKALG---YPRVKGYAGSWGEWGNHPDTPVEL-- 271 
St2_Y.lipolytica   ---PSKNMHVVFYCQSGVRARMAEKQGEQCG---YENRGIYLGSWKEWSQYETEVGQC-- 143 
St3_Y.lipolytica   ---PDINDELVFYCQAGIRSAKAESLAETCG---YQLRANYPGSYNDWLAHQK------- 194 
MST_C.elegans      ---IKVGDTVVIGCGIGLSASAIWLAAARSG----IVAKLYNGGVHELAYKAPQHLNTKG 300 
                                *     .                    * *.  :              
MST_P.anserina     TVEQHSE-- 346 
MST_N.crassa       KAE------ 333 
MST_S.cerevisiae   NRD------ 304 
St1_Y.lipolytica   ENLNEANRA 315 
MST_E.coli         --------- 
MST1_A.thaliana    VESSS---- 379 
MST2_A.thaliana    SSS------ 318 
MST_T.aestivum     STGS----- 307 
MST_B.taurus       GRGKIH--- 297 
MST_H.sapiens      GRGKTH--- 297 
MST_G.gallus       GKGKTV--- 297 
MST_D.rerio        GKGKQP--- 296 
TST_H.sapiens      GKSEKA--- 297 
TST_B.taurus       GKGGKA--- 297 
TST_G.gallus       LKRNKG--- 294 
TST1_S.tokodaii    --------- 
TST2_S.tokodaii    EP------- 293 
MST_A.vinelandii   --------- 
TST_A.vinelandii   --------- 
St2_Y.lipolytica   --------- 
St3_Y.lipolytica   --------- 
MST_C.elegans      --------- 
 
Figure 9.6  Alignment of the st1 subunit with tandem rhodanese domain repeat enzymes 
from other organisms 
Y.  lipolytica  st1  subunit  exibits the  highest  similarity  to  a  sulfurtransferase  of  another  Ascomycota  fungus 
Podospora anserina. The 3-mercaptopyruvate:cyanide sulfurtransferase (MST) catalytic modules  containing 
six-amino-acid active-site loop are highlighted in grey; the conserved cysteine residue is highlighted in red; the 
thiosulfate:cyanide sulfurtransferase (TST) active sites are highlighted in blue; the active site of the st1 subunit 
is highlighted in green; the active site of single rhodanese domain-type enzymes of which two candidate open 
reading frames CAG82611.1 (st2 - theoretical protein) and CAG78833 (st3 - theoretical protein) were identified 
in the Y. lipolytica genomic sequence are highlighted in yellow. For the cladogram of tandem rhodanese domain 
repeat enzymes see Figure 9.7 
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Figure 9.7 The cladogram of tandem rhodanese domain repeat enzymes aligned in 9.4.3 
The cladogram was predicted with the CLUSTALW software (EMBL-EBI, Heidelberg, Germany). 
 
9.4.4  Alignment of S. cerevisiae and Y. lipolytica mitochondrial FASII enzymes 
 
The protein sequences of the mitochondrial fatty acid synthase type II enzymes from Y. 
lipolytica were obtained using BLAST search in Genolevures database http://www.geno 
levures.org. by comparison to the S. cerevisiae (Sc) FASII enzymes. Y. lipolytica (YAL) 
protein sequences are denoted with the accession number. 
 
 
Sc_CEM1           MSRRVVITGLGCVTPLGRSLSESWGNLLSSKNGLTPITSLPNYNEDYKLREKSIPSTITV 60 
YALI0F30679g      MTR-VVVTGLGLVSPLGVGVKQAWNRLIAGKSG---IVALDERFDALSCRVG-------- 48 
                  *:* **:**** *:*** .:.::*..*::.*.*:  *.:* :  :  . *   :   : : 
 
Sc_CEM1           GKIPENFQNENSAINKLLFTSQDERRTSSFIKLALRTTYEALHNAGLLNPNDITINTSLC 120 
YALI0F30679g      GVVPQDEWSEASSAN---LAAGEIKRVPLFAQYAMVAAQEAVNDSKLLADAGESAKH--- 102 
                  * :*::  .* *: * ::::: : :*.. * : *: :: **:::: **   . : :  :  
 
Sc_CEM1           NLDHFGCLIGSGIGSIQDIYQTSLQFHNDNKR-INPYFVPKILTNMAAGNVSIKFNLRGL 179 
YALI0F30679g      --TDIGCSIGTGIANMAELADTVTAFNNKGPRGISPLFVPRIIANMGAGHVSMRFGLQGP 160 
                   : .:** **:**..: :: :*   *:*.. * *.* ***:*::**.**:**::*.*:*  
 
Sc_CEM1           SHSVSTACATGNNSIGDAFNFIRLGMQDICVAGASETSLHPLSLAGFIRAKSITTNG--- 236 
YALI0F30679g      NHSVSTACATGAHSIGDAANFIRLGYAKAMIAGSTEACMHPIALGGFARAKSVATKWNDS 220 
                  .********** :***** ******  .  :**::*:.:**::*.** ****::*:     
 
Sc_CEM1           ---ISRPFDTQRSGFVLGEGCGMIVMESLEHAQKRNANIISELVGYGLSSDACHITSPPA 293 
YALI0F30679g      PSEASRPFDKDRGGFVMGEGSAVLVLEEYEHAVARGAPIYAEVCGYGLSGDAHHITAPPD 280     APPENDIX 
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                      *****.:*.***:***..::*:*. ***  *.* * :*: *****.** ***:**  
 
Sc_CEM1           DGNGAKRAIEMALKMARLEPTDVDYVNAHATSTLLGDKAECLAVASALLPGRSKSKPLYI 353 
YALI0F30679g      DGNGAYRAMKQALKQANVSAVKIDYVNAHATSTPLGDAAENAALT-QLFEGRNLS-DIAV 338 
                  ***** **:: *** *.:....:********** *** **  *::  *: **. *  : : 
 
Sc_CEM1           SSNKGAIGHLLGARGAVESIFTICSLKDDKMPHTLNLDNVLTLENNEADKLHFIRDKPIV 413 
YALI0F30679g      SSTKGAIGHLLGGAGSVEALFTIKALETGDLPPTLNLN---ELSDPDVFKFNFVP-KETQ 394 
                  **.*********. *:**::*** :*: ..:* ****: :: *.: :. *::*:  *    
 
Sc_CEM1           GANPKYALCNSFGFGGVNTSLLFKKWEGS 442 
YALI0F30679g      HRDVRYALNNSFGFGGTNSSLLFGKV--- 420 
                    : :*** *******.*:**** *     
 
Figure 9.8 Mitochondrial beta-keto-acyl synthase (CEM1) 
Cem1 posses possible role in fatty acid synthesis and is required for mitochondrial respiration. 
 
 
ETR1 homologue YALI0C19624g 
 
Sc_ETR1           KTLAFPINPSDINQLQGVYPSRPEKTYDYSTDEPAAIAGNEGVFEVVSLPSGSSKGDLKL 114 
YALI0C19624g      KSLGFTINPADINQLEGVYPSVPPKSVQINNED-AAIGGNEGLFQVLDP---GAKSGLKK 116 
                  *:*.*.***:*****:***** * *: : ..:: ***.****:*:*:.    .:*..**  
 
Sc_ETR1           GDRVIPLQANQGTWSNYRVFSSSSDLIKVN--DLDLFSAATVSVNGCTGFQLVSDYIDWN 172 
YALI0C19624g      GDWVLPRKTCFGTWRSHALVEADT-VVKIDNTDLTKVQATTVSVNPSTAYEMLKDLKEG- 174 
                  ** *:* ::  *** .: :..:.: ::*::  **  ..*:***** .*.::::.*  :   
 
Sc_ETR1           SNGNEWIIQNAGTSSVSKIVTQVAKAKGIKTLSVIRDRDNFDEVAKVLEDKYGATKVISE 232 
YALI0C19624g      ----DWFIQNGGNSGVGRAAIQIGHIRGLKSISVVRDRPDLEVLKKELTD-LGATHVITE 229 
                      :*:***.*.*.*.: . *:.: :*:*::**:*** ::: : * * *  ***:**:* 
 
Sc_ETR1           SQNNDKTFAKEVLSKILGENARVRLALNSVGGKSSASIARKLENNALMLTYGGMSKQPVT 292 
YALI0C19624g      EEASDKLFSKQIKSWTGGK---IKLALNCIGGKSATSIMRQLGAGGSIVTYGGMSKKPLT 286 
                  .: .** *:*:: *   *:   ::****.:****::** *:*  .. ::*******:*:* 
 
Sc_ETR1           LPTSLHIFKGLTSKGYWVTEKNKKNPQSKIDTISDFIKMYNYGHIISPRDEIETLTWN-T 351 
YALI0C19624g      FPTGPFIFKDITAKGYWLTRWADKHPEEKAKTIENIFKFYREKKFVAPPVNISTLDFSKG 346 
                  :**. .***.:*:****:*.  .*:*:.* .**.:::*:*.  ::::*  :*.** :.   
 
Sc_ETR1           NTTTDEQLLELVKKGITGKGKKKMVVLEW- 380 
YALI0C19624g      NDVVLSEFLDALGKAQKGGGKKQLVQWVEY 376 
                  * .. .::*: : *. .* ***::*      
 
 
ETR1 homologue YALI0B12386g 
 
Sc_ETR1           MLPTFKRYMSSSAHQIPKHFKSLIYSTHEVEDCTKVLSVKNYTPKQDLSQSIVLKTLAFP 60 
YALI0B12386g      --------------------MKSVQVKDDKGPAENLYIGEGPTPNPQNGQ-LLVKTEYFG 39 
                  ::  :   :      :   : . :  ..:   . ::   :. **: : .* :::**  *  
 
Sc_ETR1           INPSDINQLQGVYPSRPEKTYDYSTDEPAAIAGNEGVFEVVSLPSGSSKGDLKLGDRVIP 120 
YALI0B12386g      LNRMDLLQRLGNYPLPPQAPKTLGVEFSGTIEKSE-------------SDKFAVGDKVFG 86 
                  :*  *: *  * **  *: .   ..: ..:*  .* :: :: :     ...: :**:*:  
 
Sc_ETR1           LQANQGTWSNYRVFSSSSDLIKVNDLDLFSAATVSVNGCTGFQLVSDYIDWNSNGNEWII 180 
YALI0B12386g      LVYG-GAYAEYVVAAEETLIKVPDDLSMEVAAGLPEVWFTGIQVLTTVGKFQKGDS--VL 143 
                  *  . *::::* * :..: :   :**.:  ** :.    **:*:::   .::....  ::  
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Sc_ETR1           QNAGTSSVSKIVTQVAKAKGIKTLSVIRDRDNFDEVAKVLEDKYGATKVISESQNNDKTF 240 
YALI0B12386g      FHAGASSVGIAVIQLAASLGASKIFTTVGSDEKCEFVKKLGNKFGVTVVPINYHNED--- 200 
                   :**:***.  * *:* : * ..: .  . *:  *..* * :*:*.* *  : :*:*  : 
 
Sc_ETR1           AKEVLSKILGEN--ARVRLALNSVGGKSSASIARKLENNALMLTYGGMSKQPVT--LPTS 296 
YALI0B12386g      FKEVISKHYDASKGEGVNVIIDPVGQTYFVRNLEIAAKDARIVLMGAMSGPIVKGDVPIG 260 
                   ***:**  . .    *.: ::.** .  .   .   ::* ::  *.**   *.  :* . 
 
Sc_ETR1           LHIFKGLTSKGYWVTEKNKKNPQSKIDTISDFIKMYNYGHIISPRDEIETLTWNTNTTTD 356 
YALI0B12386g      LIIYKRLVVQGTTLRSRD----LAYQEKLRDFFVSHVVPLILEG--KIDTFVDKLFNFTT 314 
                  * *:* *. :*  : .::     :  :.: **:  :    *:.   :*:*:. :  . *  
 
Sc_ETR1           EQLLELVKKGITGKGKKKMVVLEW 380 
YALI0B12386g      EDIVASHKYLESNKSMGKVIVKI- 337 
                  *:::   *   :.*.  *::*    
 
Figure 9.9  2-enoyl thioester reductase (ETR1) 
The ETR1 is the member of the medium chain dehydrogenase/reductase family. It is localized into the 
mitochondria, where it has a probable role in fatty acid synthesis. Two different ETR1 homologues are present 
in Y. lipolytica. 
 
 
Sc_HFA1           ------------------------------------------------------------ 
YALI0C11407g      MRLQLRTLTRRFFSMASGSSTPDVAPLVDPNIHKGLASHFFGLNSVHTAKPSKVKEFVAS 60 
                                                                               
 
Sc_HFA1           ----------------------MRSIRKWAYETFNDEKIIQFVVMATPDDLHANSEYIRM 38 
YALI0C11407g      HGGHTVINKVLIANNGIAAVKEIRSVRKWAYETFGDERAISFTVMATPEDLAANADYIRM 120 
                                        :**:********.**: *.*.*****:** **::**** 
 
Sc_HFA1           ADQYVQVPGGTNNNNYANIDLILDVAEQTDVDAVWAGWGHASENPCLPELLASSQRKILF 98 
YALI0C11407g      ADQYVEVPGGTNNNNYANVELIVDVAERFGVDAVWAGWGHASENPLLPESLAASPRKIVF 180 
                  *****:************::**:****: .*************** *** **:* ***:* 
 
Sc_HFA1           IGPPGRAMRSLGDKISSTIVAQSAKIPCIPWSGSHIDTIHIDNKTNFVSVPDDVYVRGCC 158 
YALI0C11407g      IGPPGAAMRSLGDKISSTIVAQHAKVPCIPWSGTGVDEVVVDKSTNLVSVSEEVYTKGCT 240 
                  ***** **************** **:*******: :* : :*:.**:***.::**.:**  
 
Sc_HFA1           SSPEDALEKAKLIGFPVMIKASEGGGGKGIRRVDNEDDFIALYRQAVNETPGSPMFVMKV 218 
YALI0C11407g      TGPKQGLEKAKQIGFPVMIKASEGGGGKGIRKVEREEDFEAAYHQVEGEIPGSPIFIMQL 300 
                  :.*::.***** *******************:*:.*:** * *:*. .* ****:*:*:: 
 
Sc_HFA1           VTDARHLEVQLLADQYGTNITLFGRDCSIQRRHQKIIEEAPVTITKPETFQRMERAAIRL 278 
YALI0C11407g      AGNARHLEVQLLADQYGNNISLFGRDCSVQRRHQKIIEEAPVTVAGQQTFTAMEKAAVRL 360 
                  . :**************.**:*******:**************::  :**  **:**:** 
 
Sc_HFA1           GELVGYVSAGTVEYLYSPKDDKFYFLELNPRLQVEHPTTEMISGVNLPATQLQIAMGIPM 338 
YALI0C11407g      GKLVGYVSAGTVEYLYSHEDDKFYFLELNPRLQVEHPTTEMVTGVNLPAAQLQIAMGIPL 420 
                  *:*************** :**********************::******:*********: 
 
Sc_HFA1           HMISDIRKLYGLDPTGTSYIDFKN--------LKRPSPKGHCISCRITSEDPNEGFKPST 390 
YALI0C11407g      DRIKDIRLFYGVNPHTTTPIDFDFSGEDADKTQRRPVPRGHTTACRITSEDPGEGFKPSG 480 
                  . *.*** :**::*  *: ***.          :** *:**  :********.******  
 
Sc_HFA1           GKIHELNFRSSSNVWGYFSVGNNGAIHSFSDSQFGHIFAVGNDRQDAKQNMVLALKDFSI 450 
YALI0C11407g      GTMHELNFRSSSNVWGYFSVGNQGGIHSFSDSQFGHIFAFGENRSASRKHMVVALKELSI 540 
                  *.:*******************:*.**************.*::*. ::::**:***::** 
 
Sc_HFA1           RGEFKTPIEYLIELLETRDFESNNISTGWLDDLILKNLSSDSKLDPTLAIICGAAMKAYV 510     APPENDIX 
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YALI0C11407g      RGDFRTTVEYLIKLLETPDFEDNTITTGWLDELISNKLTAE-RPDSFLAVVCGAATKAHR 599 
                  **:*:*.:****:**** ***.*.*:*****:** ::*::: : *. **::**** **:  
 
Sc_HFA1           FTEKVRNKYLELLRRGQVPPKDFLKTKFPVDFIFDNNRYLFNVAQSSEEQFILSINKSQC 570 
YALI0C11407g      ASEDSIATYMASLEKGQVPARDILKTLFPVDFIYEGQRYKFTATRSSEDSYTLFINGSRC 659 
                   :*.   .*:  *.:****.:*:*** ******::.:** *..::***:.: * ** *:* 
 
Sc_HFA1           EVNVQKLSSDCLLISVDGKCHTVYWKDDIRGTRLSIDSNTIFLEAELNPTQVISPTPGKL 630 
YALI0C11407g      DIGVRPLSDGGILCLVGGRSHNVYWKEEVGATRLSVDSKTCLLEVENDPTQLRSPSPGKL 719 
                  ::.*: **.. :*  *.*:.*.****::: .****:**:* :**.* :***: **:**** 
 
Sc_HFA1           VKYLVRSGDHVFAGQQYAEIEIMKMQMPLVAKSDGVIELLRQPGSIIEAGDVIAKLTLDS 690 
YALI0C11407g      VKFLVENGDHVRANQPYAEIEVMKMYMTLTAQEDGIVQLMKQPGSTIEAGDILGILALDD 779 
                  **:**..**** *.* *****:*** *.*.*:.**:::*::**** *****::. *:**. 
 
Sc_HFA1           PSKANESSLYRGELPVLGPPLIEGSRPNHKLRVLINRLENILNGYHENSGIETTLKELIK 750 
YALI0C11407g      PSKVKHAKPFEGQLPELGPPTLSGNKPHQRYEHCQNVLHNILLGFDNQVVMKSTLQEMVG 839 
                  ***.:.:. :.*:** **** :.*.:*::: .   * *.*** *:.::  :::**:*::  
 
Sc_HFA1           ILRDGRLPYSEWDSQISTVRNRLPRQLNEGLGNLVKKSVS----FPAKELHKLMKRYLEE 806 
YALI0C11407g      LLRNPELPYLQWAHQVSSLHTRMSAKLDATLAGLIDKAKQRGGEFPAKQLLRALEKEASS 899 
                  :**: .*** :*  *:*:::.*:. :*:  *..*:.*: .    ****:* : :::  .. 
 
Sc_HFA1           NTNDHVVYVALQPLLKISERYSEGLANHECEIFLKLIKKYYAVEKIFENHDIHEERNLLN 866 
YALI0C11407g      GEVDALFQQTLAPLFDLAREYQDGLAIHELQVAAGLLQAYYDSEARFCGPNVRDEDVILK 959 
                  .  * :.  :* **:.::..*.:*** ** ::   *:: **  *  * . ::::*  :*: 
 
Sc_HFA1           LRRKDLTNLKKILCISLSHANVVAKNKLVTAILHEYEPLCQDSSK-------MSLKFRAV 919 
YALI0C11407g      LREENRDSLRKVVMAQLSHSRVGAKNNLVLALLDEYKVADQAGTDSPASNVHVAKYLRPV 1019 
                  **.::  .*:*::  .***:.* ***:** *:*.**:   * .:.       ::  :*.* 
 
Sc_HFA1           IHDLASLESKWAKEVAVKARSVLLRGIFPPIKKRKEHIKTLLQLHIKDTGAENIHSRNIY 979 
YALI0C11407g      LRKIVELESRASAKVSLKAREILIQCALPSLKERTDQLEHILRSSVVESRYGEVGLEHRT 1079 
                  ::.:..***: : :*::***.:*::  :*.:*:*.:::: :*:  : ::   ::  .:   
 
Sc_HFA1           SCMRDFGNLIHSNLIQLQDLFFFFGHQDTALSSIASEIYARYAYGNYQLKSIKIHKG-AP 1038 
YALI0C11407g      PRADILKEVVDSKYIVFDVLAQFFAHDDPWIVLAALELYIRRACKAYSILDINYHQDSDL 1139 
                  .    : :::.*: * :: *  **.*:*. :   * *:* * *   *.: .*: *:.    
 
Sc_HFA1           DLLMSWQF------SSLRNYLVNSDGESDEFTKLSKPPSTS-------GKSSANSFGLLV 1085 
YALI0C11407g      PPVISWRFRLPTMSSALYNSVVSSGSKTPTSPSVSRADSVSDFSYTVERDSAPARTGAIV 1199 
                    ::**:*      *:* * :*.*..::   ..:*:. *.*        .*:.   * :* 
 
Sc_HFA1           NMRALESLEKTLDEVYEQIHIPEE--RLSSGEN-----------------------SLIV 1120 
YALI0C11407g      AVPHLDDLEDALTRVLENLPKRGAGLAISVGASNKSAAASARDAAAAAASSVDTGLSNIC 1259 
                   :  *:.**.:* .* *::        :* * .                       * *  
 
Sc_HFA1           NILSPIRYRSEND--LIKTLKIKLHENERGLSKLKVNRITFAFIAANAPAVKFYSFDGTT 1178 
YALI0C11407g      NVMIGRVDESDDDDTLIARISQVIEDFKEDFEACSLRRITFSFGNSRGTYPKYFTFRGPA 1319 
                  *::     .*::*  **  :.  :.: :..:.  .:.****:*  :...  *:::* *.: 
 
Sc_HFA1           YDEISQIRNMDPSYEAPLELGKMSNYKIRSLPTYDSSIRIFEGISKFTPLDKRFFVRKII 1238 
YALI0C11407g      YEEDPTIRHIEPALAFQLELARLSNFDIKPVHTDNRNIHVYEATGKNAASDKRFFTRGIV 1379 
                  *:* . **:::*:    ***.::**:.*:.: * : .*:::*. .* :. *****.* *: 
 
Sc_HFA1           NSFMYNDQKTTEENLKAEINAQVVYMLEHLGAVDISNSDLNHIFLSFNTVLNIPVHRLEE 1298 
YALI0C11407g      RPGRLRENIPTSEYLISEADRLMSDILDALEVIGTTNSDLNHIFINFSAVFALKPEEVEA 1439 
                  ..   .:: .*.* * :* :  :  :*: * .:. :********:.*.:*: :  ..:*  
 
Sc_HFA1           IVSTILKTHETRLFQERITDVEICISVECLETKKPAPLRLLISNKSGYVVKIETYYEKIG 1358 
YALI0C11407g      AFGGFLERFGRRLWRLRVTGAEIRMMVSDPETGSAFPLRAMINNVSGYVVQSELYAEAKN 1499 
                   .. :*: .  **:: *:*..** : *.  ** .. *** :*.* *****: * * *  .  
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Sc_HFA1           KNGNLILEPCSEQSHYSQKSLSLPYSVKDWLQPKRYKAQFMGTTYVYDFPGLFHQAAIQQ 1418 
YALI0C11407g      DKGQWIFKSLGKPGSMHMRSINTPYPTKEWLQPKRYKAHLMGTTYCYDFPELFRQSIESD 1559 
                  .:*: *::. .: .    :*:. **..*:*********::***** **** **:*:  .: 
 
Sc_HFA1           WKRYFPKHKLNDSFFSWVELIEQNGNLIKVNREPGLNNIGMVAFEIMVQTPEYPEGRNMI 1478 
YALI0C11407g      WKKYDGKAPDDLMTCNELILDEDSGELQEVNREPGANNVGMVAWKFEAKTPEYPRGRSFI 1619 
                  **:*  *   :    . : * *:.*:* :****** **:****::: .:*****.**.:* 
 
Sc_HFA1           VISNDITYNIGSFGPREDLFFDRVTNYARERGIPRIYLAANSGAKLGIAEELIPLFRVAW 1538 
YALI0C11407g      VVANDITFQIGSFGPAEDQFFFKVTELARKLGIPRIYLSANSGARIGIADELVGKYKVAW 1679 
                  *::****::****** ** ** :**: **: *******:*****::***:**:  ::*** 
 
Sc_HFA1           NDPSDPTKGFQYLYLAPKDMQLLKDSGKGNSVVVEHKMVYGEERYIIKAIVGFEEGLGVE 1598 
YALI0C11407g      NDETDPSKGFKYLYFTPESLATLKPDTVVTTEIEEEGPNGVEKRHVIDYIVGEKDGLGVE 1739 
                  ** :**:***:***::*:.:  ** .   .: : *.     *:*::*. *** ::***** 
 
Sc_HFA1           CLQGSGLIAGATSKAYRDIFTITAVTCRSVGIGSYLVRLGQRTIQVEDKPIILTGASAIN 1658 
YALI0C11407g      CLRGSGLIAGATSRAYKDIFTLTLVTCRSVGIGAYLVRLGQRAIQIEGQPIILTGAPAIN 1799 
                  **:**********:**:****:* *********:********:**:*.:*******.*** 
 
Sc_HFA1           KVLGTDIYTSNLQIGGTQIMYKNGIAHLTASNDMKAIEKIMTWLSYVPAKRDMSPPLL-E 1717 
YALI0C11407g      KLLGREVYSSNLQLGGTQIMYNNGVSHLTARDDLNGVHKIMQWLSYIPASRGLPVPVLPH 1859 
                  *:** ::*:****:*******:**::**** :*::.:.*** ****:**.*.:. *:* . 
 
Sc_HFA1           TMDRWDRDVDFKPAKQVPYEARWLIEGKWDSNNNFQSGLFDKDSFFETLSGWAKGVIVGR 1777 
YALI0C11407g      KTDVWDRDVTFQPVRGEQYDVRWLISGRTLEDGAFESGLFDKDSFQETLSGWAKGVVVGR 1919 
                  . * ***** *:*.:   *:.****.*:  .:. *:********* **********:*** 
 
Sc_HFA1           ARLGGIPVGVIAVETKTIEEIIPADPANLDSSEFSVKEAGQVWYPNSAFKTAQTINDFNY 1837 
YALI0C11407g      ARLGGIPFGVIGVETATVDNTTPADPANPDSIEMSTSEAGQVWYPNSAFKTSQAINDFNH 1979 
                  *******.***.*** *:::  ****** ** *:*..**************:*:*****: 
 
Sc_HFA1           GEQLPLIILANWRGFSGGQRDMYNEVLKYGSFIVDALVDYKQPILIYIPPFGELRGGSWV 1897 
YALI0C11407g      GEALPLMILANWRGFSGGQRDMYNEVLKYGSFIVDALVDYKQPIMVYIPPTGELRGGSWV 2039 
                  ** ***:*************************************::**** ********* 
 
Sc_HFA1           VIDPTINPEQMEMYADVESRGGVLEPDGVVSIKYRKEKMIETMIRLDSTYGHLRRTLTEK 1957 
YALI0C11407g      VVDPTINSDMMEMYADVESRGGVLEPEGMVGIKYRRDKLLDTMARLDPEYSSLKKQLEES 2099 
                  *:*****.: ****************:*:*.****::*:::** ***. *. *:: * *. 
 
Sc_HFA1           KLSLEKQNDLTKRLKIRERQLIPIYNQISIQFADLHDRSTRMLVKGVIRNELEWKKSRRF 2017 
YALI0C11407g      PDSEE----LKVKLSVREKSLMPIYQQISVQFADLHDRAGRMEAKGVIREALVWKDARRF 2155 
                    * *    *. :*.:**:.*:***:***:********: ** .*****: * **.:*** 
 
Sc_HFA1           LYWRLRRRLNEGQVIKRLQKKTCDNKTKMKYDDLLKIVQSWYNDLDVNDDRAVVEFIERN 2077 
YALI0C11407g      FFWRIRRRLVEEYLITKINSILPS---CTRLECLARIKSWKPATLDQGSDRGVAEWFDEN 2212 
                  ::**:**** *  :*.:::.   .     : : * :* .     ** ..**.*.*:::.* 
 
Sc_HFA1           SKKIDKNIEEFEISLLIDELKKKFE-DRRGNIVLEELTRLVDSKRKR 2123 
YALI0C11407g      SDAVSARLSELKKDASAQSFASQLRKDRQGTLQ-------------- 2245 
                  *. :. .:.*:: .   :.: .::. **:*.:                
 
 
 
Figure 9.10  Mitochondrial acetyl-coenzyme A carboxylase (HFA1) 
HFA1 catalyzes the production of malonyl-CoA in mitochondrial fatty acid biosynthesis. 
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Sc_HTD2           MKSKTWIFRDVLSSHRTKAFDSLLCRR------LPVSKATKHLQLGEHFLFFPP--SFEK 52 
YALI0A19096g      MLRQFIRSYSTASSSTASSIAALKARAPWRKLDYVSPTQSQMLKTSISHLFQQPEKQFQV 60 
                  *  :     .. **  :.:: :* .*          .. :: *: .  .**  *  .*:  
 
Sc_HTD2           LDRD------GYFNYQNPASLLG--------NPDLRYRRRIWGQG--ELVQYLPVTLDQE 96 
YALI0A19096g      GDAVPPGFHMAYFNPCDPEPTLASDGYSEQQAPGEPYVNRMWLGGSVEFHKGRQLSMGEQ 120 
                   *        .***  :* . *.         *.  * .*:*  *  *: :   :::.:: 
 
Sc_HTD2           YTCHESIKYVKKIR-DEHVVCIERTLLQERPENVSSPMDICLFERRVLMYTNSPAN---- 151 
YALI0A19096g      STCSESLVQVREPGSSTSGDKLLVTIQRDLRNDSAPAEEPAVTEKRTLIYMKAETGQKRG 180 
                   ** **:  *::   .     :  *: ::  :: :.. : .: *:*.*:* :: :.     
 
Sc_HTD2           KTAVKMPVGEENYKILKNFTVTDMDIVAYGQMSLNPHRIHWDKEYSRYVEGYDDIIMQGP 211 
YALI0A19096g      ATFEKIISPPDGATHSVSFVPSSTLLFRYSALTFNGHKIHYDPDYAREVESLPAVIVHGP 240 
                   *  *:    :. .   .*. :.  :. *. :::* *:**:* :*:* **.   :*::** 
 
Sc_HTD2           FSVQLLQKCIQPFLEQPIR-----QLRYRNLNYIYPNTTLSICQSLSSSSGMYTFQIRDL 266 
YALI0A19096g      LTVTLMLTWMNGVIQKDLPGKRIAAFEYKNVLPLFCNNELTLRCKPLMNSDGYKVWIENH 300 
                  ::* *: . :: .::: :       :.*:*:  :: *. *::  .   .*. *.. *.:  
 
Sc_HTD2           QKANLVYMKADVFC 280 
YALI0A19096g      HQSLCMNGTVKVE- 313 
                  :::  :  ...*   
Figure 9.11  Mitochondrial 3-hydroxyacyl-thioester dehydratase (HTD2) 
HTD2 is involved in the fatty acid biosynthesis and is required for respiratory growth and normal mitochondrial 
morphology 
 
Sc_MCT1           --MKLLTFPGQGTSISISILKAIIRNKSREFQTILSQNGKESNDLLQYIFQNPSSPGSIA 58 
YALI0E18590g      MSLRAAFFPGQGLQRPRMLQKLWQQSAIR--ETLKPALDQLKTEVQEVLLGNSS------ 52 
                    ::   ***** . .  : *   :.  * ::*: .  .: ..:: : :: *.*    :  
 
Sc_MCT1           VCSNLFYQLYQILSNPSDPQDQAPKNMTKIDSPDKKDNEQCYLLGHSLGELTCLSVNSLF 118 
YALI0E18590g      --LGEDEQMKLITQTQNAQPGILLSSYASFLANQGASKNYSHLLGHSLGEYSALVCGGYL 110 
                  :  .   *:  * .. .   .   .. :.: : :  .:: .:******** :.*  .. : 
 
Sc_MCT1           SLKDLFDIANFRNKLMVTSTEKYLVAHNINRSNKFEMWALSSPRATDLPQEVQKLLNSPN 178 
YALI0E18590g      TLEQGVQLVQKR--------GYYMQRANDESGKETAMVALLLHRTVDINRLVQACEG--- 159 
                  :*:: .::.: *  :::     *:   * : .::  * **   *:.*: : **   .    
 
Sc_MCT1           LLSSSQNTISVANANSVKQCVVTGLVDDLESLRTELNLRFPRLRITELTNPYNIPFHNST 238 
YALI0E18590g      -----WNGANVANINSSGQVVLSGERSAINELVAHLKASKLRVLKAIPLN-VSAPFH-SA 212 
                  ::    *  .*** **  * *::*  . ::.* :.*:    *:  :   *  . *** *: 
 
Sc_MCT1           VLRPVQEPLYDYIWDILKKNGTHTLMELNHPIIANLDGNISYYIHHALDRFVKCSSRTVQ 298 
YALI0E18590g      IMAPVVSELDAVCQQLKIR---PDFSADKPQVVSNASGKPFGSADEMYESMIGSPVHTVN 269 
                  :: ** . *     ::  :     :   :  :::* .*:     ..  : :: .. :**: 
 
Sc_MCT1           FTMCYDTINSGTPVEIDKSICFGPGNVIYNLIRRNCPQVDTIEYTSLATIDAYHKAAEEN 358 
YALI0E18590g      WLASVEYLKHVGVVESDG---YGPGCVDIGKMVLPGERYD-------------------- 306 
                  :  . : ::    ** *  : :*** *  . :     : * :    :  :           
 
Sc_MCT1           KD 360 
YALI0E18590g      -- 
 
Figure 9.12  Predicted malonyl-CoA:ACP transferase (MCT1) 
MCT1 is a putative component of a type-II mitochondrial fatty acid synthase, which produces intermediates for 
phospholipid remodelling. 
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OAR1 homologue YALI0F29975g 
 
Sc_OAR1           -MHYLPVAIVTGATRGIGKAICQKLFQKGLSCIILGSTKESIERTAIDRGQLQSGLSYQR 59 
YALI0F29975g      MSLRNTTALITGGSGGIGYRISKAFASAGARVIILSHKKEEIDTALFALPERLEGEKHHE 60 
                       ..*::**.: ***  *.: : . *   ***. .**.*: : :   :  .* .::. 
 
Sc_OAR1           QCAIAIDFKKWPHWLDYESYDGIEYFKDRPPLKQKYSTLFDPCNKWSNNERRYYVNLLIN 119 
YALI0F29975g      GIVHNVTSEQPPAGVDFSEVD-----------------------------------VLVN 85 
                    .  :  :: *  :*:.. *                                   :*:* 
 
Sc_OAR1           CAGLTQESLSVRTTASQIQDIMNVNFMSPVTMTNICIKYMMKSQRRWPELSGQS-ARPTI 178 
YALI0F29975g      CAGISLTGLLSTTSTKDIQNVVNVNLVGTMFMTKFAMEAWQKRYPERAASDRKAEGNGCI 145 
                  ***::  .*   *::.:**:::***::..: **::.::   *   . .  . :: ..  * 
 
Sc_OAR1           VNISSILHSGKMKVPGTSVYSASKAALSRFTEVLAAEMEPRNIRCFTISPGLVKGTDMIQ 238 
YALI0F29975g      INISSILG-LRAVSPGLSIYAATKTALIMFTKSMCVEGGRMAIRSNAICPGYVR-TEMTK 203 
                  :******   :   ** *:*:*:*:**  **: :..*     **. :*.** *: *:* : 
 
Sc_OAR1           NLPVEAKEMLERTIGASGTSAPAEIAEEVWSLYSRTALET------------ 278 
YALI0F29975g      AHELSFKTPLQ-EFGDTGDVSVESIANAAMYFATNPQVSGSILSVDKGICAN 254 
                     :. *  *:  :* :*  :  .**: .  : :.. :.              
 
 
OAR1 homologue YALI0C19965g 
 
Sc_OAR1           MHYLPVAIVTGATRGIGKAICQKLFQKGLSCIILGSTKESIERTAIDRGQLQSGLSYQRQ 60 
YALI0C19965g      MFLRPLQNSQRVINPLVRKYSISASSLSGKTALVTGGSGGIGLVIAKKLAANG----ARV 56 
                  *.  *:     . . : :  . .  . . .  :: . . .*  .  .:   :.     *  
 
Sc_OAR1           CAIAIDFKKWPHWLDYESYDGIEYFKDRPPLKQKYSTL-FDPCNKWSNNERRY-YVNLLI 118 
YALI0C19965g      ILLARDETKLNGALEELTHTLKDEQTQRDITQTAHSTISYDIAKATTPPEIDFKMVDLLV 116 
                    :* * .*    *:  ::   :  .:*   :  :**: :* .:  :  *  :  *:**: 
 
Sc_OAR1           NCAGLTQESLSVRTTASQIQDIMNVNFMSPVTMTNICIKYMMKSQRRWPELSGQSARPTI 178 
YALI0C19965g      NCAGVTQTSLLMTTKN--IDQIIGTNLAGAIKMSQYAMRPWMKRKSG-----------CI 163 
                  ****:** ** : *.   *::*:..*: ..:.*:: .::  ** :              * 
 
Sc_OAR1           VNISSILHSGKMKVPGTSVYSASKAALSRFTEVLAAEMEPRNIRCFTISPGLVKGTDMIQ 238 
YALI0C19965g      VNISSVLGLRGLTG-GSTVYSAAKAGLVGFTKALAVEVGARGIRVNCVCPGLVE-TEMTQ 221 
                  *****:*    :.  *::****:**.*  **:.**.*: .*.**   :.****: *:* * 
 
Sc_OAR1           NLPVEAKEMLERT-IGASGTSAPAEIAEEVWSLYSRTALET------------ 278 
YALI0C19965g      NVTVQNGFATPLQGMGKDNYVSADSVADAVLYLAASEEQTGSILTIDKGLSAV 274 
                  *:.*:         :* ..  :. .:*: *  * :                   
 
 
Figure 9.13  Mitochondrial 3-oxoacyl-[acyl-carrier-protein] reductase (OAR1) 
There are two homologues of OAR1, which are components of the type II mitochondrial fatty acid synthase of 
Y. lipolytica. 
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9.5  The mass spectrometric analysis of mitochondrial phospholipids  
 
Masses of phospholipids determined experimentally are indicated above the spectra in black, 
whereas the theoretical values in violet. Numbers in brackets separated by a colon indicate 
the number of carbon atoms in the acyl-chains (first number) and the number of carbon 
atoms involved in the double bond formation in unsaturated chains (second number).  
 
 
 
 
 
Figure 9.14  The MALDI-MS spectrum of cardiolipin identified in fraction 18 
Identification of cardiolipin species substituted with unsaturated acyl-chains containing from 1 to 4 double 
bonds [72:2-8].  
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Figure 9.15  The MALDI-MS spectrum of cardiolipin identified in fraction 19 
Identification of several cardiolipin species substituted with unsaturated acyl-chains.  
 
 
Figure 9.16  The MALDI-MS spectrum of phosphatidylethanolamine identified in 
  fraction 24 
Identification of several species of phosphatidylethanolamine substituted with unsaturated acyl-chains.      APPENDIX 
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Figure 9.17  The MALDI-MS spectrum of phosphatidylinositol identified in fraction 28 
Identification of several species of phosphatidylinositol substituted with unsaturated acyl-chains.  
 
 
 
Figure 9.18  The MALDI-MS spectrum of phosphatidic acid identified in fraction 30 
Identification of several species of phosphatidic acid substituted with unsaturated acyl-chains.  
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Figure 9.19  The MALDI-MS spectrum of lyso-phosphatidylcholine identified in 
  fraction 52 
Identification of several species of lyso-phosphatidylcholine (LPC) substituted with saturated and unsaturated 
acyl-chains  in  positive  mode.  The  peak  for  LPC  found  at  a  mass  of  496.35  indicates  substitution  with  a 
palmitoyl-chain  (16:0; theoretical  mass  496.34  Da),  wheareas at the  mass range  518.35  -  524.39 indicates 
substitution with different species of stearoyl-chains. Also a peak corresponding to the sodium salt of the stearic 
acid  at a  mass  of  544.37  was  found. This  same  peak  value  corresponds  to  the  detected  [20:4]  acyl-chain 
(theoretical mass 544.34 Da). 
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9.6  Chemical Structures 
9.6.1  Complex I Inhibitors 
9.6.1.1  Rotenone  
   
 
 
 
9.6.1.2  2-decyl-4-quinazolinyl amine 
(DQA) 
 
 
 
 
 
 
9.6.2  Fatty Acid Synthase Inhibitor 
9.6.2.1 Cerulenin 
 
 
 
 
9.6.3  Phospholipids 
R – hydrocarbon chain  
 
 
 
9.6.3.1 Cardiolipin (CL) 
 
 
9.6.3.2 Phosphatidylinositol (PI) 
  
 
 
 
 
 
9.6.3.3 Phosphatidylethanolamine (PE) 
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9.6.3.4  Phosphatidylcholine (PC), 
lecithine 
 
9.6.4  Cofactors 
9.6.4.1 Adenosine-triphosphate (ATP) 
 
 
 
 
9.6.4.2 Flavin-adenine-dinucleotide 
(FAD) 
 
 
 
 
9.6.4.3 Flavin-mononucleotide (FMN) 
 
 
 
9.6.4.4 -Lipoic acid (LA) 
 
 
9.6.4.5 Nicotinamide-adenine-
dinucleotide (NADH) 
 
 
9.6.4.6 Phosphopantetheine 
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9.6.4.7 n-decylubiquinone (DBQ) 
 
 
 
9.6.4.8 Ubiquinone 
 
 
9.6.5  Other Structures 
 
9.6.5.1  Myristic Acid 
 
 
 
 
 
 
9.6.5.2  Phenylmethylsulfonyl Flouride 
(PMSF) 
 
 
 
 
 
 
 
9.6.5.3  Sodium-dodecylsulfate (SDS) 
 
 
 
9.6.5.4  Tetramethylethylenediamine 
(TEMED) 
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10 ABBREVIATIONS 
 
 
(mt)DNA  (mitochondrial) deoxy ribonucleic acid 
2D BN/SDS 
PAGE 
two dimensional blue native/sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
ACC. No.  accession number 
ACP        acyl carrier protein 
ACPM     mitochondrial acyl carrier protein 
AT  acyl transferase 
ATP  adenosine triphosphate 
ADP  adenosine diphosphate 
BN-PAGE  blue-native polyacrylamide gel electrophoresis 
bp  base pair 
BSA  bovine serum albumin 
CoA  coenzyme A 
DBQ  n-decylubiquinone 
DH  dehydratase 
dNADH  deamino-nicotinamide-adenine-dinucleotide (reduced form) 
DQA  2-decyl-4-quinazolinyl amine 
dSDS-PAGE  doubled sodium dodecylsulfate-polyacrylamide gel electrophoresis 
EPR  electron paramagnetic resonance 
ER  enoylreductase 
ESI-MS  electrospray ionization mass spectrometry 
ETC  electron transport chain 
FAD  flavin adenine dinucleotide 
FADH2  flavin adenine dinucleotide (reduced form)  
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FAS      fatty acid synthase 
FeS  iron-sulphur cluster 
FMN  flavin mononucleotide 
FP  flavo-protein 
HAR  hexa-ammine-ruthenium(III)-chloride 
HP  hydrophobic protein 
IMM  inner mitochondrial membrane 
IP  iron-protein 
kb  kilobase 
KGDH  -ketoglutarate dehydrogenase  
KR  β -ketoreductase 
KS  β-ketosynthase 
LHON     Leber's hereditary optic neuropathy 
MALDI-TOF-
MS  matrix-assisted laser desorption/ionization-time of flight mass spectrometry 
MAT  malonyl-coA-/acetyl-coA-ACP transacylase 
MPT  malonyl/palmitoyl transferase  
MST      3-mercaptopyruvate sulfurtransferase 
NAD
+  nicotinamide-adenine-dinucleotide (oxidised form) 
NADH  nicotinamide-adenine-dinucleotide (reduced form)  
NDH-2(i)  external alternative NADH Dehydrogenase (internal) 
ORF      open reading frame 
OXPHOS  oxidative phosphorylation 
PCR  polymerase chain reaction 
PDH  pyruvate dehydrogenase  
PMSF  phenylmethylsulfonyl flouride ABBREVIATIONS 
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PP  pantetheine-4´-phosphate  
PT  phosphopantetheine transferase 
Q  ubiquinone 
Q1  quinone with 1 isoprenyl side chain 
QH2  ubihydroquionone (Ubiquinol) 
ROS  reactive oxygen species 
RP-HPLC  reversed-phase high performance liquid chromatography 
SDS  dodecylsulfate Na-salt 
STMD  single transmembrane domain 
TE  thioesterase 
TMD  transmembrane domain 
TST      thiosulfate sulfurtransferase 
VD      ATP-ase synthase dimer LIST OF FIGURES 
 
  177 
11 LIST OF FIGURES 
 
Figure 1.1  Schematic representation of the mitochondrial electron transfer chain ....................... 2 
Figure 1.2  Supramolecular molecular structures of the respiratory chain complexes .................. 3 
Figure 1.3  Schematic representation of a binuclear and a tetranuclear iron-sulfur cluster ......... 5 
Figure 1.4 Structure of the hydrophilic domain of complex I from T. thermophilus and electron 
microscopic reconstruction of Y. lipolytica enzyme ........................................................................... 6 
Figure 1.5 Subcomplexes and subunits of bovine heart complex I ................................................... 8 
Figure 1.6  dSDS-PAGE of purified complex I from Y. lipolytica  ................................................... 12 
Figure 1.7  The acyl carrier protein structure  .................................................................................. 15 
Figure 1.8  Structural formula for the pantetheine-4´-phosphate-ACP.......................................... 16 
Figure 1.9  Reaction sequence in fatty acid synthesis  ...................................................................... 17 
Figure 1.10  Structure of type I fatty acid synthase complexes ....................................................... 18 
Figure 1.11  Superimposed NMR structures of ACP from Mycobacterium tuberculosis .............. 19 
Figure 1.12  Structures of the mitochondrial acyl carrier proteins ................................................ 20 
Figure 1.13  Reaction sequence of lipoic acid synthesis in mitochondria ...................................... 21 
Figure 1.14  Scheme representing the sulfur-transfer reaction catalyzed by rhodanese .............. 24 
Figure 1.15 Overall structure of A. vinelandii rhodanese ............................................................... 25 
Figure 2.1  Maps of plasmids ............................................................................................................ 34 
Figure 3.1  Generation of ACPM deletion constructs...................................................................... 58 
Figure 3.2  Deletion strategy for ACPMs ......................................................................................... 59 
Figure 3.3 The PCR test for the deletion of ACPM genes ............................................................... 60 
Figure 3.4 Plasmid pUB4 containing mutated versions of ACPMs ................................................ 61 
Figure 3.5 Sections of DNA sequence pherogramms from ACPM point mutants  .......................... 62 
Figure 3.6  PCR test for presence of ACPM2-S88A gene................................................................ 63 
Figure 3.7 Test digest of pUB4 plasmid containing tagged versions of ACPMs ........................... 64 
Figure 3.8 Sections of DNA sequence pherogramms from ACPM tagged versions ...................... 64 
Figure 3.9  2D-BN/SDS PAGE analysis of Y. lipolytica mitochondrial membranes ..................... 67 
Figure 3.10 Complex I subcomplexes in acpm2 and the acpm2,pACPM2-S88A strains ......... 69 
Figure 3.11  Thin layer chromatography (TLC) of lipids extracted from intact mitochondria .... 70 
Figure 3.12 HPLC profiles of phospholipids extracted from Y. lipolytica mitochondria.............. 71  
 
 
178 
Figure 3.13 The phospholipid composition of purified intact mitochondria .................................. 73 
Figure 3.14 The phospholipid to protein ratio in intact mitochondria ........................................... 74 
Figure 3.15 The MALDI-MS spectrum of lyso-phosphatidyl-ethanolamine identified in fr. 28 ... 75 
Figure 3.16  Mass Spectra of ACPM subunits ........................................................................... 77 
Figure 3.17  Analysis of tagged versions of ACPMs in dSDS-PAGE ............................................. 78 
Figure 3.18 Localization of tagged versions of ACPM in mitochondrial fractions ....................... 79 
Figure 3.19 Gel filtration purified complex I contains rhodanese-like protein ............................. 81 
Figure 3.20 MALDI-TOF mass spectrum of in-gel digested 34.6 kDa protein of Y. lipolytica 
complex I  .............................................................................................................................................. 82 
Figure 3.21  Steps of st1 strain generation .................................................................................... 84 
Figure 3.22  Test digest for the number of hygromycin B inserts ................................................... 85 
Figure 3.23  Strategy for generation of the st1 strain ................................................................... 86 
Figure 3.24 PCR test for deletion of the st1 gene ............................................................................ 87 
Figure 3.25 Test digest of the pUB4 plasmid containing the st1-strepII insert.............................. 88 
Figure 3.26 Section of DNA sequence pherogramm from the st1-strepII strain  ............................ 88 
Figure 3.27  Growth curves of the st1strain of Y. lipolytica ........................................................ 90 
Figure 3.28 BN-PAGE of mitochondrial membranes from st1 strain .......................................... 91 
Figure 3.29 St1 subunit dissociates from complex I in BN-PAGE .................................................. 92 
Figure 3.30  EPR spectra of complex I from the parental and the deletion strains  ....................... 93 
Figure 4.1  Sequence alignment of ACPM1 and ACPM2 from Y. lipolytica .................................. 95 
Figure 4.2  Predicted structures of ACPMs from Y. lipolytica........................................................ 97 
Figure 4.3 Hydropathy plots of ACPM subunits .............................................................................. 98 
Figure 4.4 Deletion of the NUJM complex I subunit leads to formation of subcomplexes ......... 100 
Figure 4.5  Doubled SDS-PAGE of complex I isolated from 39kDa subunit mutant strains ...... 103 
Figure 4.6 Sequence comparison of the st1 active-site loop with typical TST and MST loops ... 103 
Figure 4.7  Predicted structure of the st1 sulfurtransferase from Y. lipolytica  ............................ 105 
Figure 4.8 Hydropathy plots of st1 and ND6 subunits................................................................... 106 
Figure 9.1 The fragment of st1 gene encoding rhodanese  ............................................................. 141 
Figure 9.2 The ACPM1 gene used for generating the mutants ..................................................... 143 
Figure 9.3 The ACPM2 gene used for generating the mutants ..................................................... 145 LIST OF FIGURES 
 
  179 
Figure 9.4  Alignment of ACPM1 and ACPM2 subunits with acyl carrier proteins from other 
species ................................................................................................................................................ 153 
Figure 9.5  Alignment of Y. lipolytica ACPM1 and ACPM2 subunits .......................................... 154 
Figure 9.6  Alignment of the st1 subunit with tandem rhodanese domain repeat enzymes from 
other organisms ................................................................................................................................. 157 
Figure 9.7 The cladogram of tandem rhodanese domain repeat enzymes aligned in 9.4.3 ........ 158 
Figure 9.8 Mitochondrial beta-keto-acyl synthase (CEM1) .......................................................... 159 
Figure 9.9  2-enoyl thioester reductase (ETR1) ............................................................................. 160 
Figure 9.10  Mitochondrial acetyl-coenzyme A carboxylase (HFA1) .......................................... 162 
Figure 9.11  Mitochondrial 3-hydroxyacyl-thioester dehydratase (HTD2) ................................. 163 
Figure 9.12  Predicted malonyl-CoA:ACP transferase (MCT1) ................................................... 163 
Figure 9.13  Mitochondrial 3-oxoacyl-[acyl-carrier-protein] reductase (OAR1) ....................... 164 
Figure 9.14  The MALDI-MS spectrum of cardiolipin identified in fraction 18 .......................... 165 
Figure 9.15  The MALDI-MS spectrum of cardiolipin identified in fraction 19 .......................... 166 
Figure 9.16  The MALDI-MS spectrum of phosphatidylethanolamine identified in fraction 24. 166 
Figure 9.17  The MALDI-MS spectrum of phosphatidylinositol identified in fraction 28  ........... 167 
Figure 9.18  The MALDI-MS spectrum of phosphatidic acid identified in fraction 30 ............... 167 
Figure 9.19  The MALDI-MS spectrum of lyso-phosphatidylcholine identified in fraction 52 ... 168                               LIST OF TABLES             
      
  181 
12 LIST OF TABLES 
 
 
Table 1.1. Similarity and identity scores for pairwise comparisons between Y. lipolytica ACPM1 
or ACPM2 and ACP from other organisms ...................................................................................... 15 
Table 3.1  Catalytic activities of mitochondrial membranes and complex I  ................................... 66 
Table 3.2 Tryptic peptides of the 34.6 kDa protein identified by MALDI-TOF MS ....................... 82 
Table 3.3.  Similarity and identity scores for pairwise comparisons between Y. lipolytica 
sulfurtransferase and tandem rhodanese domain repeat enzymes from other organisms ............. 83 
Table 3.4   Activities of mitochondrial membranes and purified complex I from Y. lipolytica ..... 92 
Table 9.1 Oligonucleotides for generation of the st1 deletion strain ............................................ 146 
Table 9.2 Oligonucleotides for checking of the deletion via PCR ................................................. 146 
Table 9.3 Oligonucleotides for creating the strepII-tagged version of st1 gene .......................... 146 
Table 9.4 Oligonucleotides for sequencing of the st1 gene............................................................ 146 
Table 9.5 Oligonucleotides for generation of the ACPM1 deletion strain ................................... 147 
Table 9.6 Oligonucleotides for checking of the deletion via PCR ................................................. 147 
Table 9.7 Oligonucleotides for creating the strepII-tagged version of ACPM1 gene  .................. 147 
Table 9.8 Oligonucleotides for sequencing of the ACPM1 gene ................................................... 147 
Table 9.9 Oligonucleotides for mutating the phosphopantetheine-binding serine (S66A) .......... 147 
Table 9.10 Oligonucleotides for generation of the ACPM2 deletion strain ................................. 148 
Table 9.11 Oligonucleotides for checking of the deletion via PCR ............................................... 148 
Table 9.12 Oligonucleotides for creating the flag-tagged version of ACPM2 gene .................... 148 
Table 9.13 Oligonucleotides for sequencing of the ACPM2 gene ................................................. 148 
Table 9.14 Oligonucleotides for mutating the phosphopantetheine-binding serine (S88A) ........ 148 
Table 9.15 Oligonucleotides for swap strategy of ACPM1 gene ................................................... 149 
Table 9.16 Oligonucleotides for swap strategy of ACPM2 gene ................................................... 149 
Table 9.17 Oligonucleotides for URA3 gene .................................................................................. 149 
Table 9.18  Central and accessory subunits of Yarrowia lipolytica complex I ............................ 152  
  183 
13 CURRICULUM VITAE 
 
 
Personal Details 
 
Name:      DOBRYNIN, Krzysztof   
Address:    Schlossstr. 62,  D-60486 Frankfurt am Main 
Tel.:      + 49 172 14 75 676     
E-mail:     krisdobrynin@gmail.com 
Birth:      05.08.1981, Lodz, Poland 
Nationality:    Polish 
Gender:    Male 
Family Status:   Single 
Education 
01/2005 – 06/2010  Ph. D. Thesis  
      Prof. Ulrich Brandt, Molecular Bioenergetics  
Biochemistry, Chemistry and Pharmacy Department 
      Goethe University, Frankfurt am Main, Germany 
      Focus: Accessory subunits of complex I from aerobic yeast Y. lipolytica  
07/2004 – 12/2004         IAESTE Laboratory Internship 
Prof. Robert Tampe, Institute of Cellular Biochemistry,  
Biocenter Frankfurt, Germany  
Focus: Characterization of ATP-binding cassette transporter proteins 
02/2004 – 06/2004  Master Thesis Project  
Dr. Thierry Chardot,  
Institute National Agronomique Paris-Grignon, France 
 Focus: Oleosins, new emulsifiers from plants  
10/1999 – 06/2004        Technical University of Lodz, Poland 
Prof. Stanislaw Bielecki, International Faculty of Engineering, 
      Molecular Biotechnology and Technical Biochemistry Department 
      Master of Science  
02/2002 – 02/2003  University of Applied Life Sciences, Vienna, Austria 
      Erasmus Scholarship 
08/1998 – 06/1999   High School Pottsville, AR, USA 
      Secondary School Certificate  
09/1996 – 06/1998  High School XXIX, Lodz, Poland 
 
 
Frankfurt am Main, 08.07.2010 